UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number 811-03010
Fidelity Advisor Series VII
(Exact name of registrant as specified in charter)
245 Summer St., Boston, MA 02210
(Address of principal executive offices) (Zip code)
Nicole Macarchuk, Secretary
245 Summer St.
Boston, Massachusetts 02210
(Name and address of agent for service)
Registrant's telephone number, including area code:
617-563-7000
Date of fiscal year end: | July 31 |
Date of reporting period: | January 31, 2025 |
Item 1.
Reports to Stockholders
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class A
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Broadline Retail
|
||
Specialty Retail
|
||
Hotels, Restaurants & Leisure
|
||
Automobiles
|
||
Textiles, Apparel & Luxury Goods
|
||
Household Durables
|
||
Automobile Components
|
||
Building Products
|
||
Consumer Staples Distribution & Retail
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.4
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 0.6
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 94.6
|
|
Bailiwick Of Jersey - 1.9
|
|
Canada - 1.8
|
|
Brazil - 0.8
|
|
United Kingdom - 0.3
|
|
Switzerland - 0.3
|
|
France - 0.3
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Amazon.com Inc
|
||
Tesla Inc
|
||
Home Depot Inc/The
|
||
Lowe's Cos Inc
|
||
TJX Cos Inc/The
|
||
Hilton Worldwide Holdings Inc
|
||
McDonald's Corp
|
||
Dick's Sporting Goods Inc
|
||
Booking Holdings Inc
|
||
Tempur Sealy International Inc
|
||
63.3
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915203.100 185-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class M
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Aerospace & Defense
|
||
Machinery
|
||
Electrical Equipment
|
||
Ground Transportation
|
||
Building Products
|
||
Trading Companies & Distributors
|
||
Construction & Engineering
|
||
Commercial Services & Supplies
|
||
Professional Services
|
||
Others
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 1.0
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 100.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
GE Aerospace
|
||
GE Vernova Inc
|
||
Howmet Aerospace Inc
|
||
Parker-Hannifin Corp
|
||
Boeing Co
|
||
Ingersoll Rand Inc
|
||
Trane Technologies PLC
|
||
Union Pacific Corp
|
||
TransDigm Group Inc
|
||
Eaton Corp PLC
|
||
43.7
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915199.100 194-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class I
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Health Care Equipment & Supplies
|
||
Biotechnology
|
||
Health Care Providers & Services
|
||
Pharmaceuticals
|
||
Life Sciences Tools & Services
|
||
Health Care Technology
|
||
Financial Services
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 97.8
|
|
Preferred Stocks - 2.0
|
|
Preferred Securities - 0.2
|
|
Bonds - 0.1
|
|
Short-Term Investments and Net Other Assets (Liabilities) - (0.1)%
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 91.5
|
|
Netherlands - 3.4
|
|
Belgium - 1.9
|
|
Denmark - 1.4
|
|
Canada - 0.9
|
|
United Kingdom - 0.3
|
|
China - 0.2
|
|
Germany - 0.2
|
|
Israel - 0.2
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
UnitedHealth Group Inc
|
||
Boston Scientific Corp
|
||
Eli Lilly & Co
|
||
Penumbra Inc
|
||
Danaher Corp
|
||
Masimo Corp
|
||
Insulet Corp
|
||
Stryker Corp
|
||
Argenx SE ADR
|
||
Thermo Fisher Scientific Inc
|
||
52.4
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915190.100 271-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class I
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Biotechnology
|
||
Pharmaceuticals
|
||
Health Care Technology
|
||
Financial Services
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 96.7
|
|
Preferred Stocks - 2.0
|
|
Bonds - 0.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 1.3
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 87.4
|
|
Netherlands - 6.0
|
|
Denmark - 3.7
|
|
Canada - 1.9
|
|
Belgium - 0.7
|
|
China - 0.2
|
|
United Kingdom - 0.1
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
AbbVie Inc
|
||
Regeneron Pharmaceuticals Inc
|
||
Amgen Inc
|
||
Alnylam Pharmaceuticals Inc
|
||
Argenx SE ADR
|
||
Vertex Pharmaceuticals Inc
|
||
Ascendis Pharma A/S ADR
|
||
Vaxcyte Inc
|
||
Gilead Sciences Inc
|
||
Viridian Therapeutics Inc
|
||
61.1
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915228.100 116-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class I
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Electric Utilities
|
||
Multi-Utilities
|
||
Independent Power and Renewable Electricity Producers
|
||
Gas Utilities
|
||
Electrical Equipment
|
||
Semiconductors & Semiconductor Equipment
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 93.9
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 6.1
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 100.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
NextEra Energy Inc
|
||
Duke Energy Corp
|
||
Constellation Energy Corp
|
||
Vistra Corp
|
||
Sempra
|
||
Exelon Corp
|
||
Entergy Corp
|
||
Ameren Corp
|
||
CenterPoint Energy Inc
|
||
Xcel Energy Inc
|
||
56.8
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915210.100 206-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class I
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Semiconductors & Semiconductor Equipment
|
||
Technology Hardware, Storage & Peripherals
|
||
Software
|
||
Electronic Equipment, Instruments & Components
|
||
Financial Services
|
||
Metals & Mining
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 94.9
|
|
Preferred Stocks - 0.4
|
|
Preferred Securities - 0.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 4.7
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 80.7
|
|
Taiwan - 8.2
|
|
China - 4.9
|
|
Netherlands - 3.1
|
|
Israel - 2.0
|
|
Japan - 1.1
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
NVIDIA Corp
|
||
Broadcom Inc
|
||
Marvell Technology Inc
|
||
Taiwan Semiconductor Manufacturing Co Ltd ADR
|
||
Monolithic Power Systems Inc
|
||
Lam Research Corp
|
||
NXP Semiconductors NV
|
||
Micron Technology Inc
|
||
GlobalFoundries Inc
|
||
ON Semiconductor Corp
|
||
76.7
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915243.100 121-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class A
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Specialized REITs
|
||
Residential REITs
|
||
Industrial REITs
|
||
Retail REITs
|
||
Real Estate Management & Development
|
||
Health Care REITs
|
||
Office REITs
|
||
Hotel & Resort REITs
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.9
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 0.1
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 100.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Equinix Inc
|
||
Prologis Inc
|
||
American Tower Corp
|
||
CBRE Group Inc Class A
|
||
Ventas Inc
|
||
Welltower Inc
|
||
Public Storage Operating Co
|
||
Crown Castle Inc
|
||
Sun Communities Inc
|
||
CubeSmart
|
||
57.5
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915247.100 1128-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class C
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Oil, Gas & Consumable Fuels
|
||
Energy Equipment & Services
|
||
Independent Power and Renewable Electricity Producers
|
||
Machinery
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 102.8
|
|
Short-Term Investments and Net Other Assets (Liabilities) - (2.8)%
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 84.5
|
|
Canada - 12.0
|
|
United Kingdom - 3.2
|
|
Norway - 0.2
|
|
France - 0.1
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Exxon Mobil Corp
|
||
Cheniere Energy Inc
|
||
Chevron Corp
|
||
Energy Transfer LP
|
||
Cenovus Energy Inc
|
||
Schlumberger NV
|
||
Canadian Natural Resources Ltd
|
||
Marathon Petroleum Corp
|
||
Valero Energy Corp
|
||
Occidental Petroleum Corp
|
||
66.6
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915221.100 528-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class Z
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Health Care Equipment & Supplies
|
||
Biotechnology
|
||
Health Care Providers & Services
|
||
Pharmaceuticals
|
||
Life Sciences Tools & Services
|
||
Health Care Technology
|
||
Financial Services
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 97.8
|
|
Preferred Stocks - 2.0
|
|
Preferred Securities - 0.2
|
|
Bonds - 0.1
|
|
Short-Term Investments and Net Other Assets (Liabilities) - (0.1)%
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 91.5
|
|
Netherlands - 3.4
|
|
Belgium - 1.9
|
|
Denmark - 1.4
|
|
Canada - 0.9
|
|
United Kingdom - 0.3
|
|
China - 0.2
|
|
Germany - 0.2
|
|
Israel - 0.2
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
UnitedHealth Group Inc
|
||
Boston Scientific Corp
|
||
Eli Lilly & Co
|
||
Penumbra Inc
|
||
Danaher Corp
|
||
Masimo Corp
|
||
Insulet Corp
|
||
Stryker Corp
|
||
Argenx SE ADR
|
||
Thermo Fisher Scientific Inc
|
||
52.4
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915192.100 3294-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class M
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Broadline Retail
|
||
Specialty Retail
|
||
Hotels, Restaurants & Leisure
|
||
Automobiles
|
||
Textiles, Apparel & Luxury Goods
|
||
Household Durables
|
||
Automobile Components
|
||
Building Products
|
||
Consumer Staples Distribution & Retail
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.4
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 0.6
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 94.6
|
|
Bailiwick Of Jersey - 1.9
|
|
Canada - 1.8
|
|
Brazil - 0.8
|
|
United Kingdom - 0.3
|
|
Switzerland - 0.3
|
|
France - 0.3
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Amazon.com Inc
|
||
Tesla Inc
|
||
Home Depot Inc/The
|
||
Lowe's Cos Inc
|
||
TJX Cos Inc/The
|
||
Hilton Worldwide Holdings Inc
|
||
McDonald's Corp
|
||
Dick's Sporting Goods Inc
|
||
Booking Holdings Inc
|
||
Tempur Sealy International Inc
|
||
63.3
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915204.100 195-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class Z
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Banks
|
||
Capital Markets
|
||
Financial Services
|
||
Insurance
|
||
Consumer Finance
|
||
Professional Services
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.6
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 0.4
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 94.4
|
|
United Kingdom - 3.1
|
|
Puerto Rico - 1.6
|
|
Grand Cayman (UK Overseas Ter) - 0.5
|
|
Mexico - 0.4
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Mastercard Inc Class A
|
||
Wells Fargo & Co
|
||
Bank of America Corp
|
||
Citigroup Inc
|
||
Reinsurance Group of America Inc
|
||
Chubb Ltd
|
||
Morgan Stanley
|
||
Visa Inc Class A
|
||
Apollo Global Management Inc
|
||
Discover Financial Services
|
||
39.4
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915197.100 3293-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class Z
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Semiconductors & Semiconductor Equipment
|
||
Software
|
||
Technology Hardware, Storage & Peripherals
|
||
IT Services
|
||
Communications Equipment
|
||
Broadline Retail
|
||
Ground Transportation
|
||
Electronic Equipment, Instruments & Components
|
||
Entertainment
|
||
Others
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 95.4
|
|
Preferred Stocks - 1.6
|
|
Preferred Securities - 0.0
|
|
Bonds - 0.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 3.0
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 91.1
|
|
China - 3.4
|
|
Canada - 2.3
|
|
Taiwan - 2.1
|
|
Netherlands - 0.9
|
|
India - 0.2
|
|
Israel - 0.0
|
|
Korea (South) - 0.0
|
|
United Kingdom - 0.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
NVIDIA Corp
|
||
Apple Inc
|
||
Microsoft Corp
|
||
Marvell Technology Inc
|
||
Servicenow Inc
|
||
Cisco Systems Inc
|
||
NXP Semiconductors NV
|
||
ON Semiconductor Corp
|
||
Okta Inc Class A
|
||
Salesforce Inc
|
||
69.0
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915216.100 3297-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class A
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Health Care Equipment & Supplies
|
||
Biotechnology
|
||
Health Care Providers & Services
|
||
Pharmaceuticals
|
||
Life Sciences Tools & Services
|
||
Health Care Technology
|
||
Financial Services
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 97.8
|
|
Preferred Stocks - 2.0
|
|
Preferred Securities - 0.2
|
|
Bonds - 0.1
|
|
Short-Term Investments and Net Other Assets (Liabilities) - (0.1)%
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 91.5
|
|
Netherlands - 3.4
|
|
Belgium - 1.9
|
|
Denmark - 1.4
|
|
Canada - 0.9
|
|
United Kingdom - 0.3
|
|
China - 0.2
|
|
Germany - 0.2
|
|
Israel - 0.2
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
UnitedHealth Group Inc
|
||
Boston Scientific Corp
|
||
Eli Lilly & Co
|
||
Penumbra Inc
|
||
Danaher Corp
|
||
Masimo Corp
|
||
Insulet Corp
|
||
Stryker Corp
|
||
Argenx SE ADR
|
||
Thermo Fisher Scientific Inc
|
||
52.4
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915188.100 177-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class C
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Banks
|
||
Capital Markets
|
||
Financial Services
|
||
Insurance
|
||
Consumer Finance
|
||
Professional Services
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.6
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 0.4
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 94.4
|
|
United Kingdom - 3.1
|
|
Puerto Rico - 1.6
|
|
Grand Cayman (UK Overseas Ter) - 0.5
|
|
Mexico - 0.4
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Mastercard Inc Class A
|
||
Wells Fargo & Co
|
||
Bank of America Corp
|
||
Citigroup Inc
|
||
Reinsurance Group of America Inc
|
||
Chubb Ltd
|
||
Morgan Stanley
|
||
Visa Inc Class A
|
||
Apollo Global Management Inc
|
||
Discover Financial Services
|
||
39.4
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915196.100 284-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class I
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Aerospace & Defense
|
||
Machinery
|
||
Electrical Equipment
|
||
Ground Transportation
|
||
Building Products
|
||
Trading Companies & Distributors
|
||
Construction & Engineering
|
||
Commercial Services & Supplies
|
||
Professional Services
|
||
Others
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 1.0
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 100.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
GE Aerospace
|
||
GE Vernova Inc
|
||
Howmet Aerospace Inc
|
||
Parker-Hannifin Corp
|
||
Boeing Co
|
||
Ingersoll Rand Inc
|
||
Trane Technologies PLC
|
||
Union Pacific Corp
|
||
TransDigm Group Inc
|
||
Eaton Corp PLC
|
||
43.7
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915200.100 204-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class C
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Biotechnology
|
||
Pharmaceuticals
|
||
Health Care Technology
|
||
Financial Services
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 96.7
|
|
Preferred Stocks - 2.0
|
|
Bonds - 0.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 1.3
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 87.4
|
|
Netherlands - 6.0
|
|
Denmark - 3.7
|
|
Canada - 1.9
|
|
Belgium - 0.7
|
|
China - 0.2
|
|
United Kingdom - 0.1
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
AbbVie Inc
|
||
Regeneron Pharmaceuticals Inc
|
||
Amgen Inc
|
||
Alnylam Pharmaceuticals Inc
|
||
Argenx SE ADR
|
||
Vertex Pharmaceuticals Inc
|
||
Ascendis Pharma A/S ADR
|
||
Vaxcyte Inc
|
||
Gilead Sciences Inc
|
||
Viridian Therapeutics Inc
|
||
61.1
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915226.100 114-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class I
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Specialized REITs
|
||
Residential REITs
|
||
Industrial REITs
|
||
Retail REITs
|
||
Real Estate Management & Development
|
||
Health Care REITs
|
||
Office REITs
|
||
Hotel & Resort REITs
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.9
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 0.1
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 100.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Equinix Inc
|
||
Prologis Inc
|
||
American Tower Corp
|
||
CBRE Group Inc Class A
|
||
Ventas Inc
|
||
Welltower Inc
|
||
Public Storage Operating Co
|
||
Crown Castle Inc
|
||
Sun Communities Inc
|
||
CubeSmart
|
||
57.5
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915250.100 1132-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class Z
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Semiconductors & Semiconductor Equipment
|
||
Technology Hardware, Storage & Peripherals
|
||
Software
|
||
Electronic Equipment, Instruments & Components
|
||
Financial Services
|
||
Metals & Mining
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 94.9
|
|
Preferred Stocks - 0.4
|
|
Preferred Securities - 0.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 4.7
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 80.7
|
|
Taiwan - 8.2
|
|
China - 4.9
|
|
Netherlands - 3.1
|
|
Israel - 2.0
|
|
Japan - 1.1
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
NVIDIA Corp
|
||
Broadcom Inc
|
||
Marvell Technology Inc
|
||
Taiwan Semiconductor Manufacturing Co Ltd ADR
|
||
Monolithic Power Systems Inc
|
||
Lam Research Corp
|
||
NXP Semiconductors NV
|
||
Micron Technology Inc
|
||
GlobalFoundries Inc
|
||
ON Semiconductor Corp
|
||
76.7
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915246.100 3296-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class M
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Electric Utilities
|
||
Multi-Utilities
|
||
Independent Power and Renewable Electricity Producers
|
||
Gas Utilities
|
||
Electrical Equipment
|
||
Semiconductors & Semiconductor Equipment
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 93.9
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 6.1
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 100.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
NextEra Energy Inc
|
||
Duke Energy Corp
|
||
Constellation Energy Corp
|
||
Vistra Corp
|
||
Sempra
|
||
Exelon Corp
|
||
Entergy Corp
|
||
Ameren Corp
|
||
CenterPoint Energy Inc
|
||
Xcel Energy Inc
|
||
56.8
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915209.100 196-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class M
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Oil, Gas & Consumable Fuels
|
||
Energy Equipment & Services
|
||
Independent Power and Renewable Electricity Producers
|
||
Machinery
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 102.8
|
|
Short-Term Investments and Net Other Assets (Liabilities) - (2.8)%
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 84.5
|
|
Canada - 12.0
|
|
United Kingdom - 3.2
|
|
Norway - 0.2
|
|
France - 0.1
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Exxon Mobil Corp
|
||
Cheniere Energy Inc
|
||
Chevron Corp
|
||
Energy Transfer LP
|
||
Cenovus Energy Inc
|
||
Schlumberger NV
|
||
Canadian Natural Resources Ltd
|
||
Marathon Petroleum Corp
|
||
Valero Energy Corp
|
||
Occidental Petroleum Corp
|
||
66.6
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915218.100 226-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class A
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Oil, Gas & Consumable Fuels
|
||
Energy Equipment & Services
|
||
Independent Power and Renewable Electricity Producers
|
||
Machinery
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 102.8
|
|
Short-Term Investments and Net Other Assets (Liabilities) - (2.8)%
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 84.5
|
|
Canada - 12.0
|
|
United Kingdom - 3.2
|
|
Norway - 0.2
|
|
France - 0.1
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Exxon Mobil Corp
|
||
Cheniere Energy Inc
|
||
Chevron Corp
|
||
Energy Transfer LP
|
||
Cenovus Energy Inc
|
||
Schlumberger NV
|
||
Canadian Natural Resources Ltd
|
||
Marathon Petroleum Corp
|
||
Valero Energy Corp
|
||
Occidental Petroleum Corp
|
||
66.6
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915219.100 247-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class M
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Residential REITs
|
||
Retail REITs
|
||
Specialized REITs
|
||
Industrial REITs
|
||
Real Estate Management & Development
|
||
Health Care REITs
|
||
Diversified REITs
|
||
Office REITs
|
||
Hotel & Resort REITs
|
||
Others
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 100.1
|
|
Short-Term Investments and Net Other Assets (Liabilities) - (0.1)%
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 63.4
|
|
Japan - 8.6
|
|
United Kingdom - 7.7
|
|
Australia - 5.7
|
|
Canada - 2.8
|
|
Singapore - 2.8
|
|
France - 2.1
|
|
Sweden - 1.9
|
|
Germany - 1.5
|
|
Others - 3.5
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Prologis Inc
|
||
Equinix Inc
|
||
Welltower Inc
|
||
Ventas Inc
|
||
Public Storage Operating Co
|
||
Kimco Realty Corp
|
||
Digital Realty Trust Inc
|
||
UDR Inc
|
||
Equity Residential
|
||
NNN REIT Inc
|
||
41.7
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915337.100 2851-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class A
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Electric Utilities
|
||
Multi-Utilities
|
||
Independent Power and Renewable Electricity Producers
|
||
Gas Utilities
|
||
Electrical Equipment
|
||
Semiconductors & Semiconductor Equipment
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 93.9
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 6.1
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 100.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
NextEra Energy Inc
|
||
Duke Energy Corp
|
||
Constellation Energy Corp
|
||
Vistra Corp
|
||
Sempra
|
||
Exelon Corp
|
||
Entergy Corp
|
||
Ameren Corp
|
||
CenterPoint Energy Inc
|
||
Xcel Energy Inc
|
||
56.8
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915208.100 186-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class I
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Broadline Retail
|
||
Specialty Retail
|
||
Hotels, Restaurants & Leisure
|
||
Automobiles
|
||
Textiles, Apparel & Luxury Goods
|
||
Household Durables
|
||
Automobile Components
|
||
Building Products
|
||
Consumer Staples Distribution & Retail
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.4
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 0.6
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 94.6
|
|
Bailiwick Of Jersey - 1.9
|
|
Canada - 1.8
|
|
Brazil - 0.8
|
|
United Kingdom - 0.3
|
|
Switzerland - 0.3
|
|
France - 0.3
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Amazon.com Inc
|
||
Tesla Inc
|
||
Home Depot Inc/The
|
||
Lowe's Cos Inc
|
||
TJX Cos Inc/The
|
||
Hilton Worldwide Holdings Inc
|
||
McDonald's Corp
|
||
Dick's Sporting Goods Inc
|
||
Booking Holdings Inc
|
||
Tempur Sealy International Inc
|
||
63.3
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915205.100 205-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class Z
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Aerospace & Defense
|
||
Machinery
|
||
Electrical Equipment
|
||
Ground Transportation
|
||
Building Products
|
||
Trading Companies & Distributors
|
||
Construction & Engineering
|
||
Commercial Services & Supplies
|
||
Professional Services
|
||
Others
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 1.0
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 100.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
GE Aerospace
|
||
GE Vernova Inc
|
||
Howmet Aerospace Inc
|
||
Parker-Hannifin Corp
|
||
Boeing Co
|
||
Ingersoll Rand Inc
|
||
Trane Technologies PLC
|
||
Union Pacific Corp
|
||
TransDigm Group Inc
|
||
Eaton Corp PLC
|
||
43.7
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915202.100 3295-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class A
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Biotechnology
|
||
Pharmaceuticals
|
||
Health Care Technology
|
||
Financial Services
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 96.7
|
|
Preferred Stocks - 2.0
|
|
Bonds - 0.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 1.3
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 87.4
|
|
Netherlands - 6.0
|
|
Denmark - 3.7
|
|
Canada - 1.9
|
|
Belgium - 0.7
|
|
China - 0.2
|
|
United Kingdom - 0.1
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
AbbVie Inc
|
||
Regeneron Pharmaceuticals Inc
|
||
Amgen Inc
|
||
Alnylam Pharmaceuticals Inc
|
||
Argenx SE ADR
|
||
Vertex Pharmaceuticals Inc
|
||
Ascendis Pharma A/S ADR
|
||
Vaxcyte Inc
|
||
Gilead Sciences Inc
|
||
Viridian Therapeutics Inc
|
||
61.1
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915225.100 112-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class C
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Broadline Retail
|
||
Specialty Retail
|
||
Hotels, Restaurants & Leisure
|
||
Automobiles
|
||
Textiles, Apparel & Luxury Goods
|
||
Household Durables
|
||
Automobile Components
|
||
Building Products
|
||
Consumer Staples Distribution & Retail
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.4
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 0.6
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 94.6
|
|
Bailiwick Of Jersey - 1.9
|
|
Canada - 1.8
|
|
Brazil - 0.8
|
|
United Kingdom - 0.3
|
|
Switzerland - 0.3
|
|
France - 0.3
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Amazon.com Inc
|
||
Tesla Inc
|
||
Home Depot Inc/The
|
||
Lowe's Cos Inc
|
||
TJX Cos Inc/The
|
||
Hilton Worldwide Holdings Inc
|
||
McDonald's Corp
|
||
Dick's Sporting Goods Inc
|
||
Booking Holdings Inc
|
||
Tempur Sealy International Inc
|
||
63.3
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915206.100 282-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class M
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Banks
|
||
Capital Markets
|
||
Financial Services
|
||
Insurance
|
||
Consumer Finance
|
||
Professional Services
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.6
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 0.4
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 94.4
|
|
United Kingdom - 3.1
|
|
Puerto Rico - 1.6
|
|
Grand Cayman (UK Overseas Ter) - 0.5
|
|
Mexico - 0.4
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Mastercard Inc Class A
|
||
Wells Fargo & Co
|
||
Bank of America Corp
|
||
Citigroup Inc
|
||
Reinsurance Group of America Inc
|
||
Chubb Ltd
|
||
Morgan Stanley
|
||
Visa Inc Class A
|
||
Apollo Global Management Inc
|
||
Discover Financial Services
|
||
39.4
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915194.100 193-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class C
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Residential REITs
|
||
Retail REITs
|
||
Specialized REITs
|
||
Industrial REITs
|
||
Real Estate Management & Development
|
||
Health Care REITs
|
||
Diversified REITs
|
||
Office REITs
|
||
Hotel & Resort REITs
|
||
Others
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 100.1
|
|
Short-Term Investments and Net Other Assets (Liabilities) - (0.1)%
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 63.4
|
|
Japan - 8.6
|
|
United Kingdom - 7.7
|
|
Australia - 5.7
|
|
Canada - 2.8
|
|
Singapore - 2.8
|
|
France - 2.1
|
|
Sweden - 1.9
|
|
Germany - 1.5
|
|
Others - 3.5
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Prologis Inc
|
||
Equinix Inc
|
||
Welltower Inc
|
||
Ventas Inc
|
||
Public Storage Operating Co
|
||
Kimco Realty Corp
|
||
Digital Realty Trust Inc
|
||
UDR Inc
|
||
Equity Residential
|
||
NNN REIT Inc
|
||
41.7
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915336.100 2850-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class Z
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Biotechnology
|
||
Pharmaceuticals
|
||
Health Care Technology
|
||
Financial Services
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 96.7
|
|
Preferred Stocks - 2.0
|
|
Bonds - 0.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 1.3
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 87.4
|
|
Netherlands - 6.0
|
|
Denmark - 3.7
|
|
Canada - 1.9
|
|
Belgium - 0.7
|
|
China - 0.2
|
|
United Kingdom - 0.1
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
AbbVie Inc
|
||
Regeneron Pharmaceuticals Inc
|
||
Amgen Inc
|
||
Alnylam Pharmaceuticals Inc
|
||
Argenx SE ADR
|
||
Vertex Pharmaceuticals Inc
|
||
Ascendis Pharma A/S ADR
|
||
Vaxcyte Inc
|
||
Gilead Sciences Inc
|
||
Viridian Therapeutics Inc
|
||
61.1
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915229.100 3290-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class I
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Semiconductors & Semiconductor Equipment
|
||
Software
|
||
Technology Hardware, Storage & Peripherals
|
||
IT Services
|
||
Communications Equipment
|
||
Broadline Retail
|
||
Ground Transportation
|
||
Electronic Equipment, Instruments & Components
|
||
Entertainment
|
||
Others
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 95.4
|
|
Preferred Stocks - 1.6
|
|
Preferred Securities - 0.0
|
|
Bonds - 0.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 3.0
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 91.1
|
|
China - 3.4
|
|
Canada - 2.3
|
|
Taiwan - 2.1
|
|
Netherlands - 0.9
|
|
India - 0.2
|
|
Israel - 0.0
|
|
Korea (South) - 0.0
|
|
United Kingdom - 0.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
NVIDIA Corp
|
||
Apple Inc
|
||
Microsoft Corp
|
||
Marvell Technology Inc
|
||
Servicenow Inc
|
||
Cisco Systems Inc
|
||
NXP Semiconductors NV
|
||
ON Semiconductor Corp
|
||
Okta Inc Class A
|
||
Salesforce Inc
|
||
69.0
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915215.100 202-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class C
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Health Care Equipment & Supplies
|
||
Biotechnology
|
||
Health Care Providers & Services
|
||
Pharmaceuticals
|
||
Life Sciences Tools & Services
|
||
Health Care Technology
|
||
Financial Services
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 97.8
|
|
Preferred Stocks - 2.0
|
|
Preferred Securities - 0.2
|
|
Bonds - 0.1
|
|
Short-Term Investments and Net Other Assets (Liabilities) - (0.1)%
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 91.5
|
|
Netherlands - 3.4
|
|
Belgium - 1.9
|
|
Denmark - 1.4
|
|
Canada - 0.9
|
|
United Kingdom - 0.3
|
|
China - 0.2
|
|
Germany - 0.2
|
|
Israel - 0.2
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
UnitedHealth Group Inc
|
||
Boston Scientific Corp
|
||
Eli Lilly & Co
|
||
Penumbra Inc
|
||
Danaher Corp
|
||
Masimo Corp
|
||
Insulet Corp
|
||
Stryker Corp
|
||
Argenx SE ADR
|
||
Thermo Fisher Scientific Inc
|
||
52.4
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915191.100 285-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class Z
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Broadline Retail
|
||
Specialty Retail
|
||
Hotels, Restaurants & Leisure
|
||
Automobiles
|
||
Textiles, Apparel & Luxury Goods
|
||
Household Durables
|
||
Automobile Components
|
||
Building Products
|
||
Consumer Staples Distribution & Retail
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.4
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 0.6
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 94.6
|
|
Bailiwick Of Jersey - 1.9
|
|
Canada - 1.8
|
|
Brazil - 0.8
|
|
United Kingdom - 0.3
|
|
Switzerland - 0.3
|
|
France - 0.3
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Amazon.com Inc
|
||
Tesla Inc
|
||
Home Depot Inc/The
|
||
Lowe's Cos Inc
|
||
TJX Cos Inc/The
|
||
Hilton Worldwide Holdings Inc
|
||
McDonald's Corp
|
||
Dick's Sporting Goods Inc
|
||
Booking Holdings Inc
|
||
Tempur Sealy International Inc
|
||
63.3
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915207.100 3291-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class C
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Aerospace & Defense
|
||
Machinery
|
||
Electrical Equipment
|
||
Ground Transportation
|
||
Building Products
|
||
Trading Companies & Distributors
|
||
Construction & Engineering
|
||
Commercial Services & Supplies
|
||
Professional Services
|
||
Others
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 1.0
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 100.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
GE Aerospace
|
||
GE Vernova Inc
|
||
Howmet Aerospace Inc
|
||
Parker-Hannifin Corp
|
||
Boeing Co
|
||
Ingersoll Rand Inc
|
||
Trane Technologies PLC
|
||
Union Pacific Corp
|
||
TransDigm Group Inc
|
||
Eaton Corp PLC
|
||
43.7
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915201.100 283-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class C
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Semiconductors & Semiconductor Equipment
|
||
Technology Hardware, Storage & Peripherals
|
||
Software
|
||
Electronic Equipment, Instruments & Components
|
||
Financial Services
|
||
Metals & Mining
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 94.9
|
|
Preferred Stocks - 0.4
|
|
Preferred Securities - 0.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 4.7
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 80.7
|
|
Taiwan - 8.2
|
|
China - 4.9
|
|
Netherlands - 3.1
|
|
Israel - 2.0
|
|
Japan - 1.1
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
NVIDIA Corp
|
||
Broadcom Inc
|
||
Marvell Technology Inc
|
||
Taiwan Semiconductor Manufacturing Co Ltd ADR
|
||
Monolithic Power Systems Inc
|
||
Lam Research Corp
|
||
NXP Semiconductors NV
|
||
Micron Technology Inc
|
||
GlobalFoundries Inc
|
||
ON Semiconductor Corp
|
||
76.7
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915242.100 119-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class M
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Semiconductors & Semiconductor Equipment
|
||
Technology Hardware, Storage & Peripherals
|
||
Software
|
||
Electronic Equipment, Instruments & Components
|
||
Financial Services
|
||
Metals & Mining
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 94.9
|
|
Preferred Stocks - 0.4
|
|
Preferred Securities - 0.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 4.7
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 80.7
|
|
Taiwan - 8.2
|
|
China - 4.9
|
|
Netherlands - 3.1
|
|
Israel - 2.0
|
|
Japan - 1.1
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
NVIDIA Corp
|
||
Broadcom Inc
|
||
Marvell Technology Inc
|
||
Taiwan Semiconductor Manufacturing Co Ltd ADR
|
||
Monolithic Power Systems Inc
|
||
Lam Research Corp
|
||
NXP Semiconductors NV
|
||
Micron Technology Inc
|
||
GlobalFoundries Inc
|
||
ON Semiconductor Corp
|
||
76.7
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915245.100 139-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class C
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Specialized REITs
|
||
Residential REITs
|
||
Industrial REITs
|
||
Retail REITs
|
||
Real Estate Management & Development
|
||
Health Care REITs
|
||
Office REITs
|
||
Hotel & Resort REITs
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.9
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 0.1
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 100.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Equinix Inc
|
||
Prologis Inc
|
||
American Tower Corp
|
||
CBRE Group Inc Class A
|
||
Ventas Inc
|
||
Welltower Inc
|
||
Public Storage Operating Co
|
||
Crown Castle Inc
|
||
Sun Communities Inc
|
||
CubeSmart
|
||
57.5
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915248.100 1130-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class I
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Residential REITs
|
||
Retail REITs
|
||
Specialized REITs
|
||
Industrial REITs
|
||
Real Estate Management & Development
|
||
Health Care REITs
|
||
Diversified REITs
|
||
Office REITs
|
||
Hotel & Resort REITs
|
||
Others
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 100.1
|
|
Short-Term Investments and Net Other Assets (Liabilities) - (0.1)%
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 63.4
|
|
Japan - 8.6
|
|
United Kingdom - 7.7
|
|
Australia - 5.7
|
|
Canada - 2.8
|
|
Singapore - 2.8
|
|
France - 2.1
|
|
Sweden - 1.9
|
|
Germany - 1.5
|
|
Others - 3.5
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Prologis Inc
|
||
Equinix Inc
|
||
Welltower Inc
|
||
Ventas Inc
|
||
Public Storage Operating Co
|
||
Kimco Realty Corp
|
||
Digital Realty Trust Inc
|
||
UDR Inc
|
||
Equity Residential
|
||
NNN REIT Inc
|
||
41.7
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915338.100 2852-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class M
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Specialized REITs
|
||
Residential REITs
|
||
Industrial REITs
|
||
Retail REITs
|
||
Real Estate Management & Development
|
||
Health Care REITs
|
||
Office REITs
|
||
Hotel & Resort REITs
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.9
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 0.1
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 100.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Equinix Inc
|
||
Prologis Inc
|
||
American Tower Corp
|
||
CBRE Group Inc Class A
|
||
Ventas Inc
|
||
Welltower Inc
|
||
Public Storage Operating Co
|
||
Crown Castle Inc
|
||
Sun Communities Inc
|
||
CubeSmart
|
||
57.5
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915249.100 1131-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class Z
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Residential REITs
|
||
Retail REITs
|
||
Specialized REITs
|
||
Industrial REITs
|
||
Real Estate Management & Development
|
||
Health Care REITs
|
||
Diversified REITs
|
||
Office REITs
|
||
Hotel & Resort REITs
|
||
Others
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 100.1
|
|
Short-Term Investments and Net Other Assets (Liabilities) - (0.1)%
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 63.4
|
|
Japan - 8.6
|
|
United Kingdom - 7.7
|
|
Australia - 5.7
|
|
Canada - 2.8
|
|
Singapore - 2.8
|
|
France - 2.1
|
|
Sweden - 1.9
|
|
Germany - 1.5
|
|
Others - 3.5
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Prologis Inc
|
||
Equinix Inc
|
||
Welltower Inc
|
||
Ventas Inc
|
||
Public Storage Operating Co
|
||
Kimco Realty Corp
|
||
Digital Realty Trust Inc
|
||
UDR Inc
|
||
Equity Residential
|
||
NNN REIT Inc
|
||
41.7
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915339.100 3300-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class A
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Residential REITs
|
||
Retail REITs
|
||
Specialized REITs
|
||
Industrial REITs
|
||
Real Estate Management & Development
|
||
Health Care REITs
|
||
Diversified REITs
|
||
Office REITs
|
||
Hotel & Resort REITs
|
||
Others
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 100.1
|
|
Short-Term Investments and Net Other Assets (Liabilities) - (0.1)%
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 63.4
|
|
Japan - 8.6
|
|
United Kingdom - 7.7
|
|
Australia - 5.7
|
|
Canada - 2.8
|
|
Singapore - 2.8
|
|
France - 2.1
|
|
Sweden - 1.9
|
|
Germany - 1.5
|
|
Others - 3.5
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Prologis Inc
|
||
Equinix Inc
|
||
Welltower Inc
|
||
Ventas Inc
|
||
Public Storage Operating Co
|
||
Kimco Realty Corp
|
||
Digital Realty Trust Inc
|
||
UDR Inc
|
||
Equity Residential
|
||
NNN REIT Inc
|
||
41.7
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915335.100 2849-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class C
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Semiconductors & Semiconductor Equipment
|
||
Software
|
||
Technology Hardware, Storage & Peripherals
|
||
IT Services
|
||
Communications Equipment
|
||
Broadline Retail
|
||
Ground Transportation
|
||
Electronic Equipment, Instruments & Components
|
||
Entertainment
|
||
Others
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 95.4
|
|
Preferred Stocks - 1.6
|
|
Preferred Securities - 0.0
|
|
Bonds - 0.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 3.0
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 91.1
|
|
China - 3.4
|
|
Canada - 2.3
|
|
Taiwan - 2.1
|
|
Netherlands - 0.9
|
|
India - 0.2
|
|
Israel - 0.0
|
|
Korea (South) - 0.0
|
|
United Kingdom - 0.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
NVIDIA Corp
|
||
Apple Inc
|
||
Microsoft Corp
|
||
Marvell Technology Inc
|
||
Servicenow Inc
|
||
Cisco Systems Inc
|
||
NXP Semiconductors NV
|
||
ON Semiconductor Corp
|
||
Okta Inc Class A
|
||
Salesforce Inc
|
||
69.0
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915217.100 476-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class A
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Banks
|
||
Capital Markets
|
||
Financial Services
|
||
Insurance
|
||
Consumer Finance
|
||
Professional Services
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.6
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 0.4
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 94.4
|
|
United Kingdom - 3.1
|
|
Puerto Rico - 1.6
|
|
Grand Cayman (UK Overseas Ter) - 0.5
|
|
Mexico - 0.4
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Mastercard Inc Class A
|
||
Wells Fargo & Co
|
||
Bank of America Corp
|
||
Citigroup Inc
|
||
Reinsurance Group of America Inc
|
||
Chubb Ltd
|
||
Morgan Stanley
|
||
Visa Inc Class A
|
||
Apollo Global Management Inc
|
||
Discover Financial Services
|
||
39.4
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915193.100 183-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class A
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Semiconductors & Semiconductor Equipment
|
||
Technology Hardware, Storage & Peripherals
|
||
Software
|
||
Electronic Equipment, Instruments & Components
|
||
Financial Services
|
||
Metals & Mining
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 94.9
|
|
Preferred Stocks - 0.4
|
|
Preferred Securities - 0.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 4.7
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 80.7
|
|
Taiwan - 8.2
|
|
China - 4.9
|
|
Netherlands - 3.1
|
|
Israel - 2.0
|
|
Japan - 1.1
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
NVIDIA Corp
|
||
Broadcom Inc
|
||
Marvell Technology Inc
|
||
Taiwan Semiconductor Manufacturing Co Ltd ADR
|
||
Monolithic Power Systems Inc
|
||
Lam Research Corp
|
||
NXP Semiconductors NV
|
||
Micron Technology Inc
|
||
GlobalFoundries Inc
|
||
ON Semiconductor Corp
|
||
76.7
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915244.100 138-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class C
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Electric Utilities
|
||
Multi-Utilities
|
||
Independent Power and Renewable Electricity Producers
|
||
Gas Utilities
|
||
Electrical Equipment
|
||
Semiconductors & Semiconductor Equipment
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 93.9
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 6.1
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 100.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
NextEra Energy Inc
|
||
Duke Energy Corp
|
||
Constellation Energy Corp
|
||
Vistra Corp
|
||
Sempra
|
||
Exelon Corp
|
||
Entergy Corp
|
||
Ameren Corp
|
||
CenterPoint Energy Inc
|
||
Xcel Energy Inc
|
||
56.8
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915212.100 477-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class Z
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Oil, Gas & Consumable Fuels
|
||
Energy Equipment & Services
|
||
Independent Power and Renewable Electricity Producers
|
||
Machinery
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 102.8
|
|
Short-Term Investments and Net Other Assets (Liabilities) - (2.8)%
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 84.5
|
|
Canada - 12.0
|
|
United Kingdom - 3.2
|
|
Norway - 0.2
|
|
France - 0.1
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Exxon Mobil Corp
|
||
Cheniere Energy Inc
|
||
Chevron Corp
|
||
Energy Transfer LP
|
||
Cenovus Energy Inc
|
||
Schlumberger NV
|
||
Canadian Natural Resources Ltd
|
||
Marathon Petroleum Corp
|
||
Valero Energy Corp
|
||
Occidental Petroleum Corp
|
||
66.6
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915220.100 3292-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class Z
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Specialized REITs
|
||
Residential REITs
|
||
Industrial REITs
|
||
Retail REITs
|
||
Real Estate Management & Development
|
||
Health Care REITs
|
||
Office REITs
|
||
Hotel & Resort REITs
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.9
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 0.1
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 100.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Equinix Inc
|
||
Prologis Inc
|
||
American Tower Corp
|
||
CBRE Group Inc Class A
|
||
Ventas Inc
|
||
Welltower Inc
|
||
Public Storage Operating Co
|
||
Crown Castle Inc
|
||
Sun Communities Inc
|
||
CubeSmart
|
||
57.5
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915251.100 3299-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class I
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Banks
|
||
Capital Markets
|
||
Financial Services
|
||
Insurance
|
||
Consumer Finance
|
||
Professional Services
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.6
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 0.4
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 94.4
|
|
United Kingdom - 3.1
|
|
Puerto Rico - 1.6
|
|
Grand Cayman (UK Overseas Ter) - 0.5
|
|
Mexico - 0.4
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Mastercard Inc Class A
|
||
Wells Fargo & Co
|
||
Bank of America Corp
|
||
Citigroup Inc
|
||
Reinsurance Group of America Inc
|
||
Chubb Ltd
|
||
Morgan Stanley
|
||
Visa Inc Class A
|
||
Apollo Global Management Inc
|
||
Discover Financial Services
|
||
39.4
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915195.100 273-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class M
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Biotechnology
|
||
Pharmaceuticals
|
||
Health Care Technology
|
||
Financial Services
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 96.7
|
|
Preferred Stocks - 2.0
|
|
Bonds - 0.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 1.3
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 87.4
|
|
Netherlands - 6.0
|
|
Denmark - 3.7
|
|
Canada - 1.9
|
|
Belgium - 0.7
|
|
China - 0.2
|
|
United Kingdom - 0.1
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
AbbVie Inc
|
||
Regeneron Pharmaceuticals Inc
|
||
Amgen Inc
|
||
Alnylam Pharmaceuticals Inc
|
||
Argenx SE ADR
|
||
Vertex Pharmaceuticals Inc
|
||
Ascendis Pharma A/S ADR
|
||
Vaxcyte Inc
|
||
Gilead Sciences Inc
|
||
Viridian Therapeutics Inc
|
||
61.1
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915227.100 115-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class A
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Aerospace & Defense
|
||
Machinery
|
||
Electrical Equipment
|
||
Ground Transportation
|
||
Building Products
|
||
Trading Companies & Distributors
|
||
Construction & Engineering
|
||
Commercial Services & Supplies
|
||
Professional Services
|
||
Others
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 99.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 1.0
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 100.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
GE Aerospace
|
||
GE Vernova Inc
|
||
Howmet Aerospace Inc
|
||
Parker-Hannifin Corp
|
||
Boeing Co
|
||
Ingersoll Rand Inc
|
||
Trane Technologies PLC
|
||
Union Pacific Corp
|
||
TransDigm Group Inc
|
||
Eaton Corp PLC
|
||
43.7
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915198.100 184-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class A
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Semiconductors & Semiconductor Equipment
|
||
Software
|
||
Technology Hardware, Storage & Peripherals
|
||
IT Services
|
||
Communications Equipment
|
||
Broadline Retail
|
||
Ground Transportation
|
||
Electronic Equipment, Instruments & Components
|
||
Entertainment
|
||
Others
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 95.4
|
|
Preferred Stocks - 1.6
|
|
Preferred Securities - 0.0
|
|
Bonds - 0.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 3.0
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 91.1
|
|
China - 3.4
|
|
Canada - 2.3
|
|
Taiwan - 2.1
|
|
Netherlands - 0.9
|
|
India - 0.2
|
|
Israel - 0.0
|
|
Korea (South) - 0.0
|
|
United Kingdom - 0.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
NVIDIA Corp
|
||
Apple Inc
|
||
Microsoft Corp
|
||
Marvell Technology Inc
|
||
Servicenow Inc
|
||
Cisco Systems Inc
|
||
NXP Semiconductors NV
|
||
ON Semiconductor Corp
|
||
Okta Inc Class A
|
||
Salesforce Inc
|
||
69.0
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915213.100 187-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class M
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Semiconductors & Semiconductor Equipment
|
||
Software
|
||
Technology Hardware, Storage & Peripherals
|
||
IT Services
|
||
Communications Equipment
|
||
Broadline Retail
|
||
Ground Transportation
|
||
Electronic Equipment, Instruments & Components
|
||
Entertainment
|
||
Others
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 95.4
|
|
Preferred Stocks - 1.6
|
|
Preferred Securities - 0.0
|
|
Bonds - 0.0
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 3.0
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 91.1
|
|
China - 3.4
|
|
Canada - 2.3
|
|
Taiwan - 2.1
|
|
Netherlands - 0.9
|
|
India - 0.2
|
|
Israel - 0.0
|
|
Korea (South) - 0.0
|
|
United Kingdom - 0.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
NVIDIA Corp
|
||
Apple Inc
|
||
Microsoft Corp
|
||
Marvell Technology Inc
|
||
Servicenow Inc
|
||
Cisco Systems Inc
|
||
NXP Semiconductors NV
|
||
ON Semiconductor Corp
|
||
Okta Inc Class A
|
||
Salesforce Inc
|
||
69.0
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915214.100 192-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class I
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Oil, Gas & Consumable Fuels
|
||
Energy Equipment & Services
|
||
Independent Power and Renewable Electricity Producers
|
||
Machinery
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 102.8
|
|
Short-Term Investments and Net Other Assets (Liabilities) - (2.8)%
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 84.5
|
|
Canada - 12.0
|
|
United Kingdom - 3.2
|
|
Norway - 0.2
|
|
France - 0.1
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
Exxon Mobil Corp
|
||
Cheniere Energy Inc
|
||
Chevron Corp
|
||
Energy Transfer LP
|
||
Cenovus Energy Inc
|
||
Schlumberger NV
|
||
Canadian Natural Resources Ltd
|
||
Marathon Petroleum Corp
|
||
Valero Energy Corp
|
||
Occidental Petroleum Corp
|
||
66.6
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915222.100 686-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class M
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Health Care Equipment & Supplies
|
||
Biotechnology
|
||
Health Care Providers & Services
|
||
Pharmaceuticals
|
||
Life Sciences Tools & Services
|
||
Health Care Technology
|
||
Financial Services
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 97.8
|
|
Preferred Stocks - 2.0
|
|
Preferred Securities - 0.2
|
|
Bonds - 0.1
|
|
Short-Term Investments and Net Other Assets (Liabilities) - (0.1)%
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 91.5
|
|
Netherlands - 3.4
|
|
Belgium - 1.9
|
|
Denmark - 1.4
|
|
Canada - 0.9
|
|
United Kingdom - 0.3
|
|
China - 0.2
|
|
Germany - 0.2
|
|
Israel - 0.2
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
UnitedHealth Group Inc
|
||
Boston Scientific Corp
|
||
Eli Lilly & Co
|
||
Penumbra Inc
|
||
Danaher Corp
|
||
Masimo Corp
|
||
Insulet Corp
|
||
Stryker Corp
|
||
Argenx SE ADR
|
||
Thermo Fisher Scientific Inc
|
||
52.4
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915189.100 191-TSRS-0425
|
|
SEMI-ANNUAL SHAREHOLDER REPORT | AS OF
|
||
|
|
||
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
||
Class Z
|
$
|
KEY FACTS
|
||
Fund Size
|
$
|
|
Number of Holdings
|
||
Portfolio Turnover
|
TOP INDUSTRIES
(% of Fund's net assets)
|
||
Electric Utilities
|
||
Multi-Utilities
|
||
Independent Power and Renewable Electricity Producers
|
||
Gas Utilities
|
||
Electrical Equipment
|
||
Semiconductors & Semiconductor Equipment
|
||
ASSET ALLOCATION (% of Fund's net assets)
|
|
Common Stocks - 93.9
|
|
Short-Term Investments and Net Other Assets (Liabilities) - 6.1
|
|
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
|
|
United States - 100.0
|
|
TOP HOLDINGS
(% of Fund's net assets)
|
||
NextEra Energy Inc
|
||
Duke Energy Corp
|
||
Constellation Energy Corp
|
||
Vistra Corp
|
||
Sempra
|
||
Exelon Corp
|
||
Entergy Corp
|
||
Ameren Corp
|
||
CenterPoint Energy Inc
|
||
Xcel Energy Inc
|
||
56.8
|
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
|
||
![]() |
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915211.100 3298-TSRS-0425
|
|
Item 2.
Code of Ethics
Not applicable.
Item 3.
Audit Committee Financial Expert
Not applicable.
Item 4.
Principal Accountant Fees and Services
Not applicable.
Item 5.
Audit Committee of Listed Registrants
Not applicable.
Item 6.
Investments
(a)
Not applicable.
(b)
Not applicable
Item 7.
Financial Statements and Financial Highlights for Open-End Management Investment Companies


Contents
Common Stocks - 96.7%
|
|||
Shares
|
Value ($)
|
||
BELGIUM - 0.7%
|
|||
Health Care - 0.7%
|
|||
Pharmaceuticals - 0.7%
|
|||
UCB SA
|
58,300
|
11,382,415
|
|
CANADA - 1.9%
|
|||
Health Care - 1.9%
|
|||
Biotechnology - 1.9%
|
|||
Xenon Pharmaceuticals Inc (b)
|
710,758
|
28,416,105
|
|
CHINA - 0.2%
|
|||
Health Care - 0.2%
|
|||
Biotechnology - 0.2%
|
|||
Zai Lab Ltd ADR (b)
|
90,400
|
2,457,976
|
|
DENMARK - 3.7%
|
|||
Health Care - 3.7%
|
|||
Biotechnology - 3.7%
|
|||
Ascendis Pharma A/S ADR (b)
|
434,425
|
56,761,971
|
|
NETHERLANDS - 6.0%
|
|||
Health Care - 6.0%
|
|||
Biotechnology - 6.0%
|
|||
Argenx SE ADR (b)
|
114,300
|
74,881,359
|
|
Merus NV (b)(c)
|
412,609
|
16,892,212
|
|
TOTAL NETHERLANDS
|
91,773,571
|
||
UNITED KINGDOM - 0.1%
|
|||
Health Care - 0.1%
|
|||
Biotechnology - 0.1%
|
|||
Autolus Therapeutics PLC ADR (b)
|
938,039
|
2,073,066
|
|
UNITED STATES - 84.1%
|
|||
Health Care - 84.1%
|
|||
Biotechnology - 82.3%
|
|||
AbbVie Inc
|
1,939,280
|
356,633,593
|
|
Akero Therapeutics Inc (b)
|
211,444
|
11,434,892
|
|
Alnylam Pharmaceuticals Inc (b)
|
315,386
|
85,567,376
|
|
Amgen Inc
|
349,503
|
99,755,146
|
|
AnaptysBio Inc (b)
|
423,100
|
7,586,183
|
|
Apogee Therapeutics Inc (b)
|
470,123
|
19,444,287
|
|
Arcellx Inc (b)
|
198,700
|
13,537,431
|
|
Astria Therapeutics Inc (b)
|
478,438
|
3,760,523
|
|
Astria Therapeutics Inc warrants (b)
|
247,630
|
798,749
|
|
Bicara Therapeutics Inc (c)
|
476,916
|
6,018,680
|
|
Bridgebio Pharma Inc (b)
|
59,900
|
2,049,179
|
|
Bridgebio Pharma Inc (b)(d)
|
393,764
|
13,470,666
|
|
Cargo Therapeutics Inc (b)(c)
|
373,763
|
1,345,547
|
|
Celldex Therapeutics Inc (b)
|
461,252
|
11,296,061
|
|
CG oncology Inc
|
134,900
|
4,056,443
|
|
Cogent Biosciences Inc (b)
|
1,331,700
|
12,398,127
|
|
Crinetics Pharmaceuticals Inc (b)
|
480,170
|
19,350,851
|
|
Cytokinetics Inc (b)
|
401,871
|
19,876,540
|
|
Day One Biopharmaceuticals Inc (b)(c)
|
795,300
|
9,837,861
|
|
Denali Therapeutics Inc (b)
|
400,200
|
9,324,660
|
|
Dianthus Therapeutics Inc (b)(c)
|
346,162
|
7,667,488
|
|
Disc Medicine Inc (b)
|
166,122
|
9,269,608
|
|
Exact Sciences Corp (b)
|
364,700
|
20,441,435
|
|
Gilead Sciences Inc
|
314,200
|
30,540,240
|
|
Immunovant Inc (b)
|
326,800
|
7,104,632
|
|
Immunovant Inc (d)
|
272,250
|
5,918,715
|
|
Janux Therapeutics Inc (b)
|
391,585
|
17,026,116
|
|
Legend Biotech Corp ADR (b)
|
143,900
|
5,482,590
|
|
Madrigal Pharmaceuticals Inc (b)(c)
|
39,000
|
13,057,200
|
|
Maze Therapeutics Inc
|
65,900
|
1,051,105
|
|
Mineralys Therapeutics Inc (b)(c)
|
301,700
|
3,107,510
|
|
Monte Rosa Therapeutics Inc (b)(c)
|
629,658
|
4,193,522
|
|
MoonLake Immunotherapeutics Class A (b)
|
131,762
|
6,059,734
|
|
Nurix Therapeutics Inc (b)
|
757,000
|
14,920,470
|
|
Nuvalent Inc Class A (b)(c)
|
325,077
|
27,894,857
|
|
Oruka Therapeutics Inc (c)
|
458,390
|
6,165,346
|
|
Oruka Therapeutics Inc (d)
|
197,572
|
2,657,343
|
|
Perspective Therapeutics Inc (b)(c)
|
1,642,918
|
5,832,359
|
|
Regeneron Pharmaceuticals Inc (b)
|
157,500
|
105,994,351
|
|
Rezolute Inc (b)(c)
|
921,488
|
4,837,812
|
|
Rhythm Pharmaceuticals Inc (b)
|
141,400
|
8,403,402
|
|
Scholar Rock Holding Corp (b)(c)
|
663,968
|
26,811,028
|
|
Scholar Rock Holding Corp warrants 12/31/2025 (b)(d)
|
6,000
|
199,845
|
|
Soleno Therapeutics Inc (b)
|
213,100
|
10,704,013
|
|
Spyre Therapeutics Inc (b)
|
649,968
|
14,942,764
|
|
Summit Therapeutics Inc (b)(c)
|
201,200
|
4,325,800
|
|
Tectonic Therapeutic Inc (b)(c)
|
142,600
|
7,720,364
|
|
Tectonic Therapeutic Inc (d)
|
72,841
|
3,943,612
|
|
Travere Therapeutics Inc (b)
|
528,600
|
10,815,156
|
|
Tyra Biosciences Inc (b)
|
198,288
|
2,867,244
|
|
Upstream Bio Inc (c)
|
475,277
|
5,118,733
|
|
Vaxcyte Inc (b)
|
378,629
|
33,440,513
|
|
Vertex Pharmaceuticals Inc (b)
|
135,200
|
62,419,136
|
|
Viking Therapeutics Inc (b)(c)
|
605,687
|
19,836,249
|
|
Vir Biotechnology Inc (b)
|
890,300
|
9,259,120
|
|
Viridian Therapeutics Inc (b)(c)
|
1,561,407
|
30,260,068
|
|
Zenas Biopharma Inc (c)
|
749,800
|
6,013,396
|
|
1,263,845,671
|
|||
Pharmaceuticals - 1.8%
|
|||
Enliven Therapeutics Inc (b)(c)
|
500,613
|
10,943,401
|
|
Enliven Therapeutics Inc (d)
|
73,200
|
1,600,152
|
|
Enliven Therapeutics Inc rights (b)(e)
|
739,725
|
7
|
|
Rapport Therapeutics Inc (b)(c)
|
180,446
|
2,961,119
|
|
Structure Therapeutics Inc ADR (b)(c)
|
328,102
|
9,833,217
|
|
WaVe Life Sciences Ltd (b)
|
225,390
|
2,607,762
|
|
27,945,658
|
|||
TOTAL UNITED STATES
|
1,291,791,329
|
||
|
TOTAL COMMON STOCKS
(Cost $966,540,341)
|
1,484,656,433
|
||
Convertible Corporate Bonds - 0.0%
|
|||
Principal
Amount (a)
|
Value ($)
|
||
UNITED STATES - 0.0%
|
|||
Health Care - 0.0%
|
|||
Health Care Technology - 0.0%
|
|||
Wugen Inc 10% 6/14/2025 (d)(e)
(Cost $831,313)
|
831,313
|
885,016
|
|
Convertible Preferred Stocks - 2.0%
|
|||
Shares
|
Value ($)
|
||
UNITED STATES - 2.0%
|
|||
Financials - 0.2%
|
|||
Financial Services - 0.2%
|
|||
Kartos Therapeutics Inc Series C (b)(d)(e)
|
530,692
|
3,009,023
|
|
Health Care - 1.8%
|
|||
Biotechnology - 1.5%
|
|||
Bright Peak Therapeutics Inc. Series B (b)(d)(e)
|
1,920,122
|
3,110,598
|
|
Bright Peak Therapeutics Inc. Series C (d)(e)
|
873,604
|
995,908
|
|
Cardurion Pharmaceuticals Inc Series B (d)(e)
|
331,596
|
1,624,820
|
|
Endeavor BioMedicines Inc Series C (d)(e)
|
526,643
|
3,433,712
|
|
LifeMine Therapeutics Inc Series C (b)(d)(e)
|
1,950,028
|
1,443,021
|
|
Parabilis Medicines Inc Series D (b)(d)(e)
|
239,281
|
1,452,436
|
|
Sonoma Biotherapeutics Inc Series B (b)(d)(e)
|
1,967,762
|
5,667,156
|
|
Sonoma Biotherapeutics Inc Series B1 (b)(d)(e)
|
1,049,456
|
3,400,237
|
|
T-Knife Therapeutics Inc Series B (b)(d)(e)
|
1,300,097
|
1,768,132
|
|
Treeline Biosciences Series A (b)(d)(e)
|
47,600
|
334,152
|
|
23,230,172
|
|||
Health Care Technology - 0.3%
|
|||
Candid Therapeutics (d)(e)
|
1,500,060
|
1,650,066
|
|
Wugen Inc Series B (b)(d)(e)
|
580,277
|
2,210,855
|
|
3,860,921
|
|||
Pharmaceuticals - 0.0%
|
|||
Afferent Pharmaceuticals Inc Series C (b)(d)(e)
|
1,915,787
|
19
|
|
TOTAL HEALTH CARE
|
27,091,112
|
||
TOTAL UNITED STATES
|
30,100,135
|
||
|
TOTAL CONVERTIBLE PREFERRED STOCKS
(Cost $44,269,852)
|
30,100,135
|
||
Money Market Funds - 9.5%
|
||||
Yield (%)
|
Shares
|
Value ($)
|
||
Fidelity Cash Central Fund (f)
|
4.37
|
31,453,185
|
31,459,475
|
|
Fidelity Securities Lending Cash Central Fund (f)(g)
|
4.37
|
113,934,998
|
113,946,392
|
|
|
TOTAL MONEY MARKET FUNDS
(Cost $145,401,744)
|
145,405,867
|
|||
|
TOTAL INVESTMENT IN SECURITIES - 108.2%
(Cost $1,157,043,250)
|
1,661,047,451
|
NET OTHER ASSETS (LIABILITIES) - (8.2)%
|
(125,918,842)
|
NET ASSETS - 100.0%
|
1,535,128,609
|
(a)
|
Amount is stated in United States dollars unless otherwise noted.
|
(b)
|
Non-income producing
|
(c)
|
Security or a portion of the security is on loan at period end.
|
(d)
|
Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $58,775,484 or 3.8% of net assets.
|
(e)
|
Level 3 security
|
(f)
|
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
|
(g)
|
Investment made with cash collateral received from securities on loan.
|
Additional information on each restricted holding is as follows:
|
||
Security
|
Acquisition Date
|
Acquisition Cost ($)
|
Afferent Pharmaceuticals Inc Series C
|
7/01/15
|
0
|
Bridgebio Pharma Inc
|
9/25/23
|
10,737,944
|
Bright Peak Therapeutics Inc. Series B
|
5/14/21
|
7,499,997
|
Bright Peak Therapeutics Inc. Series C
|
5/07/24
|
990,230
|
Candid Therapeutics
|
8/27/24
|
1,800,072
|
Cardurion Pharmaceuticals Inc Series B
|
7/10/24
|
1,624,025
|
Endeavor BioMedicines Inc Series C
|
4/22/24
|
3,436,135
|
Enliven Therapeutics Inc
|
3/19/24
|
1,024,800
|
Immunovant Inc
|
1/13/25
|
5,445,000
|
Kartos Therapeutics Inc Series C
|
8/22/23
|
3,000,002
|
LifeMine Therapeutics Inc Series C
|
2/15/22
|
3,971,408
|
Oruka Therapeutics Inc
|
9/12/24
|
4,544,156
|
Parabilis Medicines Inc Series D
|
11/17/22
|
2,575,405
|
Scholar Rock Holding Corp warrants 12/31/2025
|
6/17/22
|
0
|
Sonoma Biotherapeutics Inc Series B
|
7/26/21
|
3,888,888
|
Sonoma Biotherapeutics Inc Series B1
|
7/26/21
|
3,111,112
|
T-Knife Therapeutics Inc Series B
|
6/30/21
|
7,500,000
|
Tectonic Therapeutic Inc
|
1/30/24
|
1,689,995
|
Treeline Biosciences Series A
|
7/30/21
|
372,589
|
Wugen Inc 10% 6/14/2025
|
6/14/24
|
831,313
|
Wugen Inc Series B
|
7/09/21
|
4,499,990
|
Affiliate
|
Value,
beginning
of period ($)
|
Purchases ($)
|
Sales
Proceeds ($)
|
Dividend
Income ($)
|
Realized
Gain (loss) ($)
|
Change in
Unrealized
appreciation
(depreciation) ($)
|
Value,
end
of period ($)
|
Shares,
end
of period
|
% ownership,
end
of period
|
Fidelity Cash Central Fund
|
21,081,884
|
223,598,671
|
213,221,080
|
330,232
|
-
|
-
|
31,459,475
|
31,453,185
|
0.1%
|
Fidelity Securities Lending Cash Central Fund
|
155,099,956
|
403,251,328
|
444,404,892
|
326,525
|
-
|
-
|
113,946,392
|
113,934,998
|
0.5%
|
Total
|
176,181,840
|
626,849,999
|
657,625,972
|
656,757
|
-
|
-
|
145,405,867
|
145,388,183
|
|
Affiliate
|
Value,
beginning
of period ($)
|
Purchases ($)
|
Sales
Proceeds ($)
|
Dividend
Income ($)
|
Realized
Gain (loss) ($)
|
Change in
Unrealized
appreciation
(depreciation) ($)
|
Value,
end
of period ($)
|
Shares,
end
of period
|
Allakos Inc
|
4,371,030
|
-
|
1,217,959
|
-
|
(6,691,265)
|
3,538,194
|
-
|
-
|
Total
|
4,371,030
|
-
|
1,217,959
|
-
|
(6,691,265)
|
3,538,194
|
-
|
-
|
Valuation Inputs at Reporting Date:
|
||||
Description
|
Total ($)
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Investments in Securities:
|
||||
Common Stocks
|
||||
Health Care
|
1,484,656,433
|
1,483,657,832
|
998,594
|
7
|
Convertible Corporate Bonds
|
||||
Health Care
|
885,016
|
-
|
-
|
885,016
|
Convertible Preferred Stocks
|
||||
Financials
|
3,009,023
|
-
|
-
|
3,009,023
|
Health Care
|
27,091,112
|
-
|
-
|
27,091,112
|
Money Market Funds
|
145,405,867
|
145,405,867
|
-
|
-
|
Total Investments in Securities:
|
1,661,047,451
|
1,629,063,699
|
998,594
|
30,985,158
|
Net Unrealized Appreciation on Unfunded Commitments
|
2,670,125
|
-
|
-
|
2,670,125
|
Total
|
2,670,125
|
-
|
-
|
2,670,125
|
Investments in Securities:
|
|||
Common Stocks
|
|||
Beginning Balance
|
$
|
383,164
|
|
Net Realized Gain (Loss) on Investment Securities
|
455,406
|
||
Net Unrealized Gain (Loss) on Investment Securities
|
(151,993)
|
||
Cost of Purchases
|
-
|
||
Proceeds of Sales
|
(686,570)
|
||
Amortization/Accretion
|
-
|
||
Transfers into Level 3
|
-
|
||
Transfers out of Level 3
|
-
|
||
Ending Balance
|
$
|
7
|
|
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at January 31, 2025
|
$
|
231,164
|
|
Convertible Corporate Bonds
|
|||
Beginning Balance
|
$
|
850,350
|
|
Net Realized Gain (Loss) on Investment Securities
|
-
|
||
Net Unrealized Gain (Loss) on Investment Securities
|
34,666
|
||
Cost of Purchases
|
-
|
||
Proceeds of Sales
|
-
|
||
Amortization/Accretion
|
-
|
||
Transfers into Level 3
|
-
|
||
Transfers out of Level 3
|
-
|
||
Ending Balance
|
$
|
885,016
|
|
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at January 31, 2025
|
$
|
34,666
|
|
Convertible Preferred Stocks
|
|||
Beginning Balance
|
$
|
32,510,460
|
|
Net Realized Gain (Loss) on Investment Securities
|
-
|
||
Net Unrealized Gain (Loss) on Investment Securities
|
(4,210,397)
|
||
Cost of Purchases
|
1,800,072
|
||
Proceeds of Sales
|
-
|
||
Amortization/Accretion
|
-
|
||
Transfers into Level 3
|
-
|
||
Transfers out of Level 3
|
-
|
||
Ending Balance
|
$
|
30,100,135
|
|
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at January 31, 2025
|
$
|
(4,210,397)
|
|
|
The information used in the above reconciliation represents fiscal year to date activity for any Investments in Securities identified as using Level 3 inputs at either the beginning or the end of the current fiscal period. Cost of purchases and proceeds of sales may include securities received and/or delivered through in-kind transactions, corporate actions or exchanges. Transfers into Level 3 were attributable to a lack of observable market data resulting from decreases in market activity, decreases in liquidity, security restructurings or corporate actions. Transfers out of Level 3 were attributable to observable market data becoming available for those securities. Transfers in or out of Level 3 represent the beginning value of any Security or Instrument where a change in the pricing level occurred from the beginning to the end of the period. Realized and unrealized gains (losses) disclosed in the reconciliation are included in Net Gain (Loss) on the Fund's Statement of Operations.
|
|||
Statement of Assets and Liabilities
|
||||
|
As of January 31, 2025 (Unaudited)
|
||||
Assets
|
||||
Investment in securities, at value (including securities loaned of $110,319,178) - See accompanying schedule:
|
||||
Unaffiliated issuers (cost $1,011,641,506)
|
$
|
1,515,641,584
|
||
Fidelity Central Funds (cost $145,401,744)
|
145,405,867
|
|||
Total Investment in Securities (cost $1,157,043,250)
|
$
|
1,661,047,451
|
||
Cash
|
1,772,905
|
|||
Receivable for investments sold
|
15,608,287
|
|||
Unrealized appreciation on unfunded commitments
|
2,710,312
|
|||
Receivable for fund shares sold
|
1,214,090
|
|||
Dividends receivable
|
3,208,291
|
|||
Interest receivable
|
52,419
|
|||
Distributions receivable from Fidelity Central Funds
|
88,423
|
|||
Prepaid expenses
|
1,551
|
|||
Other receivables
|
2,425
|
|||
Total assets
|
1,685,706,154
|
|||
Liabilities
|
||||
Payable for investments purchased
|
$
|
33,691,107
|
||
Unrealized depreciation on unfunded commitments
|
40,187
|
|||
Payable for fund shares redeemed
|
1,787,012
|
|||
Accrued management fee
|
864,419
|
|||
Distribution and service plan fees payable
|
230,812
|
|||
Other payables and accrued expenses
|
50,719
|
|||
Collateral on securities loaned
|
113,913,289
|
|||
Total liabilities
|
150,577,545
|
|||
Commitments and contingent liabilities (see Significant Accounting Policies note)
|
||||
Net Assets
|
$
|
1,535,128,609
|
||
Net Assets consist of:
|
||||
Paid in capital
|
$
|
1,086,339,251
|
||
Total accumulated earnings (loss)
|
448,789,358
|
|||
Net Assets
|
$
|
1,535,128,609
|
||
Net Asset Value and Maximum Offering Price
|
||||
Class A :
|
||||
Net Asset Value and redemption price per share ($618,358,350 ÷ 22,514,350 shares)(a)
|
$
|
27.47
|
||
Maximum offering price per share (100/94.25 of $27.47)
|
$
|
29.15
|
||
Class M :
|
||||
Net Asset Value and redemption price per share ($112,039,808 ÷ 4,485,161 shares)(a)
|
$
|
24.98
|
||
Maximum offering price per share (100/96.50 of $24.98)
|
$
|
25.89
|
||
Class C :
|
||||
Net Asset Value and offering price per share ($68,532,381 ÷ 3,223,972 shares)(a)
|
$
|
21.26
|
||
Class I :
|
||||
Net Asset Value, offering price and redemption price per share ($665,536,199 ÷ 22,058,895 shares)
|
$
|
30.17
|
||
Class Z :
|
||||
Net Asset Value, offering price and redemption price per share ($70,661,871 ÷ 2,337,834 shares)
|
$
|
30.23
|
||
(a)Redemption price per share is equal to net asset value less any applicable contingent deferred sales charge.
|
||||
Statement of Operations
|
||||
Six months ended January 31, 2025 (Unaudited)
|
||||
Investment Income
|
||||
Dividends
|
$
|
8,511,847
|
||
Interest
|
41,550
|
|||
Income from Fidelity Central Funds (including $326,525 from security lending)
|
656,757
|
|||
Total income
|
9,210,154
|
|||
Expenses
|
||||
Management fee
|
$
|
5,955,965
|
||
Distribution and service plan fees
|
1,610,053
|
|||
Custodian fees and expenses
|
11,306
|
|||
Independent trustees' fees and expenses
|
3,935
|
|||
Registration fees
|
83,266
|
|||
Audit fees
|
36,534
|
|||
Legal
|
1,840
|
|||
Miscellaneous
|
50,092
|
|||
Total expenses before reductions
|
7,752,991
|
|||
Expense reductions
|
(6,240)
|
|||
Total expenses after reductions
|
7,746,751
|
|||
Net Investment income (loss)
|
1,463,403
|
|||
Realized and Unrealized Gain (Loss)
|
||||
Net realized gain (loss) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
(5,011,394)
|
|||
Affiliated issuers
|
(6,691,265)
|
|||
Foreign currency transactions
|
2,112
|
|||
Total net realized gain (loss)
|
(11,700,547)
|
|||
Change in net unrealized appreciation (depreciation) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
(173,645,371)
|
|||
Affiliated issuers
|
3,538,194
|
|||
Unfunded commitments
|
(124,932)
|
|||
Assets and liabilities in foreign currencies
|
(1,205)
|
|||
Total change in net unrealized appreciation (depreciation)
|
(170,233,314)
|
|||
Net gain (loss)
|
(181,933,861)
|
|||
Net increase (decrease) in net assets resulting from operations
|
$
|
(180,470,458)
|
||
Statement of Changes in Net Assets
|
||||
Six months ended
January 31, 2025
(Unaudited)
|
Year ended
July 31, 2024
|
|||
Increase (Decrease) in Net Assets
|
||||
Operations
|
||||
Net investment income (loss)
|
$
|
1,463,403
|
$
|
7,323,993
|
Net realized gain (loss)
|
(11,700,547)
|
91,744,149
|
||
Change in net unrealized appreciation (depreciation)
|
(170,233,314)
|
315,812,084
|
||
Net increase (decrease) in net assets resulting from operations
|
(180,470,458)
|
414,880,226
|
||
Distributions to shareholders
|
(87,826,453)
|
(18,817,060)
|
||
Share transactions - net increase (decrease)
|
(8,758,461)
|
(217,017,143)
|
||
Total increase (decrease) in net assets
|
(277,055,372)
|
179,046,023
|
||
Net Assets
|
||||
Beginning of period
|
1,812,183,981
|
1,633,137,958
|
||
End of period
|
$
|
1,535,128,609
|
$
|
1,812,183,981
|
Fidelity Advisor® Biotechnology Fund Class A |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
32.34
|
$
|
25.34
|
$
|
22.00
|
$
|
32.58
|
$
|
31.03
|
$
|
25.48
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.01
|
.10
|
.02
|
(.06)
|
.07
|
.03
|
||||||
Net realized and unrealized gain (loss)
|
(3.25)
|
7.22
|
3.32
|
(5.16)
|
4.42
|
7.40
|
||||||
Total from investment operations
|
(3.24)
|
7.32
|
3.34
|
(5.22)
|
4.49
|
7.43
|
||||||
Distributions from net investment income
|
(.80)
|
(.32)
|
-
|
(.11)
|
(.13)
|
-
|
||||||
Distributions from net realized gain
|
(.84)
|
-
|
-
|
(5.25)
|
(2.81)
|
(1.88)
|
||||||
Total distributions
|
(1.63) C
|
(.32)
|
-
|
(5.36)
|
(2.94)
|
(1.88)
|
||||||
Net asset value, end of period
|
$
|
27.47
|
$
|
32.34
|
$
|
25.34
|
$
|
22.00
|
$
|
32.58
|
$
|
31.03
|
Total Return D,E,F
|
(10.09) % |
29.21%
|
15.18%
|
(18.95)%
|
14.03%
|
30.00%
|
||||||
Ratios to Average Net Assets B,G,H
|
||||||||||||
Expenses before reductions
|
.96% I
|
.99%
|
1.01%
|
1.00%
|
1.01%
|
1.02%
|
||||||
Expenses net of fee waivers, if any
|
.96 % I |
.98%
|
1.00%
|
1.00%
|
1.00%
|
1.02%
|
||||||
Expenses net of all reductions
|
.96% I
|
.98%
|
1.00%
|
1.00%
|
1.00%
|
1.02%
|
||||||
Net investment income (loss)
|
.10% I
|
.39%
|
.07%
|
(.23)%
|
.20%
|
.11%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
618,358
|
$
|
737,152
|
$
|
636,505
|
$
|
594,911
|
$
|
808,610
|
$
|
722,896
|
Portfolio turnover rate J
|
48 % I |
73%
|
78%
|
43%
|
72%
|
66%
|
Fidelity Advisor® Biotechnology Fund Class M |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
29.56
|
$
|
23.17
|
$
|
20.17
|
$
|
30.35
|
$
|
29.08
|
$
|
24.02
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.02)
|
.03
|
(.05)
|
(.13)
|
(.02)
|
(.05)
|
||||||
Net realized and unrealized gain (loss)
|
(2.97)
|
6.59
|
3.05
|
(4.73)
|
4.14
|
6.96
|
||||||
Total from investment operations
|
(2.99)
|
6.62
|
3.00
|
(4.86)
|
4.12
|
6.91
|
||||||
Distributions from net investment income
|
(.75)
|
(.23)
|
-
|
(.07)
|
(.07)
|
-
|
||||||
Distributions from net realized gain
|
(.84)
|
-
|
-
|
(5.25)
|
(2.78)
|
(1.85)
|
||||||
Total distributions
|
(1.59)
|
(.23)
|
-
|
(5.32)
|
(2.85)
|
(1.85)
|
||||||
Net asset value, end of period
|
$
|
24.98
|
$
|
29.56
|
$
|
23.17
|
$
|
20.17
|
$
|
30.35
|
$
|
29.08
|
Total Return C,D,E
|
(10.22) % |
28.87%
|
14.87%
|
(19.18)%
|
13.69%
|
29.64%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
1.21% H
|
1.25%
|
1.29%
|
1.28%
|
1.28%
|
1.32%
|
||||||
Expenses net of fee waivers, if any
|
1.21 % H |
1.24%
|
1.28%
|
1.28%
|
1.28%
|
1.32%
|
||||||
Expenses net of all reductions
|
1.20% H
|
1.24%
|
1.28%
|
1.28%
|
1.28%
|
1.31%
|
||||||
Net investment income (loss)
|
(.15)% H
|
.13%
|
(.20)%
|
(.51)%
|
(.07)%
|
(.18)%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
112,040
|
$
|
130,547
|
$
|
113,960
|
$
|
109,815
|
$
|
161,619
|
$
|
144,568
|
Portfolio turnover rate I
|
48 % H |
73%
|
78%
|
43%
|
72%
|
66%
|
Fidelity Advisor® Biotechnology Fund Class C |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
25.31
|
$
|
19.75
|
$
|
17.27
|
$
|
26.79
|
$
|
25.97
|
$
|
21.71
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.08)
|
(.07)
|
(.13)
|
(.21)
|
(.15)
|
(.15)
|
||||||
Net realized and unrealized gain (loss)
|
(2.53)
|
5.63
|
2.61
|
(4.07)
|
3.71
|
6.26
|
||||||
Total from investment operations
|
(2.61)
|
5.56
|
2.48
|
(4.28)
|
3.56
|
6.11
|
||||||
Distributions from net investment income
|
(.60)
|
-
|
-
|
-
|
(.01)
|
-
|
||||||
Distributions from net realized gain
|
(.84)
|
-
|
-
|
(5.24)
|
(2.73)
|
(1.85)
|
||||||
Total distributions
|
(1.44)
|
-
|
-
|
(5.24)
|
(2.74)
|
(1.85)
|
||||||
Net asset value, end of period
|
$
|
21.26
|
$
|
25.31
|
$
|
19.75
|
$
|
17.27
|
$
|
26.79
|
$
|
25.97
|
Total Return C,D,E
|
(10.40) % |
28.15%
|
14.36%
|
(19.54)%
|
13.15%
|
29.07%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
1.70% H
|
1.72%
|
1.76%
|
1.75%
|
1.75%
|
1.77%
|
||||||
Expenses net of fee waivers, if any
|
1.70 % H |
1.72%
|
1.76%
|
1.74%
|
1.75%
|
1.77%
|
||||||
Expenses net of all reductions
|
1.70% H
|
1.72%
|
1.76%
|
1.74%
|
1.75%
|
1.76%
|
||||||
Net investment income (loss)
|
(.65)% H
|
(.35)%
|
(.69)%
|
(.97)%
|
(.55)%
|
(.63)%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
68,532
|
$
|
92,046
|
$
|
119,843
|
$
|
168,797
|
$
|
328,417
|
$
|
384,420
|
Portfolio turnover rate I
|
48 % H |
73%
|
78%
|
43%
|
72%
|
66%
|
Fidelity Advisor® Biotechnology Fund Class I |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
35.37
|
$
|
27.71
|
$
|
23.99
|
$
|
35.00
|
$
|
33.16
|
$
|
27.08
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.06
|
.19
|
.09
|
.01
|
.17
|
.11
|
||||||
Net realized and unrealized gain (loss)
|
(3.56)
|
7.88
|
3.63
|
(5.61)
|
4.72
|
7.88
|
||||||
Total from investment operations
|
(3.50)
|
8.07
|
3.72
|
(5.60)
|
4.89
|
7.99
|
||||||
Distributions from net investment income
|
(.86)
|
(.41)
|
-
|
(.16)
|
(.21)
|
-
|
||||||
Distributions from net realized gain
|
(.84)
|
-
|
-
|
(5.25)
|
(2.85)
|
(1.91)
|
||||||
Total distributions
|
(1.70)
|
(.41)
|
-
|
(5.41)
|
(3.05) C
|
(1.91)
|
||||||
Net asset value, end of period
|
$
|
30.17
|
$
|
35.37
|
$
|
27.71
|
$
|
23.99
|
$
|
35.00
|
$
|
33.16
|
Total Return D,E
|
(9.97) % |
29.53%
|
15.51%
|
(18.74)%
|
14.34%
|
30.32%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
.71% H
|
.72%
|
.74%
|
.73%
|
.74%
|
.75%
|
||||||
Expenses net of fee waivers, if any
|
.71 % H |
.72%
|
.73%
|
.73%
|
.74%
|
.75%
|
||||||
Expenses net of all reductions
|
.71% H
|
.72%
|
.73%
|
.73%
|
.74%
|
.75%
|
||||||
Net investment income (loss)
|
.34% H
|
.65%
|
.34%
|
.04%
|
.47%
|
.38%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
665,536
|
$
|
768,136
|
$
|
701,786
|
$
|
697,079
|
$
|
1,129,492
|
$
|
1,092,145
|
Portfolio turnover rate I
|
48 % H |
73%
|
78%
|
43%
|
72%
|
66%
|
Fidelity Advisor® Biotechnology Fund Class Z |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
35.47
|
$
|
27.81
|
$
|
24.04
|
$
|
35.05
|
$
|
33.22
|
$
|
27.10
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.08
|
.23
|
.13
|
.05
|
.21
|
.15
|
||||||
Net realized and unrealized gain (loss)
|
(3.57)
|
7.90
|
3.64
|
(5.62)
|
4.74
|
7.90
|
||||||
Total from investment operations
|
(3.49)
|
8.13
|
3.77
|
(5.57)
|
4.95
|
8.05
|
||||||
Distributions from net investment income
|
(.91)
|
(.47)
|
-
|
(.19)
|
(.26)
|
(.02)
|
||||||
Distributions from net realized gain
|
(.84)
|
-
|
-
|
(5.25)
|
(2.87)
|
(1.91)
|
||||||
Total distributions
|
(1.75)
|
(.47)
|
-
|
(5.44)
|
(3.12) C
|
(1.93)
|
||||||
Net asset value, end of period
|
$
|
30.23
|
$
|
35.47
|
$
|
27.81
|
$
|
24.04
|
$
|
35.05
|
$
|
33.22
|
Total Return D,E
|
(9.92) % |
29.69%
|
15.68%
|
(18.63)%
|
14.49%
|
30.53%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
.58% H
|
.60%
|
.61%
|
.61%
|
.61%
|
.62%
|
||||||
Expenses net of fee waivers, if any
|
.58 % H |
.60%
|
.60%
|
.60%
|
.61%
|
.62%
|
||||||
Expenses net of all reductions
|
.58% H
|
.59%
|
.60%
|
.60%
|
.61%
|
.62%
|
||||||
Net investment income (loss)
|
.47% H
|
.78%
|
.47%
|
.16%
|
.60%
|
.51%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
70,662
|
$
|
84,303
|
$
|
61,044
|
$
|
62,729
|
$
|
89,641
|
$
|
62,743
|
Portfolio turnover rate I
|
48 % H |
73%
|
78%
|
43%
|
72%
|
66%
|
Common Stocks - 99.4%
|
|||
Shares
|
Value ($)
|
||
BAILIWICK OF JERSEY - 1.9%
|
|||
Consumer Discretionary - 1.9%
|
|||
Automobile Components - 1.9%
|
|||
Aptiv PLC
|
165,470
|
10,328,637
|
|
BRAZIL - 0.8%
|
|||
Consumer Discretionary - 0.8%
|
|||
Broadline Retail - 0.8%
|
|||
MercadoLibre Inc (a)
|
2,180
|
4,190,374
|
|
CANADA - 1.8%
|
|||
Consumer Discretionary - 1.8%
|
|||
Automobile Components - 0.4%
|
|||
Magna International Inc (United States)
|
50,980
|
2,022,377
|
|
Hotels, Restaurants & Leisure - 0.7%
|
|||
Restaurant Brands International Inc
|
63,600
|
3,910,480
|
|
Specialty Retail - 0.7%
|
|||
Aritzia Inc Subordinate Voting Shares (a)
|
83,300
|
4,006,378
|
|
TOTAL CANADA
|
9,939,235
|
||
FRANCE - 0.3%
|
|||
Consumer Discretionary - 0.3%
|
|||
Textiles, Apparel & Luxury Goods - 0.3%
|
|||
LVMH Moet Hennessy Louis Vuitton SE
|
1,867
|
1,365,532
|
|
SWITZERLAND - 0.3%
|
|||
Consumer Discretionary - 0.3%
|
|||
Textiles, Apparel & Luxury Goods - 0.3%
|
|||
On Holding AG Class A (a)
|
23,284
|
1,394,246
|
|
UNITED KINGDOM - 0.3%
|
|||
Consumer Discretionary - 0.3%
|
|||
Specialty Retail - 0.3%
|
|||
JD Sports Fashion PLC
|
1,666,300
|
1,841,260
|
|
UNITED STATES - 94.0%
|
|||
Consumer Discretionary - 92.7%
|
|||
Automobile Components - 0.4%
|
|||
LCI Industries
|
18,600
|
1,949,094
|
|
Automobiles - 17.5%
|
|||
General Motors Co
|
136,340
|
6,743,376
|
|
Tesla Inc (a)
|
216,035
|
87,407,761
|
|
94,151,137
|
|||
Broadline Retail - 26.0%
|
|||
Amazon.com Inc (a)
|
564,654
|
134,206,963
|
|
Etsy Inc (a)
|
50,380
|
2,766,366
|
|
Ollie's Bargain Outlet Holdings Inc (a)
|
30,243
|
3,372,397
|
|
140,345,726
|
|||
Hotels, Restaurants & Leisure - 16.8%
|
|||
Aramark
|
52,869
|
2,057,132
|
|
Booking Holdings Inc
|
2,319
|
10,986,402
|
|
Caesars Entertainment Inc (a)
|
70,151
|
2,528,943
|
|
Chipotle Mexican Grill Inc (a)
|
135,870
|
7,928,015
|
|
Churchill Downs Inc
|
31,444
|
3,885,850
|
|
Domino's Pizza Inc
|
20,604
|
9,253,668
|
|
Hilton Worldwide Holdings Inc
|
50,850
|
13,021,160
|
|
Marriott International Inc/MD Class A1
|
36,349
|
10,562,656
|
|
McDonald's Corp
|
43,901
|
12,674,219
|
|
Penn Entertainment Inc (a)
|
84,045
|
1,731,326
|
|
Red Rock Resorts Inc Class A
|
77,340
|
3,793,527
|
|
Royal Caribbean Cruises Ltd
|
24,880
|
6,633,008
|
|
Starbucks Corp
|
49,320
|
5,310,778
|
|
90,366,684
|
|||
Household Durables - 4.4%
|
|||
KB Home
|
38,680
|
2,595,428
|
|
PulteGroup Inc
|
47,520
|
5,406,826
|
|
Tempur Sealy International Inc
|
167,895
|
10,600,890
|
|
TopBuild Corp (a)
|
15,585
|
5,340,668
|
|
23,943,812
|
|||
Specialty Retail - 22.1%
|
|||
Academy Sports & Outdoors Inc
|
101,580
|
5,313,650
|
|
Dick's Sporting Goods Inc
|
48,919
|
11,743,006
|
|
Floor & Decor Holdings Inc Class A (a)
|
63,898
|
6,396,190
|
|
Gap Inc/The
|
70,800
|
1,704,156
|
|
Group 1 Automotive Inc
|
13,490
|
6,158,050
|
|
Home Depot Inc/The
|
59,633
|
24,567,603
|
|
Lowe's Cos Inc
|
84,802
|
22,051,912
|
|
O'Reilly Automotive Inc (a)
|
2,010
|
2,601,784
|
|
Ross Stores Inc
|
65,340
|
9,837,590
|
|
Sally Beauty Holdings Inc (a)
|
156,480
|
1,700,938
|
|
TJX Cos Inc/The
|
109,569
|
13,673,116
|
|
Ulta Beauty Inc (a)
|
8,540
|
3,519,761
|
|
Wayfair Inc Class A (a)
|
18,085
|
874,771
|
|
Williams-Sonoma Inc
|
43,010
|
9,091,024
|
|
119,233,551
|
|||
Textiles, Apparel & Luxury Goods - 5.5%
|
|||
Capri Holdings Ltd (a)
|
54,100
|
1,340,598
|
|
Deckers Outdoor Corp (a)
|
40,892
|
7,252,606
|
|
Lululemon Athletica Inc (a)
|
7,250
|
3,002,950
|
|
NIKE Inc Class B
|
86,992
|
6,689,685
|
|
PVH Corp
|
40,069
|
3,590,182
|
|
Skechers USA Inc Class A (a)
|
20,700
|
1,559,538
|
|
Tapestry Inc
|
88,144
|
6,429,223
|
|
29,864,782
|
|||
TOTAL CONSUMER DISCRETIONARY
|
499,854,786
|
||
Consumer Staples - 0.5%
|
|||
Consumer Staples Distribution & Retail - 0.5%
|
|||
Dollar Tree Inc (a)
|
23,284
|
1,707,882
|
|
Performance Food Group Co (a)
|
11,872
|
1,072,160
|
|
2,780,042
|
|||
Industrials - 0.8%
|
|||
Building Products - 0.8%
|
|||
AZEK Co Inc/The Class A (a)
|
80,341
|
4,115,869
|
|
TOTAL UNITED STATES
|
506,750,697
|
||
|
TOTAL COMMON STOCKS
(Cost $233,743,480)
|
535,809,981
|
||
Money Market Funds - 0.4%
|
||||
Yield (%)
|
Shares
|
Value ($)
|
||
Fidelity Cash Central Fund (b)
(Cost $2,400,622)
|
4.37
|
2,400,141
|
2,400,621
|
|
|
TOTAL INVESTMENT IN SECURITIES - 99.8%
(Cost $236,144,102)
|
538,210,602
|
NET OTHER ASSETS (LIABILITIES) - 0.2%
|
995,763
|
NET ASSETS - 100.0%
|
539,206,365
|
(a)
|
Non-income producing
|
(b)
|
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
|
Affiliate
|
Value,
beginning
of period ($)
|
Purchases ($)
|
Sales
Proceeds ($)
|
Dividend
Income ($)
|
Realized
Gain (loss) ($)
|
Change in
Unrealized
appreciation
(depreciation) ($)
|
Value,
end
of period ($)
|
Shares,
end
of period
|
% ownership,
end
of period
|
Fidelity Cash Central Fund
|
596,655
|
32,849,294
|
31,045,327
|
24,582
|
-
|
(1)
|
2,400,621
|
2,400,141
|
0.0%
|
Fidelity Securities Lending Cash Central Fund
|
3,858,000
|
52,701,031
|
56,559,031
|
2,383
|
-
|
-
|
-
|
-
|
0.0%
|
Total
|
4,454,655
|
85,550,325
|
87,604,358
|
26,965
|
-
|
(1)
|
2,400,621
|
2,400,141
|
|
Valuation Inputs at Reporting Date:
|
||||
Description
|
Total ($)
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Investments in Securities:
|
||||
Common Stocks
|
||||
Consumer Discretionary
|
528,914,070
|
527,548,538
|
1,365,532
|
-
|
Consumer Staples
|
2,780,042
|
2,780,042
|
-
|
-
|
Industrials
|
4,115,869
|
4,115,869
|
-
|
-
|
Money Market Funds
|
2,400,621
|
2,400,621
|
-
|
-
|
Total Investments in Securities:
|
538,210,602
|
536,845,070
|
1,365,532
|
-
|
Statement of Assets and Liabilities
|
||||
|
As of January 31, 2025 (Unaudited)
|
||||
Assets
|
||||
Investment in securities, at value - See accompanying schedule:
|
||||
Unaffiliated issuers (cost $233,743,480)
|
$
|
535,809,981
|
||
Fidelity Central Funds (cost $2,400,622)
|
2,400,621
|
|||
Total Investment in Securities (cost $236,144,102)
|
$
|
538,210,602
|
||
Cash
|
63,574
|
|||
Foreign currency held at value (cost $19,500)
|
19,288
|
|||
Receivable for investments sold
|
1,357,303
|
|||
Receivable for fund shares sold
|
150,588
|
|||
Dividends receivable
|
137,060
|
|||
Distributions receivable from Fidelity Central Funds
|
5,596
|
|||
Prepaid expenses
|
386
|
|||
Other receivables
|
2,221
|
|||
Total assets
|
539,946,618
|
|||
Liabilities
|
||||
Payable for investments purchased
|
$
|
63,574
|
||
Payable for fund shares redeemed
|
247,537
|
|||
Distributions payable
|
580
|
|||
Accrued management fee
|
300,884
|
|||
Distribution and service plan fees payable
|
95,437
|
|||
Other payables and accrued expenses
|
32,241
|
|||
Total liabilities
|
740,253
|
|||
Net Assets
|
$
|
539,206,365
|
||
Net Assets consist of:
|
||||
Paid in capital
|
$
|
228,171,964
|
||
Total accumulated earnings (loss)
|
311,034,401
|
|||
Net Assets
|
$
|
539,206,365
|
||
Net Asset Value and Maximum Offering Price
|
||||
Class A :
|
||||
Net Asset Value and redemption price per share ($248,730,141 ÷ 5,070,759 shares)(a)
|
$
|
49.05
|
||
Maximum offering price per share (100/94.25 of $49.05)
|
$
|
52.04
|
||
Class M :
|
||||
Net Asset Value and redemption price per share ($40,980,423 ÷ 923,957 shares)(a)
|
$
|
44.35
|
||
Maximum offering price per share (100/96.50 of $44.35)
|
$
|
45.96
|
||
Class C :
|
||||
Net Asset Value and offering price per share ($33,978,142 ÷ 949,365 shares)(a)
|
$
|
35.79
|
||
Class I :
|
||||
Net Asset Value, offering price and redemption price per share ($159,015,475 ÷ 2,908,170 shares)
|
$
|
54.68
|
||
Class Z :
|
||||
Net Asset Value, offering price and redemption price per share ($56,502,184 ÷ 1,025,820 shares)
|
$
|
55.08
|
||
(a)Redemption price per share is equal to net asset value less any applicable contingent deferred sales charge.
|
||||
Statement of Operations
|
||||
Six months ended January 31, 2025 (Unaudited)
|
||||
Investment Income
|
||||
Dividends
|
$
|
1,718,767
|
||
Income from Fidelity Central Funds (including $2,383 from security lending)
|
26,965
|
|||
Total income
|
1,745,732
|
|||
Expenses
|
||||
Management fee
|
$
|
1,682,623
|
||
Distribution and service plan fees
|
539,995
|
|||
Custodian fees and expenses
|
2,878
|
|||
Independent trustees' fees and expenses
|
1,061
|
|||
Registration fees
|
59,654
|
|||
Audit fees
|
26,840
|
|||
Legal
|
3,244
|
|||
Miscellaneous
|
9,907
|
|||
Total expenses
|
2,326,202
|
|||
Net Investment income (loss)
|
(580,470)
|
|||
Realized and Unrealized Gain (Loss)
|
||||
Net realized gain (loss) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
21,272,993
|
|||
Foreign currency transactions
|
(1,001)
|
|||
Total net realized gain (loss)
|
21,271,992
|
|||
Change in net unrealized appreciation (depreciation) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
73,773,675
|
|||
Fidelity Central Funds
|
(1)
|
|||
Assets and liabilities in foreign currencies
|
(896)
|
|||
Total change in net unrealized appreciation (depreciation)
|
73,772,778
|
|||
Net gain (loss)
|
95,044,770
|
|||
Net increase (decrease) in net assets resulting from operations
|
$
|
94,464,300
|
||
Statement of Changes in Net Assets
|
||||
Six months ended
January 31, 2025
(Unaudited)
|
Year ended
July 31, 2024
|
|||
Increase (Decrease) in Net Assets
|
||||
Operations
|
||||
Net investment income (loss)
|
$
|
(580,470)
|
$
|
(862,291)
|
Net realized gain (loss)
|
21,271,992
|
46,224,901
|
||
Change in net unrealized appreciation (depreciation)
|
73,772,778
|
8,840,836
|
||
Net increase (decrease) in net assets resulting from operations
|
94,464,300
|
54,203,446
|
||
Distributions to shareholders
|
(28,535,068)
|
-
|
||
Share transactions - net increase (decrease)
|
(2,277,125)
|
(86,759,146)
|
||
Total increase (decrease) in net assets
|
63,652,107
|
(32,555,700)
|
||
Net Assets
|
||||
Beginning of period
|
475,554,258
|
508,109,958
|
||
End of period
|
$
|
539,206,365
|
$
|
475,554,258
|
Fidelity Advisor® Consumer Discretionary Fund Class A |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
42.78
|
$
|
37.68
|
$
|
35.05
|
$
|
45.74
|
$
|
33.70
|
$
|
29.83
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.06)
|
(.09)
|
(.09)
|
(.16)
|
(.20)
|
(.04)
|
||||||
Net realized and unrealized gain (loss)
|
9.09
|
5.19
|
4.07
|
(7.62)
|
12.82
|
4.73
|
||||||
Total from investment operations
|
9.03
|
5.10
|
3.98
|
(7.78)
|
12.62
|
4.69
|
||||||
Distributions from net realized gain
|
(2.76)
|
-
|
(1.35)
|
(2.91)
|
(.58)
|
(.82)
|
||||||
Total distributions
|
(2.76)
|
-
|
(1.35)
|
(2.91)
|
(.58)
|
(.82)
|
||||||
Net asset value, end of period
|
$
|
49.05
|
$
|
42.78
|
$
|
37.68
|
$
|
35.05
|
$
|
45.74
|
$
|
33.70
|
Total Return C,D,E
|
21.08 % |
13.54%
|
12.14%
|
(18.26)%
|
37.68%
|
16.03%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
.99% H
|
1.01%
|
1.04%
|
1.01%
|
1.03%
|
1.07%
|
||||||
Expenses net of fee waivers, if any
|
.99 % H |
1.00%
|
1.04%
|
1.01%
|
1.03%
|
1.07%
|
||||||
Expenses net of all reductions
|
.99% H
|
1.00%
|
1.04%
|
1.01%
|
1.03%
|
1.06%
|
||||||
Net investment income (loss)
|
(.28)% H
|
(.22)%
|
(.27)%
|
(.38)%
|
(.48)%
|
(.14)%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
248,730
|
$
|
222,157
|
$
|
203,468
|
$
|
188,092
|
$
|
259,488
|
$
|
159,603
|
Portfolio turnover rate I
|
24 % H |
25% J
|
43%
|
34%
|
35%
|
41% J
|
Fidelity Advisor® Consumer Discretionary Fund Class M |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
38.95
|
$
|
34.40
|
$
|
32.20
|
$
|
42.23
|
$
|
31.23
|
$
|
27.78
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.11)
|
(.17)
|
(.16)
|
(.24)
|
(.29)
|
(.11)
|
||||||
Net realized and unrealized gain (loss)
|
8.27
|
4.72
|
3.71
|
(7.02)
|
11.87
|
4.38
|
||||||
Total from investment operations
|
8.16
|
4.55
|
3.55
|
(7.26)
|
11.58
|
4.27
|
||||||
Distributions from net realized gain
|
(2.76)
|
-
|
(1.35)
|
(2.77)
|
(.58)
|
(.82)
|
||||||
Total distributions
|
(2.76)
|
-
|
(1.35)
|
(2.77)
|
(.58)
|
(.82)
|
||||||
Net asset value, end of period
|
$
|
44.35
|
$
|
38.95
|
$
|
34.40
|
$
|
32.20
|
$
|
42.23
|
$
|
31.23
|
Total Return C,D,E
|
20.92 % |
13.23%
|
11.87%
|
(18.49)%
|
37.32%
|
15.70%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
1.26% H
|
1.28%
|
1.31%
|
1.28%
|
1.30%
|
1.34%
|
||||||
Expenses net of fee waivers, if any
|
1.26 % H |
1.27%
|
1.30%
|
1.27%
|
1.30%
|
1.34%
|
||||||
Expenses net of all reductions
|
1.26% H
|
1.27%
|
1.30%
|
1.27%
|
1.29%
|
1.33%
|
||||||
Net investment income (loss)
|
(.55)% H
|
(.49)%
|
(.53)%
|
(.64)%
|
(.75)%
|
(.41)%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
40,980
|
$
|
35,773
|
$
|
35,811
|
$
|
35,219
|
$
|
48,288
|
$
|
33,896
|
Portfolio turnover rate I
|
24 % H |
25% J
|
43%
|
34%
|
35%
|
41% J
|
Fidelity Advisor® Consumer Discretionary Fund Class C |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
31.95
|
$
|
28.35
|
$
|
26.92
|
$
|
35.82
|
$
|
26.69
|
$
|
23.97
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.18)
|
(.29)
|
(.25)
|
(.36)
|
(.40)
|
(.21)
|
||||||
Net realized and unrealized gain (loss)
|
6.78
|
3.89
|
3.03
|
(5.87)
|
10.11
|
3.75
|
||||||
Total from investment operations
|
6.60
|
3.60
|
2.78
|
(6.23)
|
9.71
|
3.54
|
||||||
Distributions from net realized gain
|
(2.76)
|
-
|
(1.35)
|
(2.67)
|
(.58)
|
(.82)
|
||||||
Total distributions
|
(2.76)
|
-
|
(1.35)
|
(2.67)
|
(.58)
|
(.82)
|
||||||
Net asset value, end of period
|
$
|
35.79
|
$
|
31.95
|
$
|
28.35
|
$
|
26.92
|
$
|
35.82
|
$
|
26.69
|
Total Return C,D,E
|
20.62 % |
12.70%
|
11.32%
|
(18.88)%
|
36.66%
|
15.14%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
1.75% H
|
1.77%
|
1.80%
|
1.77%
|
1.79%
|
1.82%
|
||||||
Expenses net of fee waivers, if any
|
1.75 % H |
1.76%
|
1.79%
|
1.76%
|
1.79%
|
1.82%
|
||||||
Expenses net of all reductions
|
1.75% H
|
1.76%
|
1.79%
|
1.76%
|
1.79%
|
1.82%
|
||||||
Net investment income (loss)
|
(1.04)% H
|
(.99)%
|
(1.02)%
|
(1.13)%
|
(1.24)%
|
(.90)%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
33,978
|
$
|
31,369
|
$
|
43,294
|
$
|
54,035
|
$
|
85,549
|
$
|
65,223
|
Portfolio turnover rate I
|
24 % H |
25% J
|
43%
|
34%
|
35%
|
41% J
|
Fidelity Advisor® Consumer Discretionary Fund Class I |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
47.37
|
$
|
41.61
|
$
|
38.45
|
$
|
49.91
|
$
|
36.63
|
$
|
32.27
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.01)
|
.02
|
- C
|
(.05)
|
(.10)
|
.04
|
||||||
Net realized and unrealized gain (loss)
|
10.08
|
5.74
|
4.51
|
(8.36)
|
13.96
|
5.14
|
||||||
Total from investment operations
|
10.07
|
5.76
|
4.51
|
(8.41)
|
13.86
|
5.18
|
||||||
Distributions from net realized gain
|
(2.76)
|
-
|
(1.35)
|
(3.05)
|
(.58)
|
(.82)
|
||||||
Total distributions
|
(2.76)
|
-
|
(1.35)
|
(3.05)
|
(.58)
|
(.82)
|
||||||
Net asset value, end of period
|
$
|
54.68
|
$
|
47.37
|
$
|
41.61
|
$
|
38.45
|
$
|
49.91
|
$
|
36.63
|
Total Return D,E
|
21.24 % |
13.84%
|
12.45%
|
(18.04)%
|
38.05%
|
16.34%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
.73% H
|
.75%
|
.77%
|
.75%
|
.77%
|
.79%
|
||||||
Expenses net of fee waivers, if any
|
.73 % H |
.74%
|
.76%
|
.74%
|
.76%
|
.79%
|
||||||
Expenses net of all reductions
|
.73% H
|
.74%
|
.76%
|
.74%
|
.76%
|
.79%
|
||||||
Net investment income (loss)
|
(.02)% H
|
.04%
|
.01%
|
(.11)%
|
(.22)%
|
.13%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
159,015
|
$
|
144,234
|
$
|
139,088
|
$
|
118,859
|
$
|
259,846
|
$
|
134,907
|
Portfolio turnover rate I
|
24 % H |
25% J
|
43%
|
34%
|
35%
|
41% J
|
Fidelity Advisor® Consumer Discretionary Fund Class Z |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
47.67
|
$
|
41.82
|
$
|
38.59
|
$
|
50.10
|
$
|
36.72
|
$
|
32.31
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.03
|
.07
|
.05
|
- C
|
(.04)
|
.09
|
||||||
Net realized and unrealized gain (loss)
|
10.14
|
5.78
|
4.53
|
(8.38)
|
14.00
|
5.14
|
||||||
Total from investment operations
|
10.17
|
5.85
|
4.58
|
(8.38)
|
13.96
|
5.23
|
||||||
Distributions from net realized gain
|
(2.76)
|
-
|
(1.35)
|
(3.13)
|
(.58)
|
(.82)
|
||||||
Total distributions
|
(2.76)
|
-
|
(1.35)
|
(3.13)
|
(.58)
|
(.82)
|
||||||
Net asset value, end of period
|
$
|
55.08
|
$
|
47.67
|
$
|
41.82
|
$
|
38.59
|
$
|
50.10
|
$
|
36.72
|
Total Return D,E
|
21.32 % |
13.99%
|
12.59%
|
(17.93)%
|
38.23%
|
16.48%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
.60% H
|
.62%
|
.64%
|
.62%
|
.64%
|
.66%
|
||||||
Expenses net of fee waivers, if any
|
.60 % H |
.62%
|
.64%
|
.62%
|
.64%
|
.66%
|
||||||
Expenses net of all reductions
|
.60% H
|
.62%
|
.64%
|
.62%
|
.64%
|
.66%
|
||||||
Net investment income (loss)
|
.11% H
|
.16%
|
.13%
|
.01%
|
(.09)%
|
.26%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
56,502
|
$
|
42,021
|
$
|
86,450
|
$
|
44,785
|
$
|
87,644
|
$
|
48,668
|
Portfolio turnover rate I
|
24 % H |
25% J
|
43%
|
34%
|
35%
|
41% J
|
Common Stocks - 102.8%
|
|||
Shares
|
Value ($)
|
||
CANADA - 12.0%
|
|||
Energy - 12.0%
|
|||
Oil, Gas & Consumable Fuels - 12.0%
|
|||
Canadian Natural Resources Ltd
|
1,627,200
|
49,431,231
|
|
Cenovus Energy Inc
|
3,906,000
|
56,493,014
|
|
Imperial Oil Ltd (a)
|
229,400
|
15,258,608
|
|
Suncor Energy Inc (a)
|
304,300
|
11,417,400
|
|
TOTAL CANADA
|
132,600,253
|
||
FRANCE - 0.1%
|
|||
Energy - 0.1%
|
|||
Energy Equipment & Services - 0.1%
|
|||
Vallourec SACA (b)
|
75,500
|
1,440,373
|
|
NORWAY - 0.2%
|
|||
Energy - 0.2%
|
|||
Energy Equipment & Services - 0.2%
|
|||
Odfjell Drilling Ltd
|
484,256
|
2,661,147
|
|
UNITED KINGDOM - 3.2%
|
|||
Energy - 3.2%
|
|||
Energy Equipment & Services - 3.2%
|
|||
Subsea 7 SA
|
61,400
|
1,016,037
|
|
TechnipFMC PLC
|
1,132,800
|
34,040,640
|
|
TOTAL UNITED KINGDOM
|
35,056,677
|
||
UNITED STATES - 87.3%
|
|||
Energy - 82.8%
|
|||
Energy Equipment & Services - 10.9%
|
|||
Baker Hughes Co Class A
|
484,600
|
22,378,828
|
|
National Energy Services Reunited Corp (b)
|
2,439,571
|
23,053,946
|
|
Noble Corp PLC (a)
|
120,600
|
3,865,230
|
|
Oceaneering International Inc (a)(b)
|
27,700
|
688,345
|
|
Schlumberger NV
|
1,247,218
|
50,237,941
|
|
Valaris Ltd (b)
|
426,200
|
20,432,028
|
|
120,656,318
|
|||
Oil, Gas & Consumable Fuels - 71.9%
|
|||
Antero Resources Corp (b)
|
565,100
|
21,089,532
|
|
Cheniere Energy Inc
|
278,800
|
62,353,620
|
|
Chevron Corp
|
414,208
|
61,795,692
|
|
Chord Energy Corp
|
46,330
|
5,209,809
|
|
ConocoPhillips
|
328,650
|
32,480,480
|
|
Diamondback Energy Inc
|
213,500
|
35,090,860
|
|
Energy Transfer LP
|
2,985,300
|
61,138,944
|
|
EOG Resources Inc
|
46,586
|
5,860,053
|
|
Exxon Mobil Corp
|
2,485,171
|
265,490,818
|
|
Hess Corp
|
231,300
|
32,157,639
|
|
Marathon Petroleum Corp
|
333,378
|
48,576,508
|
|
Northern Oil & Gas Inc
|
60,030
|
2,158,078
|
|
Occidental Petroleum Corp
|
791,900
|
36,942,135
|
|
Ovintiv Inc
|
578,500
|
24,424,270
|
|
Permian Resources Corp Class A
|
622,500
|
9,119,625
|
|
Phillips 66
|
116,418
|
13,722,190
|
|
Range Resources Corp
|
451,700
|
16,730,968
|
|
SM Energy Co
|
99,400
|
3,773,223
|
|
Targa Resources Corp
|
79,200
|
15,586,560
|
|
Valero Energy Corp
|
298,900
|
39,753,700
|
|
793,454,704
|
|||
Industrials - 1.2%
|
|||
Machinery - 1.2%
|
|||
Chart Industries Inc (b)
|
60,900
|
12,885,831
|
|
Utilities - 3.3%
|
|||
Independent Power and Renewable Electricity Producers - 3.3%
|
|||
Vistra Corp
|
215,200
|
36,160,056
|
|
TOTAL UNITED STATES
|
963,156,909
|
||
|
TOTAL COMMON STOCKS
(Cost $704,591,589)
|
1,134,915,359
|
||
Money Market Funds - 0.9%
|
||||
Yield (%)
|
Shares
|
Value ($)
|
||
Fidelity Cash Central Fund (c)
|
4.37
|
3,597,092
|
3,597,812
|
|
Fidelity Securities Lending Cash Central Fund (c)(d)
|
4.37
|
7,054,405
|
7,055,110
|
|
|
TOTAL MONEY MARKET FUNDS
(Cost $10,652,922)
|
10,652,922
|
|||
|
TOTAL INVESTMENT IN SECURITIES - 103.7%
(Cost $715,244,511)
|
1,145,568,281
|
NET OTHER ASSETS (LIABILITIES) - (3.7)%
|
(41,051,458)
|
NET ASSETS - 100.0%
|
1,104,516,823
|
(a)
|
Security or a portion of the security is on loan at period end.
|
(b)
|
Non-income producing
|
(c)
|
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
|
(d)
|
Investment made with cash collateral received from securities on loan.
|
Affiliate
|
Value,
beginning
of period ($)
|
Purchases ($)
|
Sales
Proceeds ($)
|
Dividend
Income ($)
|
Realized
Gain (loss) ($)
|
Change in
Unrealized
appreciation
(depreciation) ($)
|
Value,
end
of period ($)
|
Shares,
end
of period
|
% ownership,
end
of period
|
Fidelity Cash Central Fund
|
3,329,635
|
60,614,550
|
60,346,373
|
46,027
|
-
|
-
|
3,597,812
|
3,597,092
|
0.0%
|
Fidelity Securities Lending Cash Central Fund
|
18,242,180
|
309,537,161
|
320,724,231
|
36,787
|
-
|
-
|
7,055,110
|
7,054,405
|
0.0%
|
Total
|
21,571,815
|
370,151,711
|
381,070,604
|
82,814
|
-
|
-
|
10,652,922
|
10,651,497
|
|
Valuation Inputs at Reporting Date:
|
||||
Description
|
Total ($)
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Investments in Securities:
|
||||
Common Stocks
|
||||
Energy
|
1,085,869,472
|
1,085,869,472
|
-
|
-
|
Industrials
|
12,885,831
|
12,885,831
|
-
|
-
|
Utilities
|
36,160,056
|
36,160,056
|
-
|
-
|
Money Market Funds
|
10,652,922
|
10,652,922
|
-
|
-
|
Total Investments in Securities:
|
1,145,568,281
|
1,145,568,281
|
-
|
-
|
Statement of Assets and Liabilities
|
||||
|
As of January 31, 2025 (Unaudited)
|
||||
Assets
|
||||
Investment in securities, at value (including securities loaned of $6,548,386) - See accompanying schedule:
|
||||
Unaffiliated issuers (cost $704,591,589)
|
$
|
1,134,915,359
|
||
Fidelity Central Funds (cost $10,652,922)
|
10,652,922
|
|||
Total Investment in Securities (cost $715,244,511)
|
$
|
1,145,568,281
|
||
Foreign currency held at value (cost $50,501)
|
48,350
|
|||
Receivable for fund shares sold
|
726,315
|
|||
Dividends receivable
|
432,241
|
|||
Distributions receivable from Fidelity Central Funds
|
8,224
|
|||
Prepaid expenses
|
1,027
|
|||
Other receivables
|
109,516
|
|||
Total assets
|
1,146,893,954
|
|||
Liabilities
|
||||
Payable for investments purchased
|
$
|
147,271
|
||
Payable for fund shares redeemed
|
34,176,189
|
|||
Accrued management fee
|
670,950
|
|||
Distribution and service plan fees payable
|
179,880
|
|||
Other payables and accrued expenses
|
148,055
|
|||
Collateral on securities loaned
|
7,054,786
|
|||
Total liabilities
|
42,377,131
|
|||
Net Assets
|
$
|
1,104,516,823
|
||
Net Assets consist of:
|
||||
Paid in capital
|
$
|
841,113,619
|
||
Total accumulated earnings (loss)
|
263,403,204
|
|||
Net Assets
|
$
|
1,104,516,823
|
||
Net Asset Value and Maximum Offering Price
|
||||
Class A :
|
||||
Net Asset Value and redemption price per share ($349,100,843 ÷ 7,741,468 shares)(a)
|
$
|
45.09
|
||
Maximum offering price per share (100/94.25 of $45.09)
|
$
|
47.84
|
||
Class M :
|
||||
Net Asset Value and redemption price per share ($100,275,029 ÷ 2,162,343 shares)(a)
|
$
|
46.37
|
||
Maximum offering price per share (100/96.50 of $46.37)
|
$
|
48.05
|
||
Class C :
|
||||
Net Asset Value and offering price per share ($72,338,630 ÷ 1,765,421 shares)(a)
|
$
|
40.98
|
||
Class I :
|
||||
Net Asset Value, offering price and redemption price per share ($478,762,806 ÷ 9,984,833 shares)
|
$
|
47.95
|
||
Class Z :
|
||||
Net Asset Value, offering price and redemption price per share ($104,039,515 ÷ 2,172,200 shares)
|
$
|
47.90
|
||
(a)Redemption price per share is equal to net asset value less any applicable contingent deferred sales charge.
|
||||
Statement of Operations
|
||||
Six months ended January 31, 2025 (Unaudited)
|
||||
Investment Income
|
||||
Dividends
|
$
|
15,323,868
|
||
Income from Fidelity Central Funds (including $36,787 from security lending)
|
82,814
|
|||
Total income
|
15,406,682
|
|||
Expenses
|
||||
Management fee
|
$
|
4,094,506
|
||
Distribution and service plan fees
|
1,083,211
|
|||
Custodian fees and expenses
|
20,603
|
|||
Independent trustees' fees and expenses
|
2,708
|
|||
Registration fees
|
73,238
|
|||
Audit fees
|
28,731
|
|||
Legal
|
1,977
|
|||
Miscellaneous
|
35,996
|
|||
Total expenses
|
5,340,970
|
|||
Net Investment income (loss)
|
10,065,712
|
|||
Realized and Unrealized Gain (Loss)
|
||||
Net realized gain (loss) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
31,615,464
|
|||
Foreign currency transactions
|
(7,290)
|
|||
Total net realized gain (loss)
|
31,608,174
|
|||
Change in net unrealized appreciation (depreciation) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
(131,399,557)
|
|||
Assets and liabilities in foreign currencies
|
(1,930)
|
|||
Total change in net unrealized appreciation (depreciation)
|
(131,401,487)
|
|||
Net gain (loss)
|
(99,793,313)
|
|||
Net increase (decrease) in net assets resulting from operations
|
$
|
(89,727,601)
|
||
Statement of Changes in Net Assets
|
||||
Six months ended
January 31, 2025
(Unaudited)
|
Year ended
July 31, 2024
|
|||
Increase (Decrease) in Net Assets
|
||||
Operations
|
||||
Net investment income (loss)
|
$
|
10,065,712
|
$
|
21,340,728
|
Net realized gain (loss)
|
31,608,174
|
129,269,550
|
||
Change in net unrealized appreciation (depreciation)
|
(131,401,487)
|
(30,832,449)
|
||
Net increase (decrease) in net assets resulting from operations
|
(89,727,601)
|
119,777,829
|
||
Distributions to shareholders
|
(10,612,833)
|
(23,514,383)
|
||
Share transactions - net increase (decrease)
|
(106,600,345)
|
(146,093,812)
|
||
Total increase (decrease) in net assets
|
(206,940,779)
|
(49,830,366)
|
||
Net Assets
|
||||
Beginning of period
|
1,311,457,602
|
1,361,287,968
|
||
End of period
|
$
|
1,104,516,823
|
$
|
1,311,457,602
|
Fidelity Advisor® Energy Fund Class A |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
48.92
|
$
|
44.81
|
$
|
39.49
|
$
|
23.59
|
$
|
16.59
|
$
|
27.88
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.37
|
.73
|
.96
|
.80
|
.65 C
|
.57
|
||||||
Net realized and unrealized gain (loss)
|
(3.78)
|
4.26
|
5.26
|
15.68
|
6.94
|
(11.42)
|
||||||
Total from investment operations
|
(3.41)
|
4.99
|
6.22
|
16.48
|
7.59
|
(10.85)
|
||||||
Distributions from net investment income
|
(.42)
|
(.88)
|
(.90)
|
(.58)
|
(.59)
|
(.44)
|
||||||
Total distributions
|
(.42)
|
(.88)
|
(.90)
|
(.58)
|
(.59)
|
(.44)
|
||||||
Net asset value, end of period
|
$
|
45.09
|
$
|
48.92
|
$
|
44.81
|
$
|
39.49
|
$
|
23.59
|
$
|
16.59
|
Total Return D,E,F
|
(6.92) % |
11.44%
|
15.94%
|
71.12%
|
46.78%
|
(39.54)%
|
||||||
Ratios to Average Net Assets B,G,H
|
||||||||||||
Expenses before reductions
|
.98% I
|
1.00%
|
1.01%
|
1.05%
|
1.11%
|
1.14%
|
||||||
Expenses net of fee waivers, if any
|
.98 % I |
.99%
|
1.01%
|
1.04%
|
1.11%
|
1.14%
|
||||||
Expenses net of all reductions
|
.98% I
|
.99%
|
1.01%
|
1.04%
|
1.11%
|
1.12%
|
||||||
Net investment income (loss)
|
1.60% I
|
1.59%
|
2.29%
|
2.43%
|
3.15% C
|
2.62%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
349,101
|
$
|
397,263
|
$
|
379,351
|
$
|
361,023
|
$
|
175,221
|
$
|
114,321
|
Portfolio turnover rate J
|
15 % I |
31% K
|
21%
|
37%
|
45%
|
84% K
|
Fidelity Advisor® Energy Fund Class M |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
50.29
|
$
|
46.03
|
$
|
40.53
|
$
|
24.20
|
$
|
17.00
|
$
|
28.53
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.32
|
.63
|
.88
|
.73
|
.60 C
|
.53
|
||||||
Net realized and unrealized gain (loss)
|
(3.88)
|
4.38
|
5.39
|
16.11
|
7.13
|
(11.71)
|
||||||
Total from investment operations
|
(3.56)
|
5.01
|
6.27
|
16.84
|
7.73
|
(11.18)
|
||||||
Distributions from net investment income
|
(.36)
|
(.75)
|
(.77)
|
(.51)
|
(.53)
|
(.35)
|
||||||
Total distributions
|
(.36)
|
(.75)
|
(.77)
|
(.51)
|
(.53)
|
(.35)
|
||||||
Net asset value, end of period
|
$
|
46.37
|
$
|
50.29
|
$
|
46.03
|
$
|
40.53
|
$
|
24.20
|
$
|
17.00
|
Total Return D,E,F
|
(7.03) % |
11.14%
|
15.64%
|
70.66%
|
46.37%
|
(39.66)%
|
||||||
Ratios to Average Net Assets B,G,H
|
||||||||||||
Expenses before reductions
|
1.23% I
|
1.25%
|
1.27%
|
1.31%
|
1.38%
|
1.40%
|
||||||
Expenses net of fee waivers, if any
|
1.23 % I |
1.24%
|
1.27%
|
1.31%
|
1.38%
|
1.40%
|
||||||
Expenses net of all reductions
|
1.23% I
|
1.24%
|
1.27%
|
1.31%
|
1.38%
|
1.38%
|
||||||
Net investment income (loss)
|
1.35% I
|
1.34%
|
2.04%
|
2.16%
|
2.88% C
|
2.36%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
100,275
|
$
|
111,844
|
$
|
109,406
|
$
|
114,014
|
$
|
62,519
|
$
|
43,768
|
Portfolio turnover rate J
|
15 % I |
31% K
|
21%
|
37%
|
45%
|
84% K
|
Fidelity Advisor® Energy Fund Class C |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
44.53
|
$
|
40.83
|
$
|
36.08
|
$
|
21.60
|
$
|
15.23
|
$
|
25.58
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.18
|
.35
|
.59
|
.51
|
.45 C
|
.39
|
||||||
Net realized and unrealized gain (loss)
|
(3.42)
|
3.90
|
4.80
|
14.38
|
6.38
|
(10.52)
|
||||||
Total from investment operations
|
(3.24)
|
4.25
|
5.39
|
14.89
|
6.83
|
(10.13)
|
||||||
Distributions from net investment income
|
(.31)
|
(.55)
|
(.64)
|
(.41)
|
(.46)
|
(.22)
|
||||||
Total distributions
|
(.31)
|
(.55)
|
(.64)
|
(.41)
|
(.46)
|
(.22)
|
||||||
Net asset value, end of period
|
$
|
40.98
|
$
|
44.53
|
$
|
40.83
|
$
|
36.08
|
$
|
21.60
|
$
|
15.23
|
Total Return D,E,F
|
(7.24) % |
10.61%
|
15.09%
|
69.86%
|
45.68%
|
(39.95)%
|
||||||
Ratios to Average Net Assets B,G,H
|
||||||||||||
Expenses before reductions
|
1.73% I
|
1.74%
|
1.76%
|
1.79%
|
1.84%
|
1.86%
|
||||||
Expenses net of fee waivers, if any
|
1.73 % I |
1.74%
|
1.75%
|
1.78%
|
1.84%
|
1.86%
|
||||||
Expenses net of all reductions
|
1.73% I
|
1.74%
|
1.75%
|
1.78%
|
1.84%
|
1.84%
|
||||||
Net investment income (loss)
|
.84% I
|
.85%
|
1.55%
|
1.69%
|
2.42% C
|
1.90%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
72,339
|
$
|
80,848
|
$
|
94,348
|
$
|
105,747
|
$
|
56,068
|
$
|
45,212
|
Portfolio turnover rate J
|
15 % I |
31% K
|
21%
|
37%
|
45%
|
84% K
|
Fidelity Advisor® Energy Fund Class I |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
51.96
|
$
|
47.54
|
$
|
41.83
|
$
|
24.95
|
$
|
17.51
|
$
|
29.39
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.45
|
.91
|
1.14
|
.97
|
.74 C
|
.67
|
||||||
Net realized and unrealized gain (loss)
|
(4.00)
|
4.51
|
5.57
|
16.57
|
7.35
|
(12.02)
|
||||||
Total from investment operations
|
(3.55)
|
5.42
|
6.71
|
17.54
|
8.09
|
(11.35)
|
||||||
Distributions from net investment income
|
(.46)
|
(1.00)
|
(1.00)
|
(.66)
|
(.65)
|
(.53)
|
||||||
Total distributions
|
(.46)
|
(1.00)
|
(1.00)
|
(.66)
|
(.65)
|
(.53)
|
||||||
Net asset value, end of period
|
$
|
47.95
|
$
|
51.96
|
$
|
47.54
|
$
|
41.83
|
$
|
24.95
|
$
|
17.51
|
Total Return D,E
|
(6.78) % |
11.73%
|
16.25%
|
71.63%
|
47.26%
|
(39.33)%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
.72% H
|
.73%
|
.74%
|
.76%
|
.79%
|
.82%
|
||||||
Expenses net of fee waivers, if any
|
.72 % H |
.72%
|
.74%
|
.76%
|
.79%
|
.82%
|
||||||
Expenses net of all reductions
|
.72% H
|
.72%
|
.74%
|
.76%
|
.79%
|
.80%
|
||||||
Net investment income (loss)
|
1.86% H
|
1.86%
|
2.57%
|
2.71%
|
3.47% C
|
2.95%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
478,763
|
$
|
609,322
|
$
|
511,737
|
$
|
533,005
|
$
|
177,248
|
$
|
154,575
|
Portfolio turnover rate I
|
15 % H |
31% J
|
21%
|
37%
|
45%
|
84% J
|
Fidelity Advisor® Energy Fund Class Z |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
51.91
|
$
|
47.46
|
$
|
41.75
|
$
|
24.91
|
$
|
17.48
|
$
|
29.35
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.49
|
.97
|
1.19
|
1.02
|
.80 C
|
.69
|
||||||
Net realized and unrealized gain (loss)
|
(4.01)
|
4.51
|
5.56
|
16.52
|
7.30
|
(11.97)
|
||||||
Total from investment operations
|
(3.52)
|
5.48
|
6.75
|
17.54
|
8.10
|
(11.28)
|
||||||
Distributions from net investment income
|
(.49)
|
(1.03)
|
(1.04)
|
(.70)
|
(.67)
|
(.59)
|
||||||
Total distributions
|
(.49)
|
(1.03)
|
(1.04)
|
(.70)
|
(.67)
|
(.59)
|
||||||
Net asset value, end of period
|
$
|
47.90
|
$
|
51.91
|
$
|
47.46
|
$
|
41.75
|
$
|
24.91
|
$
|
17.48
|
Total Return D,E
|
(6.73) % |
11.90%
|
16.40%
|
71.83%
|
47.47%
|
(39.22)%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
.59% H
|
.60%
|
.62%
|
.63%
|
.65%
|
.66%
|
||||||
Expenses net of fee waivers, if any
|
.59 % H |
.59%
|
.61%
|
.62%
|
.64%
|
.66%
|
||||||
Expenses net of all reductions
|
.59% H
|
.59%
|
.61%
|
.62%
|
.64%
|
.64%
|
||||||
Net investment income (loss)
|
1.99% H
|
1.99%
|
2.69%
|
2.85%
|
3.62% C
|
3.10%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
104,040
|
$
|
112,181
|
$
|
266,447
|
$
|
263,802
|
$
|
81,903
|
$
|
40,742
|
Portfolio turnover rate I
|
15 % H |
31% J
|
21%
|
37%
|
45%
|
84% J
|
Common Stocks - 99.6%
|
|||
Shares
|
Value ($)
|
||
GRAND CAYMAN (UK OVERSEAS TER) - 0.5%
|
|||
Financials - 0.5%
|
|||
Capital Markets - 0.5%
|
|||
Patria Investments Ltd Class A
|
281,300
|
3,344,657
|
|
MEXICO - 0.4%
|
|||
Financials - 0.4%
|
|||
Capital Markets - 0.4%
|
|||
Bolsa Mexicana de Valores SAB de CV
|
1,766,541
|
2,718,607
|
|
PUERTO RICO - 1.6%
|
|||
Financials - 1.6%
|
|||
Banks - 1.6%
|
|||
Popular Inc
|
101,171
|
10,414,543
|
|
UNITED KINGDOM - 3.1%
|
|||
Financials - 3.1%
|
|||
Insurance - 3.1%
|
|||
Beazley PLC
|
295,900
|
3,074,508
|
|
Direct Line Insurance Group PLC
|
1,521,000
|
5,050,408
|
|
Hiscox Ltd
|
584,100
|
7,915,786
|
|
Lancashire Holdings Ltd
|
625,266
|
5,031,485
|
|
TOTAL UNITED KINGDOM
|
21,072,187
|
||
UNITED STATES - 94.0%
|
|||
Financials - 93.0%
|
|||
Banks - 30.4%
|
|||
Associated Banc-Corp
|
235,547
|
5,921,652
|
|
Bank of America Corp
|
716,456
|
33,171,913
|
|
BOK Financial Corp
|
49,400
|
5,454,748
|
|
Cadence Bank
|
72,124
|
2,538,765
|
|
Citigroup Inc
|
359,805
|
29,298,921
|
|
East West Bancorp Inc
|
75,400
|
7,763,938
|
|
Eastern Bankshares Inc
|
345,000
|
6,334,200
|
|
First Hawaiian Inc
|
146,500
|
4,046,330
|
|
First Interstate BancSystem Inc Class A
|
191,852
|
6,321,523
|
|
Heartland Financial USA Inc
|
30,628
|
1,980,713
|
|
KeyCorp
|
305,100
|
5,485,698
|
|
M&T Bank Corp
|
58,088
|
11,689,629
|
|
Old National Bancorp/IN
|
321,433
|
7,666,177
|
|
TriCo Bancshares
|
75,200
|
3,299,024
|
|
UMB Financial Corp (a)
|
55,600
|
6,555,240
|
|
US Bancorp
|
265,000
|
12,661,700
|
|
Wells Fargo & Co
|
549,428
|
43,294,927
|
|
WesBanco Inc
|
126,900
|
4,446,576
|
|
Wintrust Financial Corp
|
19,466
|
2,546,347
|
|
Zions Bancorp NA
|
60,900
|
3,523,674
|
|
204,001,695
|
|||
Capital Markets - 20.7%
|
|||
AllianceBernstein Holding LP
|
241,800
|
9,686,508
|
|
Blue Owl Capital Inc Class A
|
171,400
|
4,458,114
|
|
Bridge Investment Group Holdings Inc Class A
|
417,400
|
3,343,374
|
|
Carlyle Group Inc/The
|
116,600
|
6,548,256
|
|
Lazard Inc Class A
|
77,352
|
4,205,628
|
|
LPL Financial Holdings Inc
|
37,900
|
13,905,131
|
|
MarketAxess Holdings Inc
|
39,600
|
8,736,948
|
|
Moody's Corp
|
19,800
|
9,888,912
|
|
Morgan Stanley
|
118,600
|
16,417,798
|
|
Nasdaq Inc
|
117,400
|
9,666,716
|
|
Northern Trust Corp
|
97,000
|
10,892,130
|
|
Perella Weinberg Partners Class A
|
127,900
|
3,302,378
|
|
Raymond James Financial Inc
|
42,950
|
7,236,216
|
|
State Street Corp
|
139,200
|
14,145,504
|
|
Stifel Financial Corp
|
49,600
|
5,746,160
|
|
Virtu Financial Inc Class A
|
269,660
|
10,802,580
|
|
138,982,353
|
|||
Consumer Finance - 7.0%
|
|||
Discover Financial Services
|
70,500
|
14,176,845
|
|
FirstCash Holdings Inc
|
95,971
|
10,475,234
|
|
OneMain Holdings Inc
|
191,600
|
10,641,464
|
|
SLM Corp
|
409,900
|
11,440,309
|
|
46,733,852
|
|||
Financial Services - 20.4%
|
|||
Apollo Global Management Inc
|
86,900
|
14,858,162
|
|
Corebridge Financial Inc
|
236,001
|
7,967,394
|
|
Corpay Inc (b)
|
12,800
|
4,870,272
|
|
Essent Group Ltd
|
166,400
|
9,692,800
|
|
Fiserv Inc (b)
|
46,900
|
10,132,276
|
|
Global Payments Inc
|
63,200
|
7,132,120
|
|
Mastercard Inc Class A
|
101,900
|
56,598,317
|
|
NMI Holdings Inc (b)
|
32,600
|
1,259,012
|
|
Visa Inc Class A
|
43,600
|
14,902,480
|
|
Voya Financial Inc
|
132,800
|
9,427,472
|
|
136,840,305
|
|||
Insurance - 14.5%
|
|||
American Financial Group Inc/OH
|
65,900
|
8,999,304
|
|
Arthur J Gallagher & Co
|
36,500
|
11,016,430
|
|
Assurant Inc
|
40,900
|
8,801,271
|
|
Baldwin Insurance Group Inc/The Class A (b)
|
232,104
|
9,504,659
|
|
Chubb Ltd
|
61,000
|
16,584,680
|
|
Fidelity National Financial Inc
|
73,600
|
4,281,312
|
|
Marsh & McLennan Cos Inc
|
64,500
|
13,988,760
|
|
Reinsurance Group of America Inc
|
107,200
|
24,426,592
|
|
97,603,008
|
|||
Industrials - 1.0%
|
|||
Professional Services - 1.0%
|
|||
Dun & Bradstreet Holdings Inc
|
528,700
|
6,503,010
|
|
TOTAL UNITED STATES
|
630,664,223
|
||
|
TOTAL COMMON STOCKS
(Cost $457,592,526)
|
668,214,217
|
||
Money Market Funds - 1.2%
|
||||
Yield (%)
|
Shares
|
Value ($)
|
||
Fidelity Cash Central Fund (c)
|
4.37
|
2,665,741
|
2,666,274
|
|
Fidelity Securities Lending Cash Central Fund (c)(d)
|
4.37
|
5,707,304
|
5,707,875
|
|
|
TOTAL MONEY MARKET FUNDS
(Cost $8,374,149)
|
8,374,149
|
|||
|
TOTAL INVESTMENT IN SECURITIES - 100.8%
(Cost $465,966,675)
|
676,588,366
|
NET OTHER ASSETS (LIABILITIES) - (0.8)%
|
(5,346,759)
|
NET ASSETS - 100.0%
|
671,241,607
|
(a)
|
Security or a portion of the security is on loan at period end.
|
(b)
|
Non-income producing
|
(c)
|
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
|
(d)
|
Investment made with cash collateral received from securities on loan.
|
Affiliate
|
Value,
beginning
of period ($)
|
Purchases ($)
|
Sales
Proceeds ($)
|
Dividend
Income ($)
|
Realized
Gain (loss) ($)
|
Change in
Unrealized
appreciation
(depreciation) ($)
|
Value,
end
of period ($)
|
Shares,
end
of period
|
% ownership,
end
of period
|
Fidelity Cash Central Fund
|
1,868,007
|
76,023,504
|
75,225,237
|
61,609
|
-
|
-
|
2,666,274
|
2,665,741
|
0.0%
|
Fidelity Securities Lending Cash Central Fund
|
4,708,125
|
37,297,539
|
36,297,789
|
2,528
|
-
|
-
|
5,707,875
|
5,707,304
|
0.0%
|
Total
|
6,576,132
|
113,321,043
|
111,523,026
|
64,137
|
-
|
-
|
8,374,149
|
8,373,045
|
|
Valuation Inputs at Reporting Date:
|
||||
Description
|
Total ($)
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Investments in Securities:
|
||||
Common Stocks
|
||||
Financials
|
661,711,207
|
661,711,207
|
-
|
-
|
Industrials
|
6,503,010
|
6,503,010
|
-
|
-
|
Money Market Funds
|
8,374,149
|
8,374,149
|
-
|
-
|
Total Investments in Securities:
|
676,588,366
|
676,588,366
|
-
|
-
|
Statement of Assets and Liabilities
|
||||
|
As of January 31, 2025 (Unaudited)
|
||||
Assets
|
||||
Investment in securities, at value (including securities loaned of $5,482,350) - See accompanying schedule:
|
||||
Unaffiliated issuers (cost $457,592,526)
|
$
|
668,214,217
|
||
Fidelity Central Funds (cost $8,374,149)
|
8,374,149
|
|||
Total Investment in Securities (cost $465,966,675)
|
$
|
676,588,366
|
||
Receivable for fund shares sold
|
872,010
|
|||
Dividends receivable
|
241,160
|
|||
Distributions receivable from Fidelity Central Funds
|
14,601
|
|||
Prepaid expenses
|
405
|
|||
Total assets
|
677,716,542
|
|||
Liabilities
|
||||
Payable for fund shares redeemed
|
$
|
232,600
|
||
Distributions payable
|
215
|
|||
Accrued management fee
|
372,803
|
|||
Distribution and service plan fees payable
|
122,980
|
|||
Other payables and accrued expenses
|
38,462
|
|||
Collateral on securities loaned
|
5,707,875
|
|||
Total liabilities
|
6,474,935
|
|||
Net Assets
|
$
|
671,241,607
|
||
Net Assets consist of:
|
||||
Paid in capital
|
$
|
452,871,077
|
||
Total accumulated earnings (loss)
|
218,370,530
|
|||
Net Assets
|
$
|
671,241,607
|
||
Net Asset Value and Maximum Offering Price
|
||||
Class A :
|
||||
Net Asset Value and redemption price per share ($252,781,053 ÷ 6,793,745 shares)(a)
|
$
|
37.21
|
||
Maximum offering price per share (100/94.25 of $37.21)
|
$
|
39.48
|
||
Class M :
|
||||
Net Asset Value and redemption price per share ($92,402,604 ÷ 2,517,660 shares)(a)
|
$
|
36.70
|
||
Maximum offering price per share (100/96.50 of $36.70)
|
$
|
38.03
|
||
Class C :
|
||||
Net Asset Value and offering price per share ($43,918,947 ÷ 1,276,743 shares)(a)
|
$
|
34.40
|
||
Class I :
|
||||
Net Asset Value, offering price and redemption price per share ($206,628,019 ÷ 5,355,462 shares)
|
$
|
38.58
|
||
Class Z :
|
||||
Net Asset Value, offering price and redemption price per share ($75,510,984 ÷ 1,959,414 shares)
|
$
|
38.54
|
||
(a)Redemption price per share is equal to net asset value less any applicable contingent deferred sales charge.
|
||||
Statement of Operations
|
||||
Six months ended January 31, 2025 (Unaudited)
|
||||
Investment Income
|
||||
Dividends
|
$
|
6,461,478
|
||
Income from Fidelity Central Funds (including $2,528 from security lending)
|
64,137
|
|||
Total income
|
6,525,615
|
|||
Expenses
|
||||
Management fee
|
$
|
1,990,986
|
||
Distribution and service plan fees
|
676,277
|
|||
Custodian fees and expenses
|
11,209
|
|||
Independent trustees' fees and expenses
|
1,176
|
|||
Registration fees
|
72,979
|
|||
Audit fees
|
28,474
|
|||
Legal
|
518
|
|||
Miscellaneous
|
13,506
|
|||
Total expenses
|
2,795,125
|
|||
Net Investment income (loss)
|
3,730,490
|
|||
Realized and Unrealized Gain (Loss)
|
||||
Net realized gain (loss) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
26,086,499
|
|||
Foreign currency transactions
|
(2,013)
|
|||
Total net realized gain (loss)
|
26,084,486
|
|||
Change in net unrealized appreciation (depreciation) on investment securities
|
70,032,751
|
|||
Net gain (loss)
|
96,117,237
|
|||
Net increase (decrease) in net assets resulting from operations
|
$
|
99,847,727
|
||
Statement of Changes in Net Assets
|
||||
Six months ended
January 31, 2025
(Unaudited)
|
Year ended
July 31, 2024
|
|||
Increase (Decrease) in Net Assets
|
||||
Operations
|
||||
Net investment income (loss)
|
$
|
3,730,490
|
$
|
8,063,454
|
Net realized gain (loss)
|
26,084,486
|
22,789,712
|
||
Change in net unrealized appreciation (depreciation)
|
70,032,751
|
79,119,055
|
||
Net increase (decrease) in net assets resulting from operations
|
99,847,727
|
109,972,221
|
||
Distributions to shareholders
|
(29,319,921)
|
(8,982,095)
|
||
Share transactions - net increase (decrease)
|
93,299,314
|
(66,836,659)
|
||
Total increase (decrease) in net assets
|
163,827,120
|
34,153,467
|
||
Net Assets
|
||||
Beginning of period
|
507,414,487
|
473,261,020
|
||
End of period
|
$
|
671,241,607
|
$
|
507,414,487
|
Fidelity Advisor® Financials Fund Class A |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
32.88
|
$
|
25.84
|
$
|
26.31
|
$
|
28.41
|
$
|
18.00
|
$
|
21.47
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.22
|
.51
|
.51
|
.44
|
.42
|
.40
|
||||||
Net realized and unrealized gain (loss)
|
5.79
|
7.17
|
.50
|
(1.32)
|
10.55
|
(3.59)
|
||||||
Total from investment operations
|
6.01
|
7.68
|
1.01
|
(.88)
|
10.97
|
(3.19)
|
||||||
Distributions from net investment income
|
(.44)
|
(.64)
|
(.45)
|
(.43)
|
(.45)
|
(.28)
|
||||||
Distributions from net realized gain
|
(1.25)
|
-
|
(1.03)
|
(.80)
|
(.11)
|
-
|
||||||
Total distributions
|
(1.68) C
|
(.64)
|
(1.48)
|
(1.22) C
|
(.56)
|
(.28)
|
||||||
Net asset value, end of period
|
$
|
37.21
|
$
|
32.88
|
$
|
25.84
|
$
|
26.31
|
$
|
28.41
|
$
|
18.00
|
Total Return D,E,F
|
18.60 % |
30.18%
|
4.17%
|
(3.40)%
|
61.84%
|
(15.15)%
|
||||||
Ratios to Average Net Assets B,G,H
|
||||||||||||
Expenses before reductions
|
1.01% I
|
1.03%
|
1.05%
|
1.03%
|
1.07%
|
1.09%
|
||||||
Expenses net of fee waivers, if any
|
1.01 % I |
1.03%
|
1.04%
|
1.03%
|
1.07%
|
1.09%
|
||||||
Expenses net of all reductions
|
1.01% I
|
1.03%
|
1.04%
|
1.03%
|
1.06%
|
1.08%
|
||||||
Net investment income (loss)
|
1.24% I
|
1.83%
|
2.02%
|
1.55%
|
1.76%
|
1.97%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
252,781
|
$
|
203,328
|
$
|
169,271
|
$
|
189,413
|
$
|
181,251
|
$
|
104,761
|
Portfolio turnover rate J
|
43 % I |
44% K
|
55%
|
40%
|
51%
|
88% K
|
Fidelity Advisor® Financials Fund Class M |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
32.43
|
$
|
25.49
|
$
|
25.98
|
$
|
28.08
|
$
|
17.79
|
$
|
21.23
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.17
|
.44
|
.44
|
.37
|
.36
|
.34
|
||||||
Net realized and unrealized gain (loss)
|
5.71
|
7.07
|
.49
|
(1.31)
|
10.44
|
(3.55)
|
||||||
Total from investment operations
|
5.88
|
7.51
|
.93
|
(.94)
|
10.80
|
(3.21)
|
||||||
Distributions from net investment income
|
(.36)
|
(.57)
|
(.39)
|
(.37)
|
(.39)
|
(.23)
|
||||||
Distributions from net realized gain
|
(1.25)
|
-
|
(1.03)
|
(.80)
|
(.11)
|
-
|
||||||
Total distributions
|
(1.61)
|
(.57)
|
(1.42)
|
(1.16) C
|
(.51) C
|
(.23)
|
||||||
Net asset value, end of period
|
$
|
36.70
|
$
|
32.43
|
$
|
25.49
|
$
|
25.98
|
$
|
28.08
|
$
|
17.79
|
Total Return D,E,F
|
18.43 % |
29.90%
|
3.88%
|
(3.63)%
|
61.48%
|
(15.38)%
|
||||||
Ratios to Average Net Assets B,G,H
|
||||||||||||
Expenses before reductions
|
1.26% I
|
1.27%
|
1.29%
|
1.28%
|
1.32%
|
1.35%
|
||||||
Expenses net of fee waivers, if any
|
1.26 % I |
1.27%
|
1.28%
|
1.28%
|
1.32%
|
1.35%
|
||||||
Expenses net of all reductions
|
1.26% I
|
1.27%
|
1.28%
|
1.28%
|
1.31%
|
1.34%
|
||||||
Net investment income (loss)
|
1.00% I
|
1.60%
|
1.78%
|
1.30%
|
1.51%
|
1.72%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
92,403
|
$
|
76,611
|
$
|
64,588
|
$
|
69,176
|
$
|
60,508
|
$
|
34,828
|
Portfolio turnover rate J
|
43 % I |
44% K
|
55%
|
40%
|
51%
|
88% K
|
Fidelity Advisor® Financials Fund Class C |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
30.43
|
$
|
23.92
|
$
|
24.44
|
$
|
26.48
|
$
|
16.80
|
$
|
20.04
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.08
|
.28
|
.30
|
.21
|
.22
|
.23
|
||||||
Net realized and unrealized gain (loss)
|
5.35
|
6.64
|
.46
|
(1.23)
|
9.85
|
(3.37)
|
||||||
Total from investment operations
|
5.43
|
6.92
|
.76
|
(1.02)
|
10.07
|
(3.14)
|
||||||
Distributions from net investment income
|
(.22)
|
(.41)
|
(.25)
|
(.23)
|
(.28)
|
(.10)
|
||||||
Distributions from net realized gain
|
(1.25)
|
-
|
(1.03)
|
(.80)
|
(.11)
|
-
|
||||||
Total distributions
|
(1.46) C
|
(.41)
|
(1.28)
|
(1.02) C
|
(.39)
|
(.10)
|
||||||
Net asset value, end of period
|
$
|
34.40
|
$
|
30.43
|
$
|
23.92
|
$
|
24.44
|
$
|
26.48
|
$
|
16.80
|
Total Return D,E,F
|
18.16 % |
29.23%
|
3.38%
|
(4.13)%
|
60.62%
|
(15.79)%
|
||||||
Ratios to Average Net Assets B,G,H
|
||||||||||||
Expenses before reductions
|
1.76% I
|
1.78%
|
1.79%
|
1.79%
|
1.83%
|
1.84%
|
||||||
Expenses net of fee waivers, if any
|
1.76 % I |
1.77%
|
1.79%
|
1.78%
|
1.82%
|
1.84%
|
||||||
Expenses net of all reductions
|
1.76% I
|
1.77%
|
1.79%
|
1.78%
|
1.82%
|
1.83%
|
||||||
Net investment income (loss)
|
.50% I
|
1.09%
|
1.27%
|
.80%
|
1.00%
|
1.22%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
43,919
|
$
|
36,108
|
$
|
41,339
|
$
|
58,177
|
$
|
57,856
|
$
|
41,947
|
Portfolio turnover rate J
|
43 % I |
44% K
|
55%
|
40%
|
51%
|
88% K
|
Fidelity Advisor® Financials Fund Class I |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
34.10
|
$
|
26.77
|
$
|
27.20
|
$
|
29.32
|
$
|
18.55
|
$
|
22.11
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.28
|
.61
|
.60
|
.54
|
.52
|
.47
|
||||||
Net realized and unrealized gain (loss)
|
6.00
|
7.43
|
.52
|
(1.37)
|
10.86
|
(3.69)
|
||||||
Total from investment operations
|
6.28
|
8.04
|
1.12
|
(.83)
|
11.38
|
(3.22)
|
||||||
Distributions from net investment income
|
(.55)
|
(.71)
|
(.53)
|
(.50)
|
(.50)
|
(.34)
|
||||||
Distributions from net realized gain
|
(1.25)
|
-
|
(1.03)
|
(.80)
|
(.11)
|
-
|
||||||
Total distributions
|
(1.80)
|
(.71)
|
(1.55) C
|
(1.29) C
|
(.61)
|
(.34)
|
||||||
Net asset value, end of period
|
$
|
38.58
|
$
|
34.10
|
$
|
26.77
|
$
|
27.20
|
$
|
29.32
|
$
|
18.55
|
Total Return D,E
|
18.74 % |
30.52%
|
4.47%
|
(3.13)%
|
62.31%
|
(14.91)%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
.74% H
|
.76%
|
.77%
|
.76%
|
.79%
|
.80%
|
||||||
Expenses net of fee waivers, if any
|
.74 % H |
.75%
|
.77%
|
.76%
|
.79%
|
.80%
|
||||||
Expenses net of all reductions
|
.74% H
|
.75%
|
.77%
|
.76%
|
.78%
|
.78%
|
||||||
Net investment income (loss)
|
1.52% H
|
2.11%
|
2.29%
|
1.82%
|
2.04%
|
2.27%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
206,628
|
$
|
124,435
|
$
|
110,244
|
$
|
131,118
|
$
|
118,424
|
$
|
85,299
|
Portfolio turnover rate I
|
43 % H |
44% J
|
55%
|
40%
|
51%
|
88% J
|
Fidelity Advisor® Financials Fund Class Z |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
34.07
|
$
|
26.71
|
$
|
27.16
|
$
|
29.28
|
$
|
18.53
|
$
|
22.09
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.30
|
.63
|
.63
|
.57
|
.54
|
.49
|
||||||
Net realized and unrealized gain (loss)
|
6.00
|
7.44
|
.51
|
(1.37)
|
10.86
|
(3.67)
|
||||||
Total from investment operations
|
6.30
|
8.07
|
1.14
|
(.80)
|
11.40
|
(3.18)
|
||||||
Distributions from net investment income
|
(.58)
|
(.71)
|
(.57)
|
(.53)
|
(.54)
|
(.38)
|
||||||
Distributions from net realized gain
|
(1.25)
|
-
|
(1.03)
|
(.80)
|
(.11)
|
-
|
||||||
Total distributions
|
(1.83)
|
(.71)
|
(1.59) C
|
(1.32) C
|
(.65)
|
(.38)
|
||||||
Net asset value, end of period
|
$
|
38.54
|
$
|
34.07
|
$
|
26.71
|
$
|
27.16
|
$
|
29.28
|
$
|
18.53
|
Total Return D,E
|
18.82 % |
30.73%
|
4.58%
|
(3.03)%
|
62.53%
|
(14.79)%
|
||||||
Ratios to Average Net Assets A,F,G
|
||||||||||||
Expenses before reductions
|
.61% H
|
.63%
|
.64%
|
.64%
|
.66%
|
.67%
|
||||||
Expenses net of fee waivers, if any
|
.61 % H |
.62%
|
.64%
|
.63%
|
.66%
|
.67%
|
||||||
Expenses net of all reductions
|
.61% H
|
.62%
|
.64%
|
.63%
|
.65%
|
.65%
|
||||||
Net investment income (loss)
|
1.65% H
|
2.24%
|
2.42%
|
1.95%
|
2.17%
|
2.40%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
75,511
|
$
|
66,932
|
$
|
87,819
|
$
|
63,009
|
$
|
49,214
|
$
|
30,790
|
Portfolio turnover rate I
|
43 % H |
44% J
|
55%
|
40%
|
51%
|
88% J
|
Common Stocks - 97.8%
|
|||
Shares
|
Value ($)
|
||
BELGIUM - 1.9%
|
|||
Health Care - 1.9%
|
|||
Pharmaceuticals - 1.9%
|
|||
UCB SA
|
400,000
|
78,095,472
|
|
CANADA - 0.7%
|
|||
Health Care - 0.7%
|
|||
Biotechnology - 0.7%
|
|||
Xenon Pharmaceuticals Inc (b)
|
780,000
|
31,184,400
|
|
CHINA - 0.2%
|
|||
Health Care - 0.2%
|
|||
Biotechnology - 0.2%
|
|||
Beigene Ltd ADR (b)
|
45,000
|
10,124,550
|
|
DENMARK - 1.4%
|
|||
Health Care - 1.4%
|
|||
Biotechnology - 1.4%
|
|||
Ascendis Pharma A/S ADR (b)
|
450,000
|
58,797,000
|
|
Zealand Pharma A/S (b)
|
9,100
|
930,456
|
|
TOTAL DENMARK
|
59,727,456
|
||
GERMANY - 0.2%
|
|||
Health Care - 0.2%
|
|||
Biotechnology - 0.2%
|
|||
BioNTech SE ADR (b)
|
60,000
|
7,426,200
|
|
NETHERLANDS - 3.4%
|
|||
Health Care - 3.4%
|
|||
Biotechnology - 3.2%
|
|||
Argenx SE ADR (b)
|
165,000
|
108,096,450
|
|
Merus NV (b)
|
670,000
|
27,429,800
|
|
135,526,250
|
|||
Pharmaceuticals - 0.2%
|
|||
Pharvaris NV (b)(c)
|
482,489
|
8,491,806
|
|
TOTAL NETHERLANDS
|
144,018,056
|
||
UNITED KINGDOM - 0.3%
|
|||
Health Care - 0.3%
|
|||
Biotechnology - 0.3%
|
|||
Immunocore Holdings PLC ADR (b)
|
322,552
|
10,605,510
|
|
UNITED STATES - 89.7%
|
|||
Health Care - 89.7%
|
|||
Biotechnology - 18.1%
|
|||
Acumen Pharmaceuticals Inc (b)
|
700,000
|
1,050,000
|
|
Akero Therapeutics Inc (b)
|
160,000
|
8,652,800
|
|
Allogene Therapeutics Inc (b)(c)
|
2,500,000
|
4,500,000
|
|
Alnylam Pharmaceuticals Inc (b)
|
354,000
|
96,043,740
|
|
Annexon Inc (b)(c)
|
750,000
|
2,880,000
|
|
Apogee Therapeutics Inc (b)
|
33,300
|
1,377,288
|
|
Arcellx Inc (b)
|
360,000
|
24,526,800
|
|
Arcus Biosciences Inc (b)
|
450,000
|
5,805,000
|
|
Avidity Biosciences Inc (b)
|
300,000
|
9,879,000
|
|
Cargo Therapeutics Inc (b)(c)
|
637,201
|
2,293,924
|
|
Caris Life Sciences Inc (b)(d)(e)
|
1,098,028
|
3,162,321
|
|
Cartesian Therapeutics Inc (b)
|
230,254
|
4,446,205
|
|
CG oncology Inc
|
300,000
|
9,021,000
|
|
Cogent Biosciences Inc (b)
|
1,280,000
|
11,916,800
|
|
Crinetics Pharmaceuticals Inc (b)
|
450,000
|
18,135,000
|
|
Cytokinetics Inc (b)
|
470,000
|
23,246,200
|
|
Day One Biopharmaceuticals Inc (b)(c)
|
600,000
|
7,422,000
|
|
Disc Medicine Inc (b)
|
200,000
|
11,160,000
|
|
Exact Sciences Corp (b)(c)
|
1,540,000
|
86,317,000
|
|
Gilead Sciences Inc
|
560,000
|
54,432,000
|
|
Janux Therapeutics Inc (b)
|
436,604
|
18,983,542
|
|
Legend Biotech Corp ADR (b)
|
1,670,000
|
63,627,000
|
|
Metsera Inc
|
61,800
|
1,637,700
|
|
MoonLake Immunotherapeutics Class A (b)(c)
|
450,000
|
20,695,500
|
|
Nurix Therapeutics Inc (b)
|
860,000
|
16,950,600
|
|
Nuvalent Inc Class A (b)(c)
|
425,300
|
36,494,993
|
|
Oruka Therapeutics Inc
|
561,711
|
7,555,013
|
|
Oruka Therapeutics Inc (e)
|
67,978
|
914,304
|
|
Perspective Therapeutics Inc (b)
|
350,000
|
1,242,500
|
|
Regeneron Pharmaceuticals Inc (b)
|
95,000
|
63,933,100
|
|
Revolution Medicines Inc (b)
|
228,000
|
9,792,600
|
|
Rezolute Inc (b)
|
850,000
|
4,462,500
|
|
Scholar Rock Holding Corp (b)
|
51,635
|
2,085,021
|
|
Soleno Therapeutics Inc (b)
|
210,000
|
10,548,300
|
|
Spyre Therapeutics Inc (b)
|
371,400
|
8,538,486
|
|
Summit Therapeutics Inc (b)(c)
|
350,000
|
7,525,000
|
|
Upstream Bio Inc
|
521,977
|
5,621,692
|
|
Vaxcyte Inc (b)
|
450,000
|
39,744,000
|
|
Veracyte Inc (b)
|
348,000
|
15,827,040
|
|
Viking Therapeutics Inc (b)(c)
|
228,000
|
7,467,000
|
|
Viridian Therapeutics Inc (b)
|
1,366,529
|
26,483,332
|
|
756,396,301
|
|||
Health Care Equipment & Supplies - 30.5%
|
|||
Boston Scientific Corp (b)
|
4,670,000
|
478,021,201
|
|
Glaukos Corp (b)
|
385,000
|
60,229,400
|
|
Inspire Medical Systems Inc (b)
|
228,000
|
44,118,000
|
|
Insulet Corp (b)
|
495,000
|
137,798,100
|
|
Intuitive Surgical Inc (b)
|
95,000
|
54,328,600
|
|
Masimo Corp (b)
|
800,000
|
139,384,000
|
|
Medical Microinstruments Inc/Italy warrants 2/16/2031 (b)(d)(e)
|
9,982
|
122,579
|
|
Penumbra Inc (b)
|
752,500
|
200,894,925
|
|
PROCEPT BioRobotics Corp (b)(c)
|
370,000
|
26,825,000
|
|
Stryker Corp
|
350,000
|
136,951,500
|
|
1,278,673,305
|
|||
Health Care Providers & Services - 21.1%
|
|||
Alignment Healthcare Inc (b)
|
2,180,000
|
33,550,200
|
|
BrightSpring Health Services Inc (b)
|
1,400,000
|
33,040,000
|
|
Cigna Group/The
|
300,000
|
88,263,000
|
|
CVS Health Corp
|
1,150,000
|
64,952,000
|
|
LifeStance Health Group Inc (b)
|
3,300,000
|
26,301,000
|
|
McKesson Corp
|
70,000
|
41,632,500
|
|
Molina Healthcare Inc (b)
|
95,000
|
29,488,950
|
|
Privia Health Group Inc (b)
|
2,400,000
|
54,840,000
|
|
Surgery Partners Inc (b)(c)
|
1,000,000
|
25,490,000
|
|
UnitedHealth Group Inc
|
895,000
|
485,528,550
|
|
883,086,200
|
|||
Health Care Technology - 2.4%
|
|||
Phreesia Inc (b)
|
903,744
|
25,720,554
|
|
Veeva Systems Inc Class A (b)
|
320,000
|
74,643,200
|
|
100,363,754
|
|||
Life Sciences Tools & Services - 9.6%
|
|||
10X Genomics Inc Class A (b)
|
1,680,000
|
25,200,000
|
|
Bruker Corp
|
600,000
|
34,890,000
|
|
Danaher Corp
|
865,000
|
192,670,100
|
|
IQVIA Holdings Inc (b)
|
54,000
|
10,873,440
|
|
Thermo Fisher Scientific Inc
|
172,500
|
103,111,875
|
|
West Pharmaceutical Services Inc
|
100,000
|
34,155,000
|
|
400,900,415
|
|||
Pharmaceuticals - 8.0%
|
|||
Contineum Therapeutics Inc Class A
|
280,000
|
2,741,200
|
|
Eli Lilly & Co
|
260,000
|
210,880,800
|
|
Enliven Therapeutics Inc (b)
|
360,000
|
7,869,600
|
|
Merck & Co Inc
|
620,000
|
61,268,400
|
|
Rapport Therapeutics Inc (b)(c)
|
160,000
|
2,625,600
|
|
Royalty Pharma PLC Class A
|
1,000,000
|
31,580,000
|
|
Septerna Inc
|
130,200
|
2,201,682
|
|
Structure Therapeutics Inc ADR (b)
|
412,000
|
12,347,640
|
|
Third Harmonic Bio Inc (b)(c)
|
400,000
|
2,104,000
|
|
333,618,922
|
|||
TOTAL UNITED STATES
|
3,753,038,897
|
||
|
TOTAL COMMON STOCKS
(Cost $2,427,501,804)
|
4,094,220,541
|
||
Convertible Corporate Bonds - 0.1%
|
|||
Principal
Amount (a)
|
Value ($)
|
||
UNITED STATES - 0.1%
|
|||
Financials - 0.0%
|
|||
Financial Services - 0.0%
|
|||
Saluda Medical Inc 0% (d)(e)(f)
|
1,933,200
|
1,967,997
|
|
Health Care - 0.1%
|
|||
Health Care Technology - 0.0%
|
|||
Wugen Inc 10% 6/14/2025 (d)(e)
|
1,433,586
|
1,526,196
|
|
Pharmaceuticals - 0.1%
|
|||
Galvanize Therapeutics 6% 2/28/2027 (d)(e)
|
2,082,600
|
2,336,052
|
|
TOTAL HEALTH CARE
|
3,862,248
|
||
TOTAL UNITED STATES
|
5,830,245
|
||
|
TOTAL CONVERTIBLE CORPORATE BONDS
(Cost $5,449,385)
|
5,830,245
|
||
Convertible Preferred Stocks - 2.0%
|
|||
Shares
|
Value ($)
|
||
CHINA - 0.0%
|
|||
Health Care - 0.0%
|
|||
Health Care Providers & Services - 0.0%
|
|||
dMed Biopharmaceutical Co Ltd Series C (b)(d)(e)
|
205,024
|
1,802,160
|
|
ISRAEL - 0.2%
|
|||
Health Care - 0.2%
|
|||
Health Care Equipment & Supplies - 0.2%
|
|||
InSightec Ltd Series G (d)(e)
|
7,391,153
|
6,947,684
|
|
UNITED STATES - 1.8%
|
|||
Financials - 0.1%
|
|||
Financial Services - 0.1%
|
|||
Saluda Medical Inc (d)(e)
|
239,441
|
2,054,404
|
|
Saluda Medical Inc Series E (b)(d)(e)
|
542,142
|
3,339,595
|
|
5,393,999
|
|||
Health Care - 1.7%
|
|||
Biotechnology - 0.9%
|
|||
Asimov Inc Series B (b)(d)(e)
|
67,547
|
1,951,433
|
|
Caris Life Sciences Inc Series D (b)(d)(e)
|
2,082,481
|
5,997,545
|
|
Cleerly Inc Series C (b)(d)(e)
|
882,089
|
10,364,546
|
|
Element Biosciences Inc Series C (b)(d)(e)
|
376,690
|
3,650,126
|
|
Element Biosciences Inc Series D (d)(e)
|
246,623
|
1,736,226
|
|
Element Biosciences Inc Series D1 (d)(e)
|
246,623
|
1,736,226
|
|
ElevateBio LLC Series C (b)(d)(e)
|
163,300
|
473,570
|
|
Endeavor BioMedicines Inc Series C (d)(e)
|
863,746
|
5,631,624
|
|
Inscripta Inc Series E (b)(d)(e)
|
826,424
|
2,479,272
|
|
34,020,568
|
|||
Health Care Equipment & Supplies - 0.4%
|
|||
Medical Microinstruments Inc/Italy Series C (d)(e)
|
199,633
|
6,591,882
|
|
Outset Medical Inc (e)(j)
|
47,945
|
9,589,000
|
|
16,180,882
|
|||
Health Care Providers & Services - 0.0%
|
|||
Thriveworks Topco LLC (b)(d)(e)(g)
|
327,591
|
1,480,711
|
|
Health Care Technology - 0.4%
|
|||
Aledade Inc Series B1 (b)(d)(e)
|
130,618
|
5,086,265
|
|
Aledade Inc Series E1 (b)(d)(e)
|
46,526
|
1,811,722
|
|
Candid Therapeutics (d)(e)
|
1,956,465
|
2,152,112
|
|
Omada Health Inc Series E (b)(d)(e)
|
1,456,953
|
6,614,567
|
|
Wugen Inc Series B (b)(d)(e)
|
300,054
|
1,143,205
|
|
16,807,871
|
|||
Pharmaceuticals - 0.0%
|
|||
Galvanize Therapeutics Series B (b)(d)(e)
|
2,552,870
|
1,914,652
|
|
TOTAL HEALTH CARE
|
70,404,684
|
||
TOTAL UNITED STATES
|
75,798,683
|
||
|
TOTAL CONVERTIBLE PREFERRED STOCKS
(Cost $125,467,559)
|
84,548,527
|
||
Preferred Securities - 0.2%
|
|||
Principal
Amount (a)
|
Value ($)
|
||
CANADA - 0.2%
|
|||
Health Care - 0.2%
|
|||
Health Care Equipment & Supplies - 0.2%
|
|||
Kardium Inc/CA 10% 12/31/2026 (d)(e)
(Cost $8,017,078)
|
8,017,078
|
7,928,979
|
|
Money Market Funds - 1.8%
|
||||
Yield (%)
|
Shares
|
Value ($)
|
||
Fidelity Cash Central Fund (h)
|
4.37
|
273
|
273
|
|
Fidelity Securities Lending Cash Central Fund (h)(i)
|
4.37
|
74,519,068
|
74,526,520
|
|
|
TOTAL MONEY MARKET FUNDS
(Cost $74,526,793)
|
74,526,793
|
|||
|
TOTAL INVESTMENT IN SECURITIES - 101.9%
(Cost $2,640,962,619)
|
4,267,055,085
|
NET OTHER ASSETS (LIABILITIES) - (1.9)%
|
(79,691,728)
|
NET ASSETS - 100.0%
|
4,187,363,357
|
(a)
|
Amount is stated in United States dollars unless otherwise noted.
|
(b)
|
Non-income producing
|
(c)
|
Security or a portion of the security is on loan at period end.
|
(d)
|
Level 3 security
|
(e)
|
Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $102,506,955 or 2.4% of net assets.
|
(f)
|
Security is perpetual in nature with no stated maturity date.
|
(g)
|
Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.
|
(h)
|
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
|
(i)
|
Investment made with cash collateral received from securities on loan.
|
(j)
|
Security is subject to lock-up or market standoff agreement. Fair value is based on the unadjusted market price of the equivalent equity security. At the end of the period, the total value of unadjusted equity securities subject to contractual sale restrictions is $9,589,000 with varying restriction expiration dates. Under normal market conditions, there are no circumstances that could cause the restrictions to lapse.
|
Additional information on each restricted holding is as follows:
|
||
Security
|
Acquisition Date
|
Acquisition Cost ($)
|
Aledade Inc Series B1
|
5/07/21
|
5,001,455
|
Aledade Inc Series E1
|
5/20/22
|
2,317,665
|
Asimov Inc Series B
|
10/29/21
|
6,260,303
|
Candid Therapeutics
|
8/27/24
|
2,347,758
|
Caris Life Sciences Inc
|
10/06/22
|
6,148,957
|
Caris Life Sciences Inc Series D
|
5/11/21
|
16,868,096
|
Cleerly Inc Series C
|
7/08/22
|
10,391,538
|
dMed Biopharmaceutical Co Ltd Series C
|
12/01/20
|
2,911,986
|
Element Biosciences Inc Series C
|
6/21/21
|
7,743,503
|
Element Biosciences Inc Series D
|
6/28/24
|
1,934,338
|
Element Biosciences Inc Series D1
|
6/28/24
|
1,934,338
|
ElevateBio LLC Series C
|
3/09/21
|
685,044
|
Endeavor BioMedicines Inc Series C
|
4/22/24
|
5,635,597
|
Galvanize Therapeutics 6% 2/28/2027
|
2/28/24
|
2,082,600
|
Galvanize Therapeutics Series B
|
3/29/22
|
4,419,746
|
Inscripta Inc Series E
|
3/30/21
|
7,297,324
|
InSightec Ltd Series G
|
6/17/24
|
6,561,866
|
Kardium Inc/CA 10% 12/31/2026
|
5/31/24 - 12/31/24
|
8,017,078
|
Medical Microinstruments Inc/Italy Series C
|
2/16/24
|
6,654,507
|
Medical Microinstruments Inc/Italy warrants 2/16/2031
|
2/16/24
|
0
|
Omada Health Inc Series E
|
12/22/21
|
8,734,725
|
Oruka Therapeutics Inc
|
9/12/24
|
1,563,494
|
Outset Medical Inc
|
1/03/25
|
9,589,000
|
Saluda Medical Inc
|
4/06/23
|
1,933,199
|
Saluda Medical Inc 0%
|
1/03/25
|
1,933,200
|
Saluda Medical Inc Series E
|
4/06/23
|
4,377,146
|
Thriveworks Topco LLC
|
7/23/21 - 2/25/22
|
9,402,913
|
Wugen Inc 10% 6/14/2025
|
6/14/24
|
1,433,586
|
Wugen Inc Series B
|
7/09/21
|
2,326,889
|
Additional information on each lock-up table restriction is as follows:
|
|
Security
|
Restriction Expiration Date
|
Outset Medical Inc
|
2025-03-31
|
Affiliate
|
Value,
beginning
of period ($)
|
Purchases ($)
|
Sales
Proceeds ($)
|
Dividend
Income ($)
|
Realized
Gain (loss) ($)
|
Change in
Unrealized
appreciation
(depreciation) ($)
|
Value,
end
of period ($)
|
Shares,
end
of period
|
% ownership,
end
of period
|
Fidelity Cash Central Fund
|
9,058,921
|
361,518,426
|
370,577,074
|
464,963
|
-
|
-
|
273
|
273
|
0.0%
|
Fidelity Securities Lending Cash Central Fund
|
204,662,086
|
265,391,555
|
395,527,121
|
487,567
|
-
|
-
|
74,526,520
|
74,519,068
|
0.3%
|
Total
|
213,721,007
|
626,909,981
|
766,104,195
|
952,530
|
-
|
-
|
74,526,793
|
74,519,341
|
|
Valuation Inputs at Reporting Date:
|
||||
Description
|
Total ($)
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Investments in Securities:
|
||||
Common Stocks
|
||||
Health Care
|
4,094,220,541
|
4,090,935,641
|
-
|
3,284,900
|
Convertible Corporate Bonds
|
||||
Financials
|
1,967,997
|
-
|
-
|
1,967,997
|
Health Care
|
3,862,248
|
-
|
-
|
3,862,248
|
Convertible Preferred Stocks
|
||||
Financials
|
5,393,999
|
-
|
-
|
5,393,999
|
Health Care
|
79,154,528
|
9,589,000
|
-
|
69,565,528
|
Preferred Securities
|
||||
Health Care
|
7,928,979
|
-
|
-
|
7,928,979
|
Money Market Funds
|
74,526,793
|
74,526,793
|
-
|
-
|
Total Investments in Securities:
|
4,267,055,085
|
4,175,051,434
|
-
|
92,003,651
|
Net Unrealized Depreciation on Unfunded Commitments
|
(97,730)
|
-
|
-
|
(97,730)
|
Total
|
(97,730)
|
-
|
-
|
(97,730)
|
Investments in Securities:
|
|||
Common Stocks
|
|||
Beginning Balance
|
$
|
3,130,877
|
|
Net Realized Gain (Loss) on Investment Securities
|
-
|
||
Net Unrealized Gain (Loss) on Investment Securities
|
154,023
|
||
Cost of Purchases
|
-
|
||
Proceeds of Sales
|
-
|
||
Amortization/Accretion
|
-
|
||
Transfers into Level 3
|
-
|
||
Transfers out of Level 3
|
-
|
||
Ending Balance
|
$
|
3,284,900
|
|
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at January 31, 2025
|
$
|
154,023
|
|
Convertible Corporate Bonds
|
|||
Beginning Balance
|
$
|
3,643,149
|
|
Net Realized Gain (Loss) on Investment Securities
|
-
|
||
Net Unrealized Gain (Loss) on Investment Securities
|
253,896
|
||
Cost of Purchases
|
1,933,200
|
||
Proceeds of Sales
|
-
|
||
Amortization/Accretion
|
-
|
||
Transfers into Level 3
|
-
|
||
Transfers out of Level 3
|
-
|
||
Ending Balance
|
$
|
5,830,245
|
|
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at January 31, 2025
|
$
|
253,896
|
|
Convertible Preferred Stocks
|
|||
Beginning Balance
|
$
|
74,276,923
|
|
Net Realized Gain (Loss) on Investment Securities
|
(73,082)
|
||
Net Unrealized Gain (Loss) on Investment Securities
|
(1,223,651)
|
||
Cost of Purchases
|
2,348,229
|
||
Proceeds of Sales
|
(368,892)
|
||
Amortization/Accretion
|
-
|
||
Transfers into Level 3
|
-
|
||
Transfers out of Level 3
|
-
|
||
Ending Balance
|
$
|
74,959,527
|
|
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at January 31, 2025
|
$
|
(1,223,651)
|
|
Preferred Securities
|
|||
Beginning Balance
|
$
|
7,682,374
|
|
Net Realized Gain (Loss) on Investment Securities
|
-
|
||
Net Unrealized Gain (Loss) on Investment Securities
|
(204,944)
|
||
Cost of Purchases
|
451,549
|
||
Proceeds of Sales
|
-
|
||
Amortization/Accretion
|
-
|
||
Transfers into Level 3
|
-
|
||
Transfers out of Level 3
|
-
|
||
Ending Balance
|
$
|
7,928,979
|
|
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at January 31, 2025
|
$
|
(204,944)
|
|
|
The information used in the above reconciliation represents fiscal year to date activity for any Investments in Securities identified as using Level 3 inputs at either the beginning or the end of the current fiscal period. Cost of purchases and proceeds of sales may include securities received and/or delivered through in-kind transactions, corporate actions or exchanges. Transfers into Level 3 were attributable to a lack of observable market data resulting from decreases in market activity, decreases in liquidity, security restructurings or corporate actions. Transfers out of Level 3 were attributable to observable market data becoming available for those securities. Transfers in or out of Level 3 represent the beginning value of any Security or Instrument where a change in the pricing level occurred from the beginning to the end of the period. Realized and unrealized gains (losses) disclosed in the reconciliation are included in Net Gain (Loss) on the Fund's consolidated Statement of Operations.
|
|||
Consolidated Statement of Assets and Liabilities
|
||||
|
As of January 31, 2025 (Unaudited)
|
||||
Assets
|
||||
Investment in securities, at value (including securities loaned of $71,478,168) - See accompanying schedule:
|
||||
Unaffiliated issuers (cost $2,566,435,826)
|
$
|
4,192,528,292
|
||
Fidelity Central Funds (cost $74,526,793)
|
74,526,793
|
|||
Total Investment in Securities (cost $2,640,962,619)
|
$
|
4,267,055,085
|
||
Foreign currency held at value (cost $880,463)
|
848,368
|
|||
Receivable for investments sold
|
9,977,634
|
|||
Receivable for fund shares sold
|
2,475,890
|
|||
Dividends receivable
|
1,855,437
|
|||
Interest receivable
|
203,476
|
|||
Distributions receivable from Fidelity Central Funds
|
35,391
|
|||
Prepaid expenses
|
3,720
|
|||
Total assets
|
4,282,455,001
|
|||
Liabilities
|
||||
Payable to custodian bank
|
$
|
79,170
|
||
Payable for investments purchased
|
11,398,896
|
|||
Unrealized depreciation on unfunded commitments
|
97,730
|
|||
Payable for fund shares redeemed
|
5,991,755
|
|||
Accrued management fee
|
2,247,347
|
|||
Distribution and service plan fees payable
|
592,877
|
|||
Notes payable to affiliates
|
103,000
|
|||
Other payables and accrued expenses
|
56,227
|
|||
Collateral on securities loaned
|
74,524,642
|
|||
Total liabilities
|
95,091,644
|
|||
Commitments and contingent liabilities (see Significant Accounting Policies note)
|
||||
Net Assets
|
$
|
4,187,363,357
|
||
Net Assets consist of:
|
||||
Paid in capital
|
$
|
2,492,124,774
|
||
Total accumulated earnings (loss)
|
1,695,238,583
|
|||
Net Assets
|
$
|
4,187,363,357
|
||
Net Asset Value and Maximum Offering Price
|
||||
Class A :
|
||||
Net Asset Value and redemption price per share ($1,388,029,855 ÷ 23,560,280 shares)(a)
|
$
|
58.91
|
||
Maximum offering price per share (100/94.25 of $58.91)
|
$
|
62.50
|
||
Class M :
|
||||
Net Asset Value and redemption price per share ($289,698,042 ÷ 5,466,201 shares)(a)
|
$
|
53.00
|
||
Maximum offering price per share (100/96.50 of $53.00)
|
$
|
54.92
|
||
Class C :
|
||||
Net Asset Value and offering price per share ($227,288,230 ÷ 5,506,814 shares)(a)
|
$
|
41.27
|
||
Class I :
|
||||
Net Asset Value, offering price and redemption price per share ($1,788,592,995 ÷ 26,878,393 shares)
|
$
|
66.54
|
||
Class Z :
|
||||
Net Asset Value, offering price and redemption price per share ($493,754,235 ÷ 7,381,855 shares)
|
$
|
66.89
|
||
(a)Redemption price per share is equal to net asset value less any applicable contingent deferred sales charge.
|
||||
Consolidated Statement of Operations
|
||||
Six months ended January 31, 2025 (Unaudited)
|
||||
Investment Income
|
||||
Dividends
|
$
|
11,070,249
|
||
Interest
|
150,250
|
|||
Income from Fidelity Central Funds (including $487,567 from security lending)
|
952,530
|
|||
Total income
|
12,173,029
|
|||
Expenses
|
||||
Management fee
|
$
|
14,663,570
|
||
Distribution and service plan fees
|
3,827,641
|
|||
Custodian fees and expenses
|
26,439
|
|||
Independent trustees' fees and expenses
|
10,227
|
|||
Registration fees
|
93,578
|
|||
Audit fees
|
28,861
|
|||
Legal
|
3,232
|
|||
Interest
|
46,923
|
|||
Miscellaneous
|
27,577
|
|||
Total expenses
|
18,728,048
|
|||
Net Investment income (loss)
|
(6,555,019)
|
|||
Realized and Unrealized Gain (Loss)
|
||||
Net realized gain (loss) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
260,525,637
|
|||
Foreign currency transactions
|
8,058
|
|||
Total net realized gain (loss)
|
260,533,695
|
|||
Change in net unrealized appreciation (depreciation) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
(87,553,003)
|
|||
Unfunded commitments
|
(3,902,154)
|
|||
Assets and liabilities in foreign currencies
|
(81,252)
|
|||
Total change in net unrealized appreciation (depreciation)
|
(91,536,409)
|
|||
Net gain (loss)
|
168,997,286
|
|||
Net increase (decrease) in net assets resulting from operations
|
$
|
162,442,267
|
||
Consolidated Statement of Changes in Net Assets
|
||||
Six months ended
January 31, 2025
(Unaudited)
|
Year ended
July 31, 2024
|
|||
Increase (Decrease) in Net Assets
|
||||
Operations
|
||||
Net investment income (loss)
|
$
|
(6,555,019)
|
$
|
(10,109,111)
|
Net realized gain (loss)
|
260,533,695
|
306,778,453
|
||
Change in net unrealized appreciation (depreciation)
|
(91,536,409)
|
(39,300,835)
|
||
Net increase (decrease) in net assets resulting from operations
|
162,442,267
|
257,368,507
|
||
Distributions to shareholders
|
(441,537,080)
|
-
|
||
Share transactions - net increase (decrease)
|
(149,124,979)
|
(1,313,714,176)
|
||
Total increase (decrease) in net assets
|
(428,219,792)
|
(1,056,345,669)
|
||
Net Assets
|
||||
Beginning of period
|
4,615,583,149
|
5,671,928,818
|
||
End of period
|
$
|
4,187,363,357
|
$
|
4,615,583,149
|
Fidelity Advisor® Health Care Fund Class A |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
63.72
|
$
|
59.73
|
$
|
57.59
|
$
|
69.58
|
$
|
61.07
|
$
|
49.21
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.12)
|
(.19)
|
(.24)
|
(.26)
|
(.26)
|
(.04)
|
||||||
Net realized and unrealized gain (loss)
|
2.17
|
4.18
|
2.38
|
(7.58)
|
12.55
|
12.08
|
||||||
Total from investment operations
|
2.05
|
3.99
|
2.14
|
(7.84)
|
12.29
|
12.04
|
||||||
Distributions from net investment income
|
-
|
-
|
-
|
-
|
(.16)
|
-
|
||||||
Distributions from net realized gain
|
(6.86)
|
-
|
-
|
(4.15)
|
(3.62)
|
(.18)
|
||||||
Total distributions
|
(6.86)
|
-
|
-
|
(4.15)
|
(3.78)
|
(.18)
|
||||||
Net asset value, end of period
|
$
|
58.91
|
$
|
63.72
|
$
|
59.73
|
$
|
57.59
|
$
|
69.58
|
$
|
61.07
|
Total Return C,D,E
|
3.63 % |
6.68%
|
3.72%
|
(11.90)%
|
20.70%
|
24.50%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
.92% H
|
.97%
|
.98%
|
.97%
|
.98%
|
1.01%
|
||||||
Expenses net of fee waivers, if any
|
.92 % H |
.96%
|
.97%
|
.97%
|
.98%
|
1.00%
|
||||||
Expenses net of all reductions
|
.92% H
|
.96%
|
.97%
|
.97%
|
.98%
|
1.00%
|
||||||
Net investment income (loss)
|
(.39)% H
|
(.32)%
|
(.42)%
|
(.42)%
|
(.39)%
|
(.07)%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
1,388,030
|
$
|
1,437,683
|
$
|
1,535,212
|
$
|
1,488,238
|
$
|
1,735,235
|
$
|
1,372,082
|
Portfolio turnover rate I
|
48 % H |
37%
|
47%
|
33%
|
38%
|
53% J
|
Fidelity Advisor® Health Care Fund Class M |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
58.09
|
$
|
54.58
|
$
|
52.76
|
$
|
64.25
|
$
|
56.62
|
$
|
45.75
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.19)
|
(.31)
|
(.36)
|
(.38)
|
(.39)
|
(.16)
|
||||||
Net realized and unrealized gain (loss)
|
1.96
|
3.82
|
2.18
|
(6.96)
|
11.61
|
11.21
|
||||||
Total from investment operations
|
1.77
|
3.51
|
1.82
|
(7.34)
|
11.22
|
11.05
|
||||||
Distributions from net investment income
|
-
|
-
|
-
|
-
|
(.02)
|
-
|
||||||
Distributions from net realized gain
|
(6.86)
|
-
|
-
|
(4.15)
|
(3.57)
|
(.18)
|
||||||
Total distributions
|
(6.86)
|
-
|
-
|
(4.15)
|
(3.59)
|
(.18)
|
||||||
Net asset value, end of period
|
$
|
53.00
|
$
|
58.09
|
$
|
54.58
|
$
|
52.76
|
$
|
64.25
|
$
|
56.62
|
Total Return C,D,E
|
3.50 % |
6.43%
|
3.45%
|
(12.12)%
|
20.39%
|
24.19%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
1.17% H
|
1.22%
|
1.23%
|
1.22%
|
1.23%
|
1.26%
|
||||||
Expenses net of fee waivers, if any
|
1.17 % H |
1.22%
|
1.23%
|
1.22%
|
1.23%
|
1.26%
|
||||||
Expenses net of all reductions
|
1.17% H
|
1.22%
|
1.23%
|
1.22%
|
1.23%
|
1.26%
|
||||||
Net investment income (loss)
|
(.63)% H
|
(.57)%
|
(.67)%
|
(.67)%
|
(.65)%
|
(.33)%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
289,698
|
$
|
301,382
|
$
|
315,963
|
$
|
330,452
|
$
|
402,175
|
$
|
349,280
|
Portfolio turnover rate I
|
48 % H |
37%
|
47%
|
33%
|
38%
|
53% J
|
Fidelity Advisor® Health Care Fund Class C |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
46.87
|
$
|
44.26
|
$
|
43.00
|
$
|
53.40
|
$
|
47.63
|
$
|
38.70
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.27)
|
(.46)
|
(.51)
|
(.55)
|
(.58)
|
(.34)
|
||||||
Net realized and unrealized gain (loss)
|
1.53
|
3.07
|
1.77
|
(5.70)
|
9.71
|
9.45
|
||||||
Total from investment operations
|
1.26
|
2.61
|
1.26
|
(6.25)
|
9.13
|
9.11
|
||||||
Distributions from net realized gain
|
(6.86)
|
-
|
-
|
(4.15)
|
(3.36)
|
(.18)
|
||||||
Total distributions
|
(6.86)
|
-
|
-
|
(4.15)
|
(3.36)
|
(.18)
|
||||||
Net asset value, end of period
|
$
|
41.27
|
$
|
46.87
|
$
|
44.26
|
$
|
43.00
|
$
|
53.40
|
$
|
47.63
|
Total Return C,D,E
|
3.24 % |
5.90%
|
2.93%
|
(12.56)%
|
19.78%
|
23.58%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
1.67% H
|
1.71%
|
1.73%
|
1.72%
|
1.73%
|
1.76%
|
||||||
Expenses net of fee waivers, if any
|
1.67 % H |
1.70%
|
1.73%
|
1.72%
|
1.73%
|
1.76%
|
||||||
Expenses net of all reductions
|
1.67% H
|
1.70%
|
1.73%
|
1.72%
|
1.73%
|
1.75%
|
||||||
Net investment income (loss)
|
(1.13)% H
|
(1.06)%
|
(1.17)%
|
(1.17)%
|
(1.15)%
|
(.82)%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
227,288
|
$
|
265,779
|
$
|
365,165
|
$
|
501,742
|
$
|
697,626
|
$
|
654,487
|
Portfolio turnover rate I
|
48 % H |
37%
|
47%
|
33%
|
38%
|
53% J
|
Fidelity Advisor® Health Care Fund Class I |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
71.00
|
$
|
66.37
|
$
|
63.83
|
$
|
76.48
|
$
|
66.81
|
$
|
53.77
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.05)
|
(.04)
|
(.10)
|
(.11)
|
(.10)
|
.11
|
||||||
Net realized and unrealized gain (loss)
|
2.45
|
4.67
|
2.64
|
(8.39)
|
13.76
|
13.22
|
||||||
Total from investment operations
|
2.40
|
4.63
|
2.54
|
(8.50)
|
13.66
|
13.33
|
||||||
Distributions from net investment income
|
-
|
-
|
-
|
-
|
(.30)
|
-
|
||||||
Distributions from net realized gain
|
(6.86)
|
-
|
-
|
(4.15)
|
(3.69)
|
(.29)
|
||||||
Total distributions
|
(6.86)
|
-
|
-
|
(4.15)
|
(3.99)
|
(.29)
|
||||||
Net asset value, end of period
|
$
|
66.54
|
$
|
71.00
|
$
|
66.37
|
$
|
63.83
|
$
|
76.48
|
$
|
66.81
|
Total Return C,D
|
3.75 % |
6.98%
|
3.98%
|
(11.68)%
|
21.01%
|
24.84%
|
||||||
Ratios to Average Net Assets B,E,F
|
||||||||||||
Expenses before reductions
|
.67% G
|
.70%
|
.72%
|
.71%
|
.72%
|
.74%
|
||||||
Expenses net of fee waivers, if any
|
.67 % G |
.70%
|
.71%
|
.71%
|
.72%
|
.74%
|
||||||
Expenses net of all reductions
|
.67% G
|
.70%
|
.71%
|
.71%
|
.72%
|
.74%
|
||||||
Net investment income (loss)
|
(.13)% G
|
(.05)%
|
(.16)%
|
(.16)%
|
(.13)%
|
.19%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
1,788,593
|
$
|
2,031,441
|
$
|
2,593,539
|
$
|
2,743,740
|
$
|
3,410,787
|
$
|
2,546,323
|
Portfolio turnover rate H
|
48 % G |
37%
|
47%
|
33%
|
38%
|
53% I
|
Fidelity Advisor® Health Care Fund Class Z |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
71.29
|
$
|
66.56
|
$
|
63.93
|
$
|
76.55
|
$
|
66.88
|
$
|
53.84
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.01)
|
.06
|
(.02)
|
(.03)
|
(.01)
|
.19
|
||||||
Net realized and unrealized gain (loss)
|
2.47
|
4.67
|
2.65
|
(8.38)
|
13.77
|
13.22
|
||||||
Total from investment operations
|
2.46
|
4.73
|
2.63
|
(8.41)
|
13.76
|
13.41
|
||||||
Distributions from net investment income
|
-
|
-
|
-
|
-
|
(.37)
|
-
|
||||||
Distributions from net realized gain
|
(6.86)
|
-
|
-
|
(4.21)
|
(3.73)
|
(.37)
|
||||||
Total distributions
|
(6.86)
|
-
|
-
|
(4.21)
|
(4.09) C
|
(.37)
|
||||||
Net asset value, end of period
|
$
|
66.89
|
$
|
71.29
|
$
|
66.56
|
$
|
63.93
|
$
|
76.55
|
$
|
66.88
|
Total Return D,E
|
3.82 % |
7.11%
|
4.11%
|
(11.56)%
|
21.15%
|
24.98%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
.56% H
|
.56%
|
.59%
|
.59%
|
.60%
|
.61%
|
||||||
Expenses net of fee waivers, if any
|
.56 % H |
.56%
|
.59%
|
.59%
|
.60%
|
.61%
|
||||||
Expenses net of all reductions
|
.56% H
|
.56%
|
.59%
|
.59%
|
.59%
|
.61%
|
||||||
Net investment income (loss)
|
(.02)% H
|
.08%
|
(.03)%
|
(.04)%
|
(.01)%
|
.32%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
493,754
|
$
|
579,298
|
$
|
862,051
|
$
|
817,321
|
$
|
952,460
|
$
|
610,481
|
Portfolio turnover rate I
|
48 % H |
37%
|
47%
|
33%
|
38%
|
53% J
|
Common Stocks - 99.0%
|
|||
Shares
|
Value ($)
|
||
UNITED STATES - 99.0%
|
|||
Industrials - 98.2%
|
|||
Aerospace & Defense - 24.5%
|
|||
Axon Enterprise Inc (a)
|
12,200
|
7,956,596
|
|
Boeing Co (a)
|
148,064
|
26,136,257
|
|
GE Aerospace
|
220,337
|
44,854,003
|
|
General Dynamics Corp
|
41,700
|
10,716,066
|
|
HEICO Corp Class A
|
36,500
|
6,947,045
|
|
Howmet Aerospace Inc
|
285,758
|
36,171,248
|
|
Huntington Ingalls Industries Inc
|
13,800
|
2,722,188
|
|
Loar Holdings Inc (b)
|
500
|
39,740
|
|
Rocket Lab USA Inc Class A (a)
|
42,900
|
1,246,245
|
|
RTX Corp
|
29,600
|
3,816,920
|
|
Standardaero Inc (b)
|
3,000
|
80,520
|
|
TransDigm Group Inc
|
17,314
|
23,431,729
|
|
164,118,557
|
|||
Air Freight & Logistics - 0.3%
|
|||
CH Robinson Worldwide Inc
|
12,700
|
1,263,523
|
|
FedEx Corp
|
2,900
|
768,123
|
|
2,031,646
|
|||
Building Products - 10.3%
|
|||
AZEK Co Inc/The Class A (a)
|
235,400
|
12,059,542
|
|
Carlisle Cos Inc
|
19,524
|
7,603,817
|
|
Fortune Brands Innovations Inc (b)
|
157,500
|
11,288,025
|
|
Johnson Controls International plc
|
106,557
|
8,311,446
|
|
Simpson Manufacturing Co Inc
|
36,879
|
6,195,672
|
|
Trane Technologies PLC
|
66,100
|
23,977,775
|
|
69,436,277
|
|||
Commercial Services & Supplies - 2.9%
|
|||
Cintas Corp
|
35,400
|
7,100,178
|
|
Waste Connections Inc (United States)
|
67,200
|
12,349,344
|
|
19,449,522
|
|||
Construction & Engineering - 3.6%
|
|||
Comfort Systems USA Inc
|
11,600
|
5,066,300
|
|
Quanta Services Inc
|
42,700
|
13,134,947
|
|
WillScot Holdings Corp (a)
|
160,200
|
5,937,012
|
|
24,138,259
|
|||
Electrical Equipment - 13.6%
|
|||
AMETEK Inc
|
106,034
|
19,569,635
|
|
Eaton Corp PLC
|
66,516
|
21,713,483
|
|
GE Vernova Inc
|
99,659
|
37,160,848
|
|
Regal Rexnord Corp
|
50,005
|
7,937,294
|
|
Vertiv Holdings Co Class A
|
40,700
|
4,762,714
|
|
91,143,974
|
|||
Ground Transportation - 10.6%
|
|||
CSX Corp
|
65,583
|
2,155,713
|
|
Knight-Swift Transportation Holdings Inc
|
206,900
|
11,811,921
|
|
Old Dominion Freight Line Inc
|
55,000
|
10,208,550
|
|
Uber Technologies Inc (a)
|
209,100
|
13,978,335
|
|
Union Pacific Corp
|
95,400
|
23,639,166
|
|
XPO Inc (a)
|
73,200
|
9,784,644
|
|
71,578,329
|
|||
Industrial Conglomerates - 0.9%
|
|||
3M Co
|
39,100
|
5,951,020
|
|
Machinery - 22.1%
|
|||
Allison Transmission Holdings Inc
|
800
|
94,032
|
|
Caterpillar Inc
|
21,300
|
7,911,672
|
|
Chart Industries Inc (a)
|
36,400
|
7,701,876
|
|
Deere & Co
|
41,800
|
19,920,208
|
|
Dover Corp
|
100,300
|
20,429,104
|
|
Ingersoll Rand Inc
|
274,743
|
25,770,893
|
|
ITT Inc
|
127,209
|
19,211,103
|
|
Parker-Hannifin Corp
|
42,413
|
29,988,112
|
|
Westinghouse Air Brake Technologies Corp
|
85,600
|
17,797,952
|
|
148,824,952
|
|||
Professional Services - 2.6%
|
|||
KBR Inc (b)
|
129,100
|
7,025,622
|
|
Leidos Holdings Inc
|
75,300
|
10,694,859
|
|
17,720,481
|
|||
Trading Companies & Distributors - 6.8%
|
|||
Core & Main Inc Class A (a)(b)
|
161,100
|
9,092,484
|
|
FTAI Aviation Ltd
|
63,100
|
6,343,443
|
|
United Rentals Inc
|
21,400
|
16,222,484
|
|
Watsco Inc
|
11,800
|
5,647,362
|
|
WW Grainger Inc
|
8,100
|
8,607,627
|
|
45,913,400
|
|||
TOTAL INDUSTRIALS
|
660,306,417
|
||
Materials - 0.8%
|
|||
Construction Materials - 0.8%
|
|||
Eagle Materials Inc
|
20,700
|
5,314,518
|
|
TOTAL UNITED STATES
|
665,620,935
|
||
|
TOTAL COMMON STOCKS
(Cost $456,420,957)
|
665,620,935
|
||
Money Market Funds - 2.1%
|
||||
Yield (%)
|
Shares
|
Value ($)
|
||
Fidelity Cash Central Fund (c)
|
4.37
|
7,426,768
|
7,428,254
|
|
Fidelity Securities Lending Cash Central Fund (c)(d)
|
4.37
|
6,938,809
|
6,939,503
|
|
|
TOTAL MONEY MARKET FUNDS
(Cost $14,367,757)
|
14,367,757
|
|||
|
TOTAL INVESTMENT IN SECURITIES - 101.1%
(Cost $470,788,714)
|
679,988,692
|
NET OTHER ASSETS (LIABILITIES) - (1.1)%
|
(7,509,097)
|
NET ASSETS - 100.0%
|
672,479,595
|
(a)
|
Non-income producing
|
(b)
|
Security or a portion of the security is on loan at period end.
|
(c)
|
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
|
(d)
|
Investment made with cash collateral received from securities on loan.
|
Affiliate
|
Value,
beginning
of period ($)
|
Purchases ($)
|
Sales
Proceeds ($)
|
Dividend
Income ($)
|
Realized
Gain (loss) ($)
|
Change in
Unrealized
appreciation
(depreciation) ($)
|
Value,
end
of period ($)
|
Shares,
end
of period
|
% ownership,
end
of period
|
Fidelity Cash Central Fund
|
2,941,600
|
80,386,115
|
75,899,461
|
82,227
|
-
|
-
|
7,428,254
|
7,426,768
|
0.0%
|
Fidelity Securities Lending Cash Central Fund
|
10,896,975
|
74,278,963
|
78,236,435
|
3,657
|
-
|
-
|
6,939,503
|
6,938,809
|
0.0%
|
Total
|
13,838,575
|
154,665,078
|
154,135,896
|
85,884
|
-
|
-
|
14,367,757
|
14,365,577
|
|
Valuation Inputs at Reporting Date:
|
||||
Description
|
Total ($)
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Investments in Securities:
|
||||
Common Stocks
|
||||
Industrials
|
660,306,417
|
660,306,417
|
-
|
-
|
Materials
|
5,314,518
|
5,314,518
|
-
|
-
|
Money Market Funds
|
14,367,757
|
14,367,757
|
-
|
-
|
Total Investments in Securities:
|
679,988,692
|
679,988,692
|
-
|
-
|
Statement of Assets and Liabilities
|
||||
|
As of January 31, 2025 (Unaudited)
|
||||
Assets
|
||||
Investment in securities, at value (including securities loaned of $6,718,000) - See accompanying schedule:
|
||||
Unaffiliated issuers (cost $456,420,957)
|
$
|
665,620,935
|
||
Fidelity Central Funds (cost $14,367,757)
|
14,367,757
|
|||
Total Investment in Securities (cost $470,788,714)
|
$
|
679,988,692
|
||
Receivable for fund shares sold
|
481,551
|
|||
Dividends receivable
|
127,440
|
|||
Distributions receivable from Fidelity Central Funds
|
12,611
|
|||
Prepaid expenses
|
504
|
|||
Other receivables
|
2,052
|
|||
Total assets
|
680,612,850
|
|||
Liabilities
|
||||
Payable for investments purchased
|
$
|
11,920
|
||
Payable for fund shares redeemed
|
653,849
|
|||
Distributions payable
|
362
|
|||
Accrued management fee
|
370,974
|
|||
Distribution and service plan fees payable
|
121,519
|
|||
Other payables and accrued expenses
|
35,128
|
|||
Collateral on securities loaned
|
6,939,503
|
|||
Total liabilities
|
8,133,255
|
|||
Net Assets
|
$
|
672,479,595
|
||
Net Assets consist of:
|
||||
Paid in capital
|
$
|
461,884,625
|
||
Total accumulated earnings (loss)
|
210,594,970
|
|||
Net Assets
|
$
|
672,479,595
|
||
Net Asset Value and Maximum Offering Price
|
||||
Class A :
|
||||
Net Asset Value and redemption price per share ($301,884,576 ÷ 6,266,208 shares)(a)
|
$
|
48.18
|
||
Maximum offering price per share (100/94.25 of $48.18)
|
$
|
51.12
|
||
Class M :
|
||||
Net Asset Value and redemption price per share ($71,578,590 ÷ 1,551,912 shares)(a)
|
$
|
46.12
|
||
Maximum offering price per share (100/96.50 of $46.12)
|
$
|
47.79
|
||
Class C :
|
||||
Net Asset Value and offering price per share ($37,023,892 ÷ 961,901 shares)(a)
|
$
|
38.49
|
||
Class I :
|
||||
Net Asset Value, offering price and redemption price per share ($201,710,074 ÷ 3,823,760 shares)
|
$
|
52.75
|
||
Class Z :
|
||||
Net Asset Value, offering price and redemption price per share ($60,282,463 ÷ 1,143,579 shares)
|
$
|
52.71
|
||
(a)Redemption price per share is equal to net asset value less any applicable contingent deferred sales charge.
|
||||
Statement of Operations
|
||||
Six months ended January 31, 2025 (Unaudited)
|
||||
Investment Income
|
||||
Dividends
|
$
|
2,858,553
|
||
Income from Fidelity Central Funds (including $3,657 from security lending)
|
85,884
|
|||
Total income
|
2,944,437
|
|||
Expenses
|
||||
Management fee
|
$
|
2,104,949
|
||
Distribution and service plan fees
|
706,562
|
|||
Custodian fees and expenses
|
7,576
|
|||
Independent trustees' fees and expenses
|
1,305
|
|||
Registration fees
|
65,762
|
|||
Audit fees
|
28,703
|
|||
Legal
|
1,152
|
|||
Miscellaneous
|
12,033
|
|||
Total expenses
|
2,928,042
|
|||
Net Investment income (loss)
|
16,395
|
|||
Realized and Unrealized Gain (Loss)
|
||||
Net realized gain (loss) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
16,473,900
|
|||
Total net realized gain (loss)
|
16,473,900
|
|||
Change in net unrealized appreciation (depreciation) on investment securities
|
38,729,548
|
|||
Net gain (loss)
|
55,203,448
|
|||
Net increase (decrease) in net assets resulting from operations
|
$
|
55,219,843
|
||
Statement of Changes in Net Assets
|
||||
Six months ended
January 31, 2025
(Unaudited)
|
Year ended
July 31, 2024
|
|||
Increase (Decrease) in Net Assets
|
||||
Operations
|
||||
Net investment income (loss)
|
$
|
16,395
|
$
|
281,065
|
Net realized gain (loss)
|
16,473,900
|
24,765,828
|
||
Change in net unrealized appreciation (depreciation)
|
38,729,548
|
93,441,973
|
||
Net increase (decrease) in net assets resulting from operations
|
55,219,843
|
118,488,866
|
||
Distributions to shareholders
|
(24,480,678)
|
(39,770,362)
|
||
Share transactions - net increase (decrease)
|
59,730,182
|
(55,430,353)
|
||
Total increase (decrease) in net assets
|
90,469,347
|
23,288,151
|
||
Net Assets
|
||||
Beginning of period
|
582,010,248
|
558,722,097
|
||
End of period
|
$
|
672,479,595
|
$
|
582,010,248
|
Fidelity Advisor® Industrials Fund Class A |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
45.68
|
$
|
39.24
|
$
|
34.23
|
$
|
45.64
|
$
|
33.85
|
$
|
38.95
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.01)
|
.01 C
|
(.05) D
|
(.14)
|
(.17)
|
.18 E
|
||||||
Net realized and unrealized gain (loss)
|
4.35
|
9.77
|
6.24
|
(2.62)
|
12.20
|
(2.46)
|
||||||
Total from investment operations
|
4.34
|
9.78
|
6.19
|
(2.76)
|
12.03
|
(2.28)
|
||||||
Distributions from net investment income
|
(.08)
|
-
|
(.02)
|
-
|
-
|
(.25)
|
||||||
Distributions from net realized gain
|
(1.76)
|
(3.34)
|
(1.16)
|
(8.65)
|
(.24)
|
(2.57)
|
||||||
Total distributions
|
(1.84)
|
(3.34)
|
(1.18)
|
(8.65)
|
(.24)
|
(2.82)
|
||||||
Net asset value, end of period
|
$
|
48.18
|
$
|
45.68
|
$
|
39.24
|
$
|
34.23
|
$
|
45.64
|
$
|
33.85
|
Total Return F,G,H
|
9.69 % |
26.64%
|
18.68%
|
(7.79)%
|
35.63%
|
(6.58)%
|
||||||
Ratios to Average Net Assets B,I,J
|
||||||||||||
Expenses before reductions
|
.99% K
|
1.00%
|
1.03%
|
1.02%
|
1.03%
|
1.05%
|
||||||
Expenses net of fee waivers, if any
|
.99 % K |
1.00%
|
1.03%
|
1.01%
|
1.03%
|
1.05%
|
||||||
Expenses net of all reductions
|
.99% K
|
1.00%
|
1.03%
|
1.01%
|
1.01%
|
1.03%
|
||||||
Net investment income (loss)
|
(.03)% K
|
.02% C
|
(.13)% D
|
(.35)%
|
(.40)%
|
.49% E
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
301,885
|
$
|
275,457
|
$
|
226,370
|
$
|
214,576
|
$
|
264,130
|
$
|
199,835
|
Portfolio turnover rate L
|
31 % K |
29% M
|
189% M
|
106%
|
205%
|
219% M
|
Fidelity Advisor® Industrials Fund Class M |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
43.74
|
$
|
37.77
|
$
|
33.05
|
$
|
44.31
|
$
|
32.96
|
$
|
37.99
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.06)
|
(.09) C
|
(.13) D
|
(.23)
|
(.27)
|
.08 E
|
||||||
Net realized and unrealized gain (loss)
|
4.16
|
9.36
|
6.01
|
(2.53)
|
11.86
|
(2.39)
|
||||||
Total from investment operations
|
4.10
|
9.27
|
5.88
|
(2.76)
|
11.59
|
(2.31)
|
||||||
Distributions from net investment income
|
-
|
-
|
-
|
-
|
-
|
(.15)
|
||||||
Distributions from net realized gain
|
(1.72)
|
(3.30)
|
(1.16)
|
(8.50)
|
(.24)
|
(2.57)
|
||||||
Total distributions
|
(1.72)
|
(3.30)
|
(1.16)
|
(8.50)
|
(.24)
|
(2.72)
|
||||||
Net asset value, end of period
|
$
|
46.12
|
$
|
43.74
|
$
|
37.77
|
$
|
33.05
|
$
|
44.31
|
$
|
32.96
|
Total Return F,G,H
|
9.56 % |
26.30%
|
18.39%
|
(8.03)%
|
35.25%
|
(6.82)%
|
||||||
Ratios to Average Net Assets B,I,J
|
||||||||||||
Expenses before reductions
|
1.24% K
|
1.25%
|
1.29%
|
1.27%
|
1.29%
|
1.31%
|
||||||
Expenses net of fee waivers, if any
|
1.24 % K |
1.25%
|
1.28%
|
1.27%
|
1.29%
|
1.31%
|
||||||
Expenses net of all reductions
|
1.24% K
|
1.25%
|
1.28%
|
1.27%
|
1.27%
|
1.30%
|
||||||
Net investment income (loss)
|
(.28)% K
|
(.23)% C
|
(.38)% D
|
(.60)%
|
(.66)%
|
.23% E
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
71,579
|
$
|
67,472
|
$
|
54,175
|
$
|
49,501
|
$
|
56,680
|
$
|
45,157
|
Portfolio turnover rate L
|
31 % K |
29% M
|
189% M
|
106%
|
205%
|
219% M
|
Fidelity Advisor® Industrials Fund Class C |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
36.87
|
$
|
32.48
|
$
|
28.72
|
$
|
39.46
|
$
|
29.52
|
$
|
34.27
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.15)
|
(.24) C
|
(.26) D
|
(.37)
|
(.41)
|
(.08) E
|
||||||
Net realized and unrealized gain (loss)
|
3.49
|
7.93
|
5.18
|
(2.19)
|
10.59
|
(2.15)
|
||||||
Total from investment operations
|
3.34
|
7.69
|
4.92
|
(2.56)
|
10.18
|
(2.23)
|
||||||
Distributions from net investment income
|
-
|
-
|
-
|
-
|
-
|
(.03)
|
||||||
Distributions from net realized gain
|
(1.72)
|
(3.30)
|
(1.16)
|
(8.18)
|
(.24)
|
(2.49)
|
||||||
Total distributions
|
(1.72)
|
(3.30)
|
(1.16)
|
(8.18)
|
(.24)
|
(2.52)
|
||||||
Net asset value, end of period
|
$
|
38.49
|
$
|
36.87
|
$
|
32.48
|
$
|
28.72
|
$
|
39.46
|
$
|
29.52
|
Total Return F,G,H
|
9.26 % |
25.68%
|
17.81%
|
(8.48)%
|
34.58%
|
(7.27)%
|
||||||
Ratios to Average Net Assets B,I,J
|
||||||||||||
Expenses before reductions
|
1.75% K
|
1.76%
|
1.79%
|
1.77%
|
1.79%
|
1.81%
|
||||||
Expenses net of fee waivers, if any
|
1.75 % K |
1.76%
|
1.78%
|
1.77%
|
1.79%
|
1.81%
|
||||||
Expenses net of all reductions
|
1.75% K
|
1.76%
|
1.78%
|
1.77%
|
1.77%
|
1.79%
|
||||||
Net investment income (loss)
|
(.79)% K
|
(.74)% C
|
(.89)% D
|
(1.10)%
|
(1.16)%
|
(.26)% E
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
37,024
|
$
|
33,930
|
$
|
33,293
|
$
|
37,417
|
$
|
55,576
|
$
|
53,969
|
Portfolio turnover rate L
|
31 % K |
29% M
|
189% M
|
106%
|
205%
|
219% M
|
Fidelity Advisor® Industrials Fund Class I |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
49.94
|
$
|
42.55
|
$
|
36.95
|
$
|
48.64
|
$
|
35.97
|
$
|
41.20
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.06
|
.13 C
|
.05 D
|
(.03)
|
(.06)
|
.29 E
|
||||||
Net realized and unrealized gain (loss)
|
4.76
|
10.65
|
6.77
|
(2.84)
|
12.97
|
(2.60)
|
||||||
Total from investment operations
|
4.82
|
10.78
|
6.82
|
(2.87)
|
12.91
|
(2.31)
|
||||||
Distributions from net investment income
|
(.24)
|
-
|
(.06)
|
-
|
-
|
(.35)
|
||||||
Distributions from net realized gain
|
(1.76)
|
(3.39)
|
(1.16)
|
(8.82)
|
(.24)
|
(2.57)
|
||||||
Total distributions
|
(2.01) F
|
(3.39)
|
(1.22)
|
(8.82)
|
(.24)
|
(2.92)
|
||||||
Net asset value, end of period
|
$
|
52.75
|
$
|
49.94
|
$
|
42.55
|
$
|
36.95
|
$
|
48.64
|
$
|
35.97
|
Total Return G,H
|
9.83 % |
26.97%
|
19.02%
|
(7.55)%
|
35.98%
|
(6.32)%
|
||||||
Ratios to Average Net Assets B,I,J
|
||||||||||||
Expenses before reductions
|
.72% K
|
.74%
|
.76%
|
.75%
|
.76%
|
.78%
|
||||||
Expenses net of fee waivers, if any
|
.72 % K |
.73%
|
.76%
|
.75%
|
.76%
|
.78%
|
||||||
Expenses net of all reductions
|
.72% K
|
.73%
|
.76%
|
.75%
|
.74%
|
.76%
|
||||||
Net investment income (loss)
|
.24% K
|
.29% C
|
.14% D
|
(.08)%
|
(.14)%
|
.76% E
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
201,710
|
$
|
157,455
|
$
|
140,764
|
$
|
145,849
|
$
|
248,090
|
$
|
123,603
|
Portfolio turnover rate L
|
31 % K |
29% M
|
189% M
|
106%
|
205%
|
219% M
|
Fidelity Advisor® Industrials Fund Class Z |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
49.95
|
$
|
42.52
|
$
|
36.91
|
$
|
48.61
|
$
|
35.90
|
$
|
41.15
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.09
|
.18 C
|
.10 D
|
.02
|
- E
|
.34 F
|
||||||
Net realized and unrealized gain (loss)
|
4.75
|
10.65
|
6.75
|
(2.83)
|
12.95
|
(2.60)
|
||||||
Total from investment operations
|
4.84
|
10.83
|
6.85
|
(2.81)
|
12.95
|
(2.26)
|
||||||
Distributions from net investment income
|
(.32)
|
-
|
(.08)
|
-
|
-
|
(.42)
|
||||||
Distributions from net realized gain
|
(1.76)
|
(3.40)
|
(1.16)
|
(8.89)
|
(.24)
|
(2.57)
|
||||||
Total distributions
|
(2.08)
|
(3.40)
|
(1.24)
|
(8.89)
|
(.24)
|
(2.99)
|
||||||
Net asset value, end of period
|
$
|
52.71
|
$
|
49.95
|
$
|
42.52
|
$
|
36.91
|
$
|
48.61
|
$
|
35.90
|
Total Return G,H
|
9.89 % |
27.12%
|
19.14%
|
(7.42)%
|
36.16%
|
(6.21)%
|
||||||
Ratios to Average Net Assets B,I,J
|
||||||||||||
Expenses before reductions
|
.60% K
|
.61%
|
.64%
|
.63%
|
.64%
|
.65%
|
||||||
Expenses net of fee waivers, if any
|
.60 % K |
.61%
|
.63%
|
.62%
|
.64%
|
.65%
|
||||||
Expenses net of all reductions
|
.60% K
|
.61%
|
.63%
|
.62%
|
.62%
|
.63%
|
||||||
Net investment income (loss)
|
.36% K
|
.41% C
|
.26% D
|
.04%
|
(.01)%
|
.89% F
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
60,282
|
$
|
47,696
|
$
|
104,120
|
$
|
23,974
|
$
|
50,167
|
$
|
29,168
|
Portfolio turnover rate L
|
31 % K |
29% M
|
189% M
|
106%
|
205%
|
219% M
|
Common Stocks - 94.9%
|
|||
Shares
|
Value ($)
|
||
CHINA - 4.9%
|
|||
Information Technology - 4.9%
|
|||
Semiconductors & Semiconductor Equipment - 4.9%
|
|||
NXP Semiconductors NV
|
695,296
|
145,003,981
|
|
ISRAEL - 2.0%
|
|||
Information Technology - 2.0%
|
|||
Semiconductors & Semiconductor Equipment - 2.0%
|
|||
Nova Ltd (b)(c)
|
247,932
|
60,787,968
|
|
JAPAN - 1.1%
|
|||
Information Technology - 1.1%
|
|||
Semiconductors & Semiconductor Equipment - 1.1%
|
|||
Allegro MicroSystems Inc (c)
|
1,036,667
|
24,973,308
|
|
Kioxia Holdings Corp (b)(c)
|
712,600
|
8,277,541
|
|
TOTAL JAPAN
|
33,250,849
|
||
NETHERLANDS - 3.1%
|
|||
Information Technology - 3.1%
|
|||
Semiconductors & Semiconductor Equipment - 3.1%
|
|||
ASML Holding NV depository receipt
|
123,677
|
91,435,643
|
|
TAIWAN - 8.2%
|
|||
Information Technology - 8.2%
|
|||
Semiconductors & Semiconductor Equipment - 8.2%
|
|||
Silicon Motion Technology Corp ADR
|
418,000
|
22,826,980
|
|
Taiwan Semiconductor Manufacturing Co Ltd ADR
|
1,054,988
|
220,830,088
|
|
TOTAL TAIWAN
|
243,657,068
|
||
UNITED STATES - 75.6%
|
|||
Information Technology - 75.6%
|
|||
Electronic Equipment, Instruments & Components - 0.3%
|
|||
Aeva Technologies Inc (b)(c)
|
23,620
|
100,149
|
|
Coherent Corp (c)
|
93,301
|
8,442,807
|
|
8,542,956
|
|||
Semiconductors & Semiconductor Equipment - 71.8%
|
|||
Advanced Micro Devices Inc (c)
|
112,023
|
12,989,067
|
|
Applied Materials Inc
|
17,500
|
3,156,125
|
|
Astera Labs Inc (c)
|
411,980
|
41,783,012
|
|
Broadcom Inc
|
1,668,350
|
369,155,805
|
|
Enphase Energy Inc (b)(c)
|
43,712
|
2,722,382
|
|
GlobalFoundries Inc (c)
|
2,987,983
|
123,911,655
|
|
Impinj Inc (c)
|
198,259
|
25,157,085
|
|
Lam Research Corp
|
1,799,460
|
145,846,233
|
|
Lattice Semiconductor Corp (c)
|
102,528
|
5,846,147
|
|
MACOM Technology Solutions Holdings Inc (c)
|
363,792
|
48,111,492
|
|
Marvell Technology Inc
|
1,986,403
|
224,185,443
|
|
Micron Technology Inc
|
1,563,501
|
142,653,831
|
|
Monolithic Power Systems Inc
|
229,500
|
146,276,415
|
|
NVIDIA Corp
|
5,492,636
|
659,500,805
|
|
ON Semiconductor Corp (c)
|
1,938,957
|
101,485,009
|
|
QUALCOMM Inc
|
26,758
|
4,627,261
|
|
Synaptics Inc (c)
|
234,721
|
19,927,813
|
|
Teradyne Inc
|
491,500
|
56,910,785
|
|
Wolfspeed Inc (b)(c)
|
54,700
|
335,310
|
|
2,134,581,675
|
|||
Software - 0.6%
|
|||
Synopsys Inc (c)
|
34,800
|
18,286,704
|
|
Technology Hardware, Storage & Peripherals - 2.9%
|
|||
Western Digital Corp (c)
|
1,326,589
|
86,400,742
|
|
TOTAL UNITED STATES
|
2,247,812,077
|
||
|
TOTAL COMMON STOCKS
(Cost $1,690,433,314)
|
2,821,947,586
|
||
Convertible Preferred Stocks - 0.4%
|
|||
Shares
|
Value ($)
|
||
UNITED STATES - 0.4%
|
|||
Financials - 0.1%
|
|||
Financial Services - 0.1%
|
|||
Akeana Series C (d)(e)
|
11,132
|
140,819
|
|
Tenstorrent Holdings Inc Series C1 (c)(d)(e)
|
1,740
|
129,508
|
|
Tenstorrent Holdings Inc Series D1 (d)(e)
|
21,358
|
1,683,652
|
|
Tenstorrent Holdings Inc Series D2 (d)(e)
|
1,019
|
77,515
|
|
2,031,494
|
|||
Information Technology - 0.3%
|
|||
Electronic Equipment, Instruments & Components - 0.1%
|
|||
Frore Systems Inc Series C (d)(e)
|
143,630
|
2,282,281
|
|
Menlo Microsystems Inc Series C (c)(d)(e)
|
79,800
|
55,860
|
|
2,338,141
|
|||
Semiconductors & Semiconductor Equipment - 0.1%
|
|||
Alif Semiconductor Series C (c)(d)(e)
|
48,363
|
894,232
|
|
Retym Inc (d)
|
13,663
|
144,691
|
|
Retym Inc Series C (c)(d)(e)
|
55,074
|
552,392
|
|
SiMa Technologies Inc Series B (c)(d)(e)
|
30,638
|
191,488
|
|
SiMa Technologies Inc Series B1 (c)(d)(e)
|
18,145
|
132,458
|
|
1,915,261
|
|||
Software - 0.0%
|
|||
Lyte Ai Inc (d)(e)
|
34,117
|
460,238
|
|
Technology Hardware, Storage & Peripherals - 0.1%
|
|||
Lightmatter Inc (d)(e)
|
23,200
|
1,853,680
|
|
Lightmatter Inc Series C1 (c)(d)(e)
|
32,553
|
2,103,575
|
|
Lightmatter Inc Series C2 (c)(d)(e)
|
5,113
|
336,487
|
|
4,293,742
|
|||
TOTAL INFORMATION TECHNOLOGY
|
9,007,382
|
||
Materials - 0.0%
|
|||
Metals & Mining - 0.0%
|
|||
Diamond Foundry Inc Series C (c)(d)(e)
|
18,335
|
498,345
|
|
TOTAL UNITED STATES
|
11,537,221
|
||
|
TOTAL CONVERTIBLE PREFERRED STOCKS
(Cost $9,664,073)
|
11,537,221
|
||
Preferred Securities - 0.0%
|
|||
Principal
Amount (a)
|
Value ($)
|
||
UNITED STATES - 0.0%
|
|||
Information Technology - 0.0%
|
|||
Semiconductors & Semiconductor Equipment - 0.0%
|
|||
SiMa Technologies Inc 10% 12/31/2027 (d)(e)
(Cost $47,612)
|
47,612
|
49,127
|
|
Money Market Funds - 3.5%
|
||||
Yield (%)
|
Shares
|
Value ($)
|
||
Fidelity Cash Central Fund (f)
|
4.37
|
58,098,404
|
58,110,024
|
|
Fidelity Securities Lending Cash Central Fund (f)(g)
|
4.37
|
47,366,574
|
47,371,310
|
|
|
TOTAL MONEY MARKET FUNDS
(Cost $105,481,334)
|
105,481,334
|
|||
|
TOTAL INVESTMENT IN SECURITIES - 98.8%
(Cost $1,805,626,333)
|
2,939,015,268
|
NET OTHER ASSETS (LIABILITIES) - 1.2%
|
34,458,620
|
NET ASSETS - 100.0%
|
2,973,473,888
|
(a)
|
Amount is stated in United States dollars unless otherwise noted.
|
(b)
|
Security or a portion of the security is on loan at period end.
|
(c)
|
Non-income producing
|
(d)
|
Level 3 security
|
(e)
|
Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $11,441,657 or 0.4% of net assets.
|
(f)
|
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
|
(g)
|
Investment made with cash collateral received from securities on loan.
|
Additional information on each restricted holding is as follows:
|
||
Security
|
Acquisition Date
|
Acquisition Cost ($)
|
Akeana Series C
|
1/23/24
|
142,053
|
Alif Semiconductor Series C
|
3/08/22
|
981,698
|
Diamond Foundry Inc Series C
|
3/15/21
|
440,040
|
Frore Systems Inc Series C
|
5/10/24
|
2,308,192
|
Lightmatter Inc
|
10/11/24
|
1,861,348
|
Lightmatter Inc Series C1
|
5/19/23
|
535,718
|
Lightmatter Inc Series C2
|
12/18/23
|
132,947
|
Lyte Ai Inc
|
8/13/24
|
432,812
|
Menlo Microsystems Inc Series C
|
2/09/22
|
105,775
|
Retym Inc Series C
|
5/17/23 - 6/20/23
|
428,575
|
SiMa Technologies Inc 10% 12/31/2027
|
4/08/24 - 12/31/24
|
47,612
|
SiMa Technologies Inc Series B
|
5/10/21
|
157,093
|
SiMa Technologies Inc Series B1
|
4/25/22 - 10/17/22
|
128,664
|
Tenstorrent Holdings Inc Series C1
|
4/23/21
|
103,509
|
Tenstorrent Holdings Inc Series D1
|
7/16/24 - 1/15/25
|
1,683,575
|
Tenstorrent Holdings Inc Series D2
|
7/17/24
|
77,424
|
Affiliate
|
Value,
beginning
of period ($)
|
Purchases ($)
|
Sales
Proceeds ($)
|
Dividend
Income ($)
|
Realized
Gain (loss) ($)
|
Change in
Unrealized
appreciation
(depreciation) ($)
|
Value,
end
of period ($)
|
Shares,
end
of period
|
% ownership,
end
of period
|
Fidelity Cash Central Fund
|
483
|
566,629,535
|
508,519,994
|
1,419,115
|
-
|
-
|
58,110,024
|
58,098,404
|
0.1%
|
Fidelity Securities Lending Cash Central Fund
|
80,711,425
|
200,244,987
|
233,585,102
|
202,405
|
-
|
-
|
47,371,310
|
47,366,574
|
0.2%
|
Total
|
80,711,908
|
766,874,522
|
742,105,096
|
1,621,520
|
-
|
-
|
105,481,334
|
105,464,978
|
|
Valuation Inputs at Reporting Date:
|
||||
Description
|
Total ($)
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Investments in Securities:
|
||||
Common Stocks
|
||||
Information Technology
|
2,821,947,586
|
2,813,670,045
|
8,277,541
|
-
|
Convertible Preferred Stocks
|
||||
Financials
|
2,031,494
|
-
|
-
|
2,031,494
|
Information Technology
|
9,007,382
|
-
|
-
|
9,007,382
|
Materials
|
498,345
|
-
|
-
|
498,345
|
Preferred Securities
|
||||
Information Technology
|
49,127
|
-
|
-
|
49,127
|
Money Market Funds
|
105,481,334
|
105,481,334
|
-
|
-
|
Total Investments in Securities:
|
2,939,015,268
|
2,919,151,379
|
8,277,541
|
11,586,348
|
Statement of Assets and Liabilities
|
||||
|
As of January 31, 2025 (Unaudited)
|
||||
Assets
|
||||
Investment in securities, at value (including securities loaned of $46,611,828) - See accompanying schedule:
|
||||
Unaffiliated issuers (cost $1,700,144,999)
|
$
|
2,833,533,934
|
||
Fidelity Central Funds (cost $105,481,334)
|
105,481,334
|
|||
Total Investment in Securities (cost $1,805,626,333)
|
$
|
2,939,015,268
|
||
Receivable for investments sold
|
83,306,514
|
|||
Receivable for fund shares sold
|
2,890,166
|
|||
Distributions receivable from Fidelity Central Funds
|
265,575
|
|||
Prepaid expenses
|
2,093
|
|||
Total assets
|
3,025,479,616
|
|||
Liabilities
|
||||
Payable for fund shares redeemed
|
$
|
2,356,240
|
||
Accrued management fee
|
1,694,556
|
|||
Distribution and service plan fees payable
|
536,597
|
|||
Other payables and accrued expenses
|
47,025
|
|||
Collateral on securities loaned
|
47,371,310
|
|||
Total liabilities
|
52,005,728
|
|||
Net Assets
|
$
|
2,973,473,888
|
||
Net Assets consist of:
|
||||
Paid in capital
|
$
|
1,848,307,535
|
||
Total accumulated earnings (loss)
|
1,125,166,353
|
|||
Net Assets
|
$
|
2,973,473,888
|
||
Net Asset Value and Maximum Offering Price
|
||||
Class A :
|
||||
Net Asset Value and redemption price per share ($1,172,700,958 ÷ 14,531,630 shares)(a)
|
$
|
80.70
|
||
Maximum offering price per share (100/94.25 of $80.70)
|
$
|
85.62
|
||
Class M :
|
||||
Net Asset Value and redemption price per share ($189,635,990 ÷ 2,534,450 shares)(a)
|
$
|
74.82
|
||
Maximum offering price per share (100/96.50 of $74.82)
|
$
|
77.53
|
||
Class C :
|
||||
Net Asset Value and offering price per share ($230,362,040 ÷ 3,652,519 shares)(a)
|
$
|
63.07
|
||
Class I :
|
||||
Net Asset Value, offering price and redemption price per share ($1,122,163,556 ÷ 12,765,345 shares)
|
$
|
87.91
|
||
Class Z :
|
||||
Net Asset Value, offering price and redemption price per share ($258,611,344 ÷ 2,932,367 shares)
|
$
|
88.19
|
||
(a)Redemption price per share is equal to net asset value less any applicable contingent deferred sales charge.
|
||||
Statement of Operations
|
||||
Six months ended January 31, 2025 (Unaudited)
|
||||
Investment Income
|
||||
Dividends
|
$
|
6,894,651
|
||
Income from Fidelity Central Funds (including $202,405 from security lending)
|
1,621,520
|
|||
Total income
|
8,516,171
|
|||
Expenses
|
||||
Management fee
|
$
|
9,418,977
|
||
Distribution and service plan fees
|
2,986,890
|
|||
Custodian fees and expenses
|
24,793
|
|||
Independent trustees' fees and expenses
|
6,109
|
|||
Registration fees
|
130,134
|
|||
Audit fees
|
24,809
|
|||
Legal
|
2,222
|
|||
Miscellaneous
|
54,151
|
|||
Total expenses before reductions
|
12,648,085
|
|||
Expense reductions
|
(1,218)
|
|||
Total expenses after reductions
|
12,646,867
|
|||
Net Investment income (loss)
|
(4,130,696)
|
|||
Realized and Unrealized Gain (Loss)
|
||||
Net realized gain (loss) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
102,110,780
|
|||
Foreign currency transactions
|
(18,778)
|
|||
Total net realized gain (loss)
|
102,092,002
|
|||
Change in net unrealized appreciation (depreciation) on investment securities
|
(21,858,599)
|
|||
Net gain (loss)
|
80,233,403
|
|||
Net increase (decrease) in net assets resulting from operations
|
$
|
76,102,707
|
||
Statement of Changes in Net Assets
|
||||
Six months ended
January 31, 2025
(Unaudited)
|
Year ended
July 31, 2024
|
|||
Increase (Decrease) in Net Assets
|
||||
Operations
|
||||
Net investment income (loss)
|
$
|
(4,130,696)
|
$
|
(5,211,730)
|
Net realized gain (loss)
|
102,092,002
|
100,769,422
|
||
Change in net unrealized appreciation (depreciation)
|
(21,858,599)
|
572,951,806
|
||
Net increase (decrease) in net assets resulting from operations
|
76,102,707
|
668,509,498
|
||
Distributions to shareholders
|
(193,954,449)
|
(51,832,290)
|
||
Share transactions - net increase (decrease)
|
393,108,319
|
649,803,004
|
||
Total increase (decrease) in net assets
|
275,256,577
|
1,266,480,212
|
||
Net Assets
|
||||
Beginning of period
|
2,698,217,311
|
1,431,737,099
|
||
End of period
|
$
|
2,973,473,888
|
$
|
2,698,217,311
|
Fidelity Advisor® Semiconductors Fund Class A |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
83.81
|
$
|
62.13
|
$
|
42.85
|
$
|
46.29
|
$
|
29.79
|
$
|
23.03
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.14)
|
(.22)
|
(.05)
|
(.13)
|
(.08)
|
.14
|
||||||
Net realized and unrealized gain (loss)
|
2.79
|
23.97
|
20.53
|
(.83)
|
18.29
|
6.90
|
||||||
Total from investment operations
|
2.65
|
23.75
|
20.48
|
(.96)
|
18.21
|
7.04
|
||||||
Distributions from net investment income
|
-
|
-
|
-
|
-
|
(.04)
|
(.07)
|
||||||
Distributions from net realized gain
|
(5.76)
|
(2.07)
|
(1.20)
|
(2.48)
|
(1.67)
|
(.20)
|
||||||
Total distributions
|
(5.76)
|
(2.07)
|
(1.20)
|
(2.48)
|
(1.71)
|
(.28) C
|
||||||
Net asset value, end of period
|
$
|
80.70
|
$
|
83.81
|
$
|
62.13
|
$
|
42.85
|
$
|
46.29
|
$
|
29.79
|
Total Return D,E,F
|
2.76 % |
39.52%
|
49.31%
|
(3.21)%
|
62.45%
|
30.65%
|
||||||
Ratios to Average Net Assets B,G,H
|
||||||||||||
Expenses before reductions
|
.94% I
|
.97%
|
1.01%
|
1.01%
|
1.04%
|
1.10%
|
||||||
Expenses net of fee waivers, if any
|
.94 % I |
.96%
|
1.00%
|
1.01%
|
1.04%
|
1.09%
|
||||||
Expenses net of all reductions
|
.94% I
|
.96%
|
1.00%
|
1.01%
|
1.03%
|
1.08%
|
||||||
Net investment income (loss)
|
(.34)% I
|
(.31)%
|
(.10)%
|
(.27)%
|
(.21)%
|
.53%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
1,172,701
|
$
|
1,056,998
|
$
|
581,690
|
$
|
319,402
|
$
|
279,755
|
$
|
140,072
|
Portfolio turnover rate J
|
54 % I |
30%
|
40%
|
32%
|
41%
|
136%
|
Fidelity Advisor® Semiconductors Fund Class M |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
78.19
|
$
|
58.24
|
$
|
40.34
|
$
|
43.75
|
$
|
28.25
|
$
|
21.89
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.23)
|
(.37)
|
(.15)
|
(.23)
|
(.17)
|
.06
|
||||||
Net realized and unrealized gain (loss)
|
2.62
|
22.39
|
19.25
|
(.76)
|
17.31
|
6.55
|
||||||
Total from investment operations
|
2.39
|
22.02
|
19.10
|
(.99)
|
17.14
|
6.61
|
||||||
Distributions from net investment income
|
-
|
-
|
-
|
-
|
-
|
(.05)
|
||||||
Distributions from net realized gain
|
(5.76)
|
(2.07)
|
(1.20)
|
(2.42)
|
(1.64)
|
(.20)
|
||||||
Total distributions
|
(5.76)
|
(2.07)
|
(1.20)
|
(2.42)
|
(1.64)
|
(.25)
|
||||||
Net asset value, end of period
|
$
|
74.82
|
$
|
78.19
|
$
|
58.24
|
$
|
40.34
|
$
|
43.75
|
$
|
28.25
|
Total Return C,D,E
|
2.63 % |
39.18%
|
48.95%
|
(3.43)%
|
61.98%
|
30.28%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
1.19% H
|
1.21%
|
1.25%
|
1.26%
|
1.30%
|
1.38%
|
||||||
Expenses net of fee waivers, if any
|
1.19 % H |
1.21%
|
1.25%
|
1.25%
|
1.30%
|
1.38%
|
||||||
Expenses net of all reductions
|
1.19% H
|
1.21%
|
1.25%
|
1.25%
|
1.29%
|
1.37%
|
||||||
Net investment income (loss)
|
(.59)% H
|
(.56)%
|
(.35)%
|
(.52)%
|
(.47)%
|
.24%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
189,636
|
$
|
176,276
|
$
|
94,006
|
$
|
48,499
|
$
|
49,963
|
$
|
29,262
|
Portfolio turnover rate I
|
54 % H |
30%
|
40%
|
32%
|
41%
|
136%
|
Fidelity Advisor® Semiconductors Fund Class C |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
66.90
|
$
|
50.38
|
$
|
35.24
|
$
|
38.59
|
$
|
25.18
|
$
|
19.59
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.36)
|
(.60)
|
(.31)
|
(.40)
|
(.31)
|
(.05)
|
||||||
Net realized and unrealized gain (loss)
|
2.29
|
19.19
|
16.65
|
(.61)
|
15.35
|
5.86
|
||||||
Total from investment operations
|
1.93
|
18.59
|
16.34
|
(1.01)
|
15.04
|
5.81
|
||||||
Distributions from net investment income
|
-
|
-
|
-
|
-
|
-
|
(.01)
|
||||||
Distributions from net realized gain
|
(5.76)
|
(2.07)
|
(1.20)
|
(2.34)
|
(1.63)
|
(.20)
|
||||||
Total distributions
|
(5.76)
|
(2.07)
|
(1.20)
|
(2.34)
|
(1.63)
|
(.22) C
|
||||||
Net asset value, end of period
|
$
|
63.07
|
$
|
66.90
|
$
|
50.38
|
$
|
35.24
|
$
|
38.59
|
$
|
25.18
|
Total Return D,E,F
|
2.38 % |
38.46%
|
48.18%
|
(3.93)%
|
61.17%
|
29.73%
|
||||||
Ratios to Average Net Assets B,G,H
|
||||||||||||
Expenses before reductions
|
1.69% I
|
1.72%
|
1.76%
|
1.76%
|
1.79%
|
1.85%
|
||||||
Expenses net of fee waivers, if any
|
1.69 % I |
1.71%
|
1.76%
|
1.76%
|
1.79%
|
1.85%
|
||||||
Expenses net of all reductions
|
1.69% I
|
1.71%
|
1.76%
|
1.76%
|
1.79%
|
1.83%
|
||||||
Net investment income (loss)
|
(1.09)% I
|
(1.07)%
|
(.86)%
|
(1.03)%
|
(.97)%
|
(.23)%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
230,362
|
$
|
221,749
|
$
|
129,390
|
$
|
88,592
|
$
|
86,217
|
$
|
57,320
|
Portfolio turnover rate J
|
54 % I |
30%
|
40%
|
32%
|
41%
|
136%
|
Fidelity Advisor® Semiconductors Fund Class I |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
90.71
|
$
|
66.91
|
$
|
45.93
|
$
|
49.39
|
$
|
31.68
|
$
|
24.42
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.04)
|
(.05)
|
.08
|
(.01)
|
.03
|
.22
|
||||||
Net realized and unrealized gain (loss)
|
3.00
|
25.92
|
22.10
|
(.92)
|
19.47
|
7.34
|
||||||
Total from investment operations
|
2.96
|
25.87
|
22.18
|
(.93)
|
19.50
|
7.56
|
||||||
Distributions from net investment income
|
-
|
-
|
-
|
-
|
(.12)
|
(.10)
|
||||||
Distributions from net realized gain
|
(5.76)
|
(2.07)
|
(1.20)
|
(2.53)
|
(1.67)
|
(.20)
|
||||||
Total distributions
|
(5.76)
|
(2.07)
|
(1.20)
|
(2.53)
|
(1.79)
|
(.30)
|
||||||
Net asset value, end of period
|
$
|
87.91
|
$
|
90.71
|
$
|
66.91
|
$
|
45.93
|
$
|
49.39
|
$
|
31.68
|
Total Return C,D
|
2.90 % |
39.87%
|
49.71%
|
(2.96)%
|
62.86%
|
31.08%
|
||||||
Ratios to Average Net Assets B,E,F
|
||||||||||||
Expenses before reductions
|
.69% G
|
.72%
|
.74%
|
.75%
|
.77%
|
.81%
|
||||||
Expenses net of fee waivers, if any
|
.69 % G |
.71%
|
.74%
|
.74%
|
.77%
|
.81%
|
||||||
Expenses net of all reductions
|
.69% G
|
.71%
|
.74%
|
.74%
|
.76%
|
.79%
|
||||||
Net investment income (loss)
|
(.09)% G
|
(.07)%
|
.16%
|
(.01)%
|
.06%
|
.81%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
1,122,164
|
$
|
1,016,505
|
$
|
530,775
|
$
|
309,873
|
$
|
257,502
|
$
|
126,660
|
Portfolio turnover rate H
|
54 % G |
30%
|
40%
|
32%
|
41%
|
136%
|
Fidelity Advisor® Semiconductors Fund Class Z |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
90.94
|
$
|
66.99
|
$
|
45.93
|
$
|
49.35
|
$
|
31.65
|
$
|
24.38
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.01
|
.04
|
.14
|
.06
|
.08
|
.26
|
||||||
Net realized and unrealized gain (loss)
|
3.00
|
25.98
|
22.12
|
(.92)
|
19.45
|
7.33
|
||||||
Total from investment operations
|
3.01
|
26.02
|
22.26
|
(.86)
|
19.53
|
7.59
|
||||||
Distributions from net investment income
|
-
|
-
|
-
|
-
|
(.16)
|
(.11)
|
||||||
Distributions from net realized gain
|
(5.76)
|
(2.07)
|
(1.20)
|
(2.56)
|
(1.67)
|
(.20)
|
||||||
Total distributions
|
(5.76)
|
(2.07)
|
(1.20)
|
(2.56)
|
(1.83)
|
(.32) C
|
||||||
Net asset value, end of period
|
$
|
88.19
|
$
|
90.94
|
$
|
66.99
|
$
|
45.93
|
$
|
49.35
|
$
|
31.65
|
Total Return D,E
|
2.94 % |
40.05%
|
49.89%
|
(2.83)%
|
63.06%
|
31.22%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
.57% H
|
.60%
|
.62%
|
.62%
|
.64%
|
.68%
|
||||||
Expenses net of fee waivers, if any
|
.57 % H |
.59%
|
.62%
|
.62%
|
.64%
|
.68%
|
||||||
Expenses net of all reductions
|
.57% H
|
.59%
|
.62%
|
.62%
|
.64%
|
.66%
|
||||||
Net investment income (loss)
|
.03% H
|
.05%
|
.28%
|
.11%
|
.18%
|
.94%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
258,611
|
$
|
226,689
|
$
|
95,876
|
$
|
47,782
|
$
|
26,856
|
$
|
7,920
|
Portfolio turnover rate I
|
54 % H |
30%
|
40%
|
32%
|
41%
|
136%
|
Common Stocks - 95.4%
|
|||
Shares
|
Value ($)
|
||
CANADA - 2.3%
|
|||
Information Technology - 2.3%
|
|||
IT Services - 2.3%
|
|||
Shopify Inc Class A (United States) (b)
|
1,375,100
|
160,611,680
|
|
CHINA - 3.3%
|
|||
Health Care - 0.0%
|
|||
Pharmaceuticals - 0.0%
|
|||
Chime Biologics Wuhan Co Ltd (b)(c)
|
387,462
|
4
|
|
Information Technology - 3.3%
|
|||
Semiconductors & Semiconductor Equipment - 3.3%
|
|||
NXP Semiconductors NV
|
1,112,245
|
231,958,695
|
|
TOTAL CHINA
|
231,958,699
|
||
INDIA - 0.0%
|
|||
Information Technology - 0.0%
|
|||
Software - 0.0%
|
|||
Pine Labs Pvt Ltd (b)(c)(d)
|
3,660
|
1,807,491
|
|
ISRAEL - 0.0%
|
|||
Information Technology - 0.0%
|
|||
Semiconductors & Semiconductor Equipment - 0.0%
|
|||
Xsight Labs Ltd warrants 1/11/2034 (b)(c)(d)
|
27,709
|
77,585
|
|
Xsight Labs Ltd warrants 12/30/2031 (b)(c)(d)
|
24,567
|
38,324
|
|
TOTAL ISRAEL
|
115,909
|
||
KOREA (SOUTH) - 0.0%
|
|||
Materials - 0.0%
|
|||
Chemicals - 0.0%
|
|||
LG Chem Ltd
|
9,410
|
1,521,330
|
|
NETHERLANDS - 0.9%
|
|||
Information Technology - 0.9%
|
|||
Semiconductors & Semiconductor Equipment - 0.9%
|
|||
ASML Holding NV
|
85,100
|
62,953,817
|
|
TAIWAN - 2.1%
|
|||
Health Care - 0.0%
|
|||
Life Sciences Tools & Services - 0.0%
|
|||
Eden Biologics Inc (b)(c)
|
387,462
|
0
|
|
Information Technology - 2.1%
|
|||
Semiconductors & Semiconductor Equipment - 2.1%
|
|||
Taiwan Semiconductor Manufacturing Co Ltd
|
4,502,000
|
149,208,525
|
|
TOTAL TAIWAN
|
149,208,525
|
||
UNITED STATES - 86.8%
|
|||
Communication Services - 0.9%
|
|||
Entertainment - 0.9%
|
|||
Netflix Inc (b)
|
61,466
|
60,037,530
|
|
Consumer Discretionary - 2.1%
|
|||
Broadline Retail - 1.9%
|
|||
Amazon.com Inc (b)
|
567,000
|
134,764,560
|
|
Hotels, Restaurants & Leisure - 0.2%
|
|||
Airbnb Inc Class A (b)
|
110,300
|
14,468,051
|
|
Consumer Staples - 0.0%
|
|||
Consumer Staples Distribution & Retail - 0.0%
|
|||
Maplebear Inc (b)(e)
|
29,110
|
1,405,431
|
|
Industrials - 1.4%
|
|||
Ground Transportation - 1.4%
|
|||
Lyft Inc Class A (b)
|
713,642
|
9,662,713
|
|
TuSimple Holdings Inc Class A (b)
|
86,300
|
34,520
|
|
Uber Technologies Inc (b)
|
1,337,064
|
89,382,728
|
|
99,079,961
|
|||
Information Technology - 82.4%
|
|||
Communications Equipment - 3.6%
|
|||
Cisco Systems Inc
|
4,204,800
|
254,810,880
|
|
Electronic Equipment, Instruments & Components - 0.9%
|
|||
Amphenol Corp Class A
|
907,022
|
64,199,017
|
|
IT Services - 3.9%
|
|||
Okta Inc Class A (b)
|
1,864,135
|
175,638,800
|
|
Snowflake Inc Class A (b)
|
558,933
|
101,451,929
|
|
277,090,729
|
|||
Semiconductors & Semiconductor Equipment - 33.7%
|
|||
Astera Labs Inc (b)
|
439,171
|
44,540,722
|
|
GlobalFoundries Inc (b)
|
4,046,706
|
167,816,898
|
|
Marvell Technology Inc
|
3,039,964
|
343,090,337
|
|
Micron Technology Inc
|
1,593,900
|
145,427,436
|
|
NVIDIA Corp
|
11,745,180
|
1,410,243,763
|
|
ON Semiconductor Corp (b)
|
3,643,805
|
190,716,754
|
|
Teradyne Inc
|
668,900
|
77,451,931
|
|
2,379,287,841
|
|||
Software - 22.1%
|
|||
Coreweave Inc Class A (c)(d)
|
23,100
|
21,710,535
|
|
Crowdstrike Holdings Inc Class A (b)
|
80,000
|
31,845,600
|
|
Datadog Inc Class A (b)
|
1,103,460
|
157,474,777
|
|
HubSpot Inc (b)
|
139,403
|
108,668,821
|
|
Manhattan Associates Inc (b)
|
266,877
|
55,667,873
|
|
Microsoft Corp
|
1,621,600
|
673,061,296
|
|
OpenAI Global LLC rights (b)(c)(d)
|
3,749,900
|
3,749,900
|
|
Palantir Technologies Inc Class A (b)
|
468,100
|
38,613,569
|
|
Salesforce Inc
|
510,539
|
174,451,176
|
|
Servicenow Inc (b)
|
262,234
|
267,053,861
|
|
Zscaler Inc (b)
|
135,600
|
27,471,204
|
|
1,559,768,612
|
|||
Technology Hardware, Storage & Peripherals - 18.2%
|
|||
Apple Inc
|
4,852,616
|
1,145,217,376
|
|
Seagate Technology Holdings PLC
|
401,355
|
38,674,567
|
|
Western Digital Corp (b)
|
1,583,943
|
103,162,208
|
|
1,287,054,151
|
|||
TOTAL INFORMATION TECHNOLOGY
|
5,822,211,230
|
||
TOTAL UNITED STATES
|
6,131,966,763
|
||
|
TOTAL COMMON STOCKS
(Cost $3,372,632,417)
|
6,740,144,214
|
||
Convertible Corporate Bonds - 0.0%
|
|||
Principal
Amount (a)
|
Value ($)
|
||
UNITED STATES - 0.0%
|
|||
Information Technology - 0.0%
|
|||
Electronic Equipment, Instruments & Components - 0.0%
|
|||
Enevate Corp 10% 5/12/2025 (c)(d)
(Cost $147,191)
|
147,191
|
150,399
|
|
Convertible Preferred Stocks - 1.6%
|
|||
Shares
|
Value ($)
|
||
CHINA - 0.1%
|
|||
Communication Services - 0.1%
|
|||
Interactive Media & Services - 0.1%
|
|||
ByteDance Ltd Series E1 (b)(c)(d)
|
26,036
|
6,448,076
|
|
INDIA - 0.2%
|
|||
Consumer Discretionary - 0.0%
|
|||
Broadline Retail - 0.0%
|
|||
Meesho Series E1 (c)(d)
|
3,406
|
184,060
|
|
Meesho Series F (b)(c)(d)
|
46,600
|
2,562,068
|
|
2,746,128
|
|||
Information Technology - 0.2%
|
|||
Software - 0.2%
|
|||
Pine Labs Pvt Ltd Series 1 (b)(c)(d)
|
8,747
|
4,319,706
|
|
Pine Labs Pvt Ltd Series A (b)(c)(d)
|
2,186
|
1,079,556
|
|
Pine Labs Pvt Ltd Series B (b)(c)(d)
|
2,378
|
1,174,375
|
|
Pine Labs Pvt Ltd Series B2 (b)(c)(d)
|
1,923
|
949,674
|
|
Pine Labs Pvt Ltd Series C (b)(c)(d)
|
3,578
|
1,766,995
|
|
Pine Labs Pvt Ltd Series C1 (b)(c)(d)
|
754
|
372,363
|
|
Pine Labs Pvt Ltd Series D (b)(c)(d)
|
806
|
398,043
|
|
10,060,712
|
|||
TOTAL INDIA
|
12,806,840
|
||
ISRAEL - 0.0%
|
|||
Information Technology - 0.0%
|
|||
Semiconductors & Semiconductor Equipment - 0.0%
|
|||
Xsight Labs Ltd Series D (b)(c)(d)
|
101,300
|
638,190
|
|
Xsight Labs Ltd Series E (c)(d)
|
122,838
|
951,995
|
|
Xsight Labs Ltd Series E1 (c)(d)
|
92,364
|
851,596
|
|
TOTAL ISRAEL
|
2,441,781
|
||
UNITED STATES - 1.3%
|
|||
Consumer Discretionary - 0.0%
|
|||
Hotels, Restaurants & Leisure - 0.0%
|
|||
Discord Inc Series I (b)(c)(d)
|
500
|
123,510
|
|
Consumer Staples - 0.0%
|
|||
Consumer Staples Distribution & Retail - 0.0%
|
|||
GoBrands Inc Series G (b)(c)(d)
|
14,100
|
459,942
|
|
Financials - 0.1%
|
|||
Financial Services - 0.1%
|
|||
Akeana Series C (c)(d)
|
35,600
|
450,340
|
|
Tenstorrent Holdings Inc Series C1 (b)(c)(d)
|
12,823
|
954,416
|
|
Tenstorrent Holdings Inc Series D1 (c)(d)
|
50,147
|
3,953,088
|
|
Tenstorrent Holdings Inc Series D2 (c)(d)
|
4,547
|
345,890
|
|
5,703,734
|
|||
Industrials - 0.0%
|
|||
Aerospace & Defense - 0.0%
|
|||
Relativity Space Inc Series E (b)(c)(d)
|
482,616
|
453,659
|
|
Information Technology - 1.1%
|
|||
Electronic Equipment, Instruments & Components - 0.2%
|
|||
Enevate Corp Series E (b)(c)(d)
|
9,477,386
|
5,307,336
|
|
Vast Data Ltd Series A (b)(c)(d)
|
30,141
|
670,939
|
|
Vast Data Ltd Series A1 (b)(c)(d)
|
74,185
|
1,651,358
|
|
Vast Data Ltd Series A2 (b)(c)(d)
|
85,337
|
1,899,602
|
|
Vast Data Ltd Series B (b)(c)(d)
|
67,904
|
1,511,543
|
|
Vast Data Ltd Series C (b)(c)(d)
|
1,979
|
44,052
|
|
Vast Data Ltd Series E (b)(c)(d)
|
64,886
|
1,444,362
|
|
12,529,192
|
|||
Semiconductors & Semiconductor Equipment - 0.1%
|
|||
Retym Inc (c)
|
34,592
|
366,329
|
|
Retym Inc Series C (b)(c)(d)
|
139,441
|
1,398,593
|
|
SiMa Technologies Inc Series B (b)(c)(d)
|
231,000
|
1,443,750
|
|
SiMa Technologies Inc Series B1 (b)(c)(d)
|
100,683
|
734,986
|
|
3,943,658
|
|||
Software - 0.7%
|
|||
Anthropic PBC Series B (c)(d)
|
190,100
|
10,662,709
|
|
Anthropic PBC Series D (c)(d)
|
195,705
|
11,448,743
|
|
Coreweave Inc Series C (c)(d)
|
1,482
|
1,568,193
|
|
Databricks Inc (c)(d)
|
38,610
|
3,571,425
|
|
Databricks Inc Series G (b)(c)(d)
|
37,800
|
3,496,500
|
|
Databricks Inc Series H (b)(c)(d)
|
99,786
|
9,230,205
|
|
Databricks Inc Series I (b)(c)(d)
|
1,265
|
117,013
|
|
Runway AI Inc (c)(d)
|
53,827
|
6,163,192
|
|
xAI Corp Series C (c)(d)
|
227,400
|
4,923,210
|
|
51,181,190
|
|||
Technology Hardware, Storage & Peripherals - 0.1%
|
|||
Lightmatter Inc (c)(d)
|
54,900
|
4,386,510
|
|
Lightmatter Inc Series C1 (b)(c)(d)
|
82,421
|
5,326,045
|
|
Lightmatter Inc Series C2 (b)(c)(d)
|
12,946
|
851,976
|
|
10,564,531
|
|||
Materials - 0.1%
|
|||
Metals & Mining - 0.1%
|
|||
Diamond Foundry Inc Series C (b)(c)(d)
|
151,757
|
4,124,755
|
|
TOTAL UNITED STATES
|
89,084,171
|
||
|
TOTAL CONVERTIBLE PREFERRED STOCKS
(Cost $101,904,653)
|
110,780,868
|
||
Preferred Securities - 0.0%
|
|||
Principal
Amount (a)
|
Value ($)
|
||
UNITED STATES - 0.0%
|
|||
Information Technology - 0.0%
|
|||
Electronic Equipment, Instruments & Components - 0.0%
|
|||
Enevate Corp 6% (c)(d)(f)
|
526,698
|
467,849
|
|
Semiconductors & Semiconductor Equipment - 0.0%
|
|||
SiMa Technologies Inc 10% 12/31/2027 (c)(d)
|
323,717
|
334,018
|
|
TOTAL INFORMATION TECHNOLOGY
|
801,867
|
||
|
TOTAL PREFERRED SECURITIES
(Cost $850,415)
|
801,867
|
||
Money Market Funds - 2.7%
|
||||
Yield (%)
|
Shares
|
Value ($)
|
||
Fidelity Cash Central Fund (g)
|
4.37
|
191,964,857
|
192,003,250
|
|
Fidelity Securities Lending Cash Central Fund (g)(h)
|
4.37
|
1,014,899
|
1,015,000
|
|
|
TOTAL MONEY MARKET FUNDS
(Cost $193,018,250)
|
193,018,250
|
|||
|
TOTAL INVESTMENT IN SECURITIES - 99.7%
(Cost $3,668,552,926)
|
7,044,895,598
|
NET OTHER ASSETS (LIABILITIES) - 0.3%
|
17,716,988
|
NET ASSETS - 100.0%
|
7,062,612,586
|
(a)
|
Amount is stated in United States dollars unless otherwise noted.
|
(b)
|
Non-income producing
|
(c)
|
Level 3 security
|
(d)
|
Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $138,750,640 or 2.0% of net assets.
|
(e)
|
Security or a portion of the security is on loan at period end.
|
(f)
|
Security is perpetual in nature with no stated maturity date.
|
(g)
|
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
|
(h)
|
Investment made with cash collateral received from securities on loan.
|
Additional information on each restricted holding is as follows:
|
||
Security
|
Acquisition Date
|
Acquisition Cost ($)
|
Akeana Series C
|
1/23/24
|
454,284
|
Anthropic PBC Series B
|
3/22/24
|
5,932,010
|
Anthropic PBC Series D
|
5/31/24
|
5,872,031
|
ByteDance Ltd Series E1
|
11/18/20
|
2,852,873
|
Coreweave Inc Class A
|
11/29/23
|
7,157,766
|
Coreweave Inc Series C
|
5/17/24
|
1,154,552
|
Databricks Inc
|
12/17/24
|
3,571,425
|
Databricks Inc Series G
|
2/01/21
|
2,234,836
|
Databricks Inc Series H
|
8/31/21
|
7,332,688
|
Databricks Inc Series I
|
9/14/23
|
92,978
|
Diamond Foundry Inc Series C
|
3/15/21
|
3,642,168
|
Discord Inc Series I
|
9/15/21
|
275,312
|
Enevate Corp 10% 5/12/2025
|
11/12/24
|
147,191
|
Enevate Corp 6%
|
11/02/23 - 10/31/24
|
526,698
|
Enevate Corp Series E
|
1/29/21
|
10,507,436
|
GoBrands Inc Series G
|
3/02/21
|
3,521,014
|
Lightmatter Inc
|
10/11/24
|
4,404,654
|
Lightmatter Inc Series C1
|
5/19/23
|
1,356,386
|
Lightmatter Inc Series C2
|
12/18/23
|
336,619
|
Meesho Series E1
|
4/18/24
|
190,736
|
Meesho Series F
|
9/21/21
|
3,572,929
|
OpenAI Global LLC rights
|
9/30/24
|
3,749,900
|
Pine Labs Pvt Ltd
|
6/30/21
|
1,364,668
|
Pine Labs Pvt Ltd Series 1
|
6/30/21
|
3,261,406
|
Pine Labs Pvt Ltd Series A
|
6/30/21
|
815,072
|
Pine Labs Pvt Ltd Series B
|
6/30/21
|
886,661
|
Pine Labs Pvt Ltd Series B2
|
6/30/21
|
717,010
|
Pine Labs Pvt Ltd Series C
|
6/30/21
|
1,334,093
|
Pine Labs Pvt Ltd Series C1
|
6/30/21
|
281,136
|
Pine Labs Pvt Ltd Series D
|
6/30/21
|
300,525
|
Relativity Space Inc Series E
|
5/27/21
|
11,020,585
|
Retym Inc Series C
|
5/17/23 - 6/20/23
|
1,085,102
|
Runway AI Inc
|
9/06/24
|
5,835,803
|
SiMa Technologies Inc 10% 12/31/2027
|
4/08/24 - 12/31/24
|
323,717
|
SiMa Technologies Inc Series B
|
5/10/21
|
1,184,429
|
SiMa Technologies Inc Series B1
|
4/25/22 - 10/17/22
|
713,933
|
Tenstorrent Holdings Inc Series C1
|
4/23/21
|
762,398
|
Tenstorrent Holdings Inc Series D1
|
7/16/24 - 1/15/25
|
3,952,910
|
Tenstorrent Holdings Inc Series D2
|
7/17/24
|
345,481
|
Vast Data Ltd Series A
|
11/28/23
|
331,551
|
Vast Data Ltd Series A1
|
11/28/23
|
816,035
|
Vast Data Ltd Series A2
|
11/28/23
|
938,707
|
Vast Data Ltd Series B
|
11/28/23
|
746,944
|
Vast Data Ltd Series C
|
11/28/23
|
21,769
|
Vast Data Ltd Series E
|
11/28/23
|
1,427,492
|
xAI Corp Series C
|
11/22/24
|
4,923,210
|
Xsight Labs Ltd Series D
|
2/16/21
|
809,995
|
Xsight Labs Ltd Series E
|
11/04/24 - 12/30/24
|
982,706
|
Xsight Labs Ltd Series E1
|
1/11/24
|
738,543
|
Xsight Labs Ltd warrants 1/11/2034
|
1/11/24
|
0
|
Xsight Labs Ltd warrants 12/30/2031
|
11/04/24 - 12/30/24
|
0
|
Affiliate
|
Value,
beginning
of period ($)
|
Purchases ($)
|
Sales
Proceeds ($)
|
Dividend
Income ($)
|
Realized
Gain (loss) ($)
|
Change in
Unrealized
appreciation
(depreciation) ($)
|
Value,
end
of period ($)
|
Shares,
end
of period
|
% ownership,
end
of period
|
Fidelity Cash Central Fund
|
64,896,079
|
1,459,802,045
|
1,332,694,874
|
3,568,123
|
-
|
-
|
192,003,250
|
191,964,857
|
0.3%
|
Fidelity Securities Lending Cash Central Fund
|
1,473,625
|
93,325,529
|
93,784,154
|
7,668
|
-
|
-
|
1,015,000
|
1,014,899
|
0.0%
|
Total
|
66,369,704
|
1,553,127,574
|
1,426,479,028
|
3,575,791
|
-
|
-
|
193,018,250
|
192,979,756
|
|
Valuation Inputs at Reporting Date:
|
||||
Description
|
Total ($)
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Investments in Securities:
|
||||
Common Stocks
|
||||
Communication Services
|
60,037,530
|
60,037,530
|
-
|
-
|
Consumer Discretionary
|
149,232,611
|
149,232,611
|
-
|
-
|
Consumer Staples
|
1,405,431
|
1,405,431
|
-
|
-
|
Health Care
|
4
|
-
|
-
|
4
|
Industrials
|
99,079,961
|
99,079,961
|
-
|
-
|
Information Technology
|
6,428,867,347
|
6,189,321,170
|
212,162,342
|
27,383,835
|
Materials
|
1,521,330
|
-
|
1,521,330
|
-
|
Convertible Corporate Bonds
|
||||
Information Technology
|
150,399
|
-
|
-
|
150,399
|
Convertible Preferred Stocks
|
||||
Communication Services
|
6,448,076
|
-
|
-
|
6,448,076
|
Consumer Discretionary
|
2,869,638
|
-
|
-
|
2,869,638
|
Consumer Staples
|
459,942
|
-
|
-
|
459,942
|
Financials
|
5,703,734
|
-
|
-
|
5,703,734
|
Industrials
|
453,659
|
-
|
-
|
453,659
|
Information Technology
|
90,721,064
|
-
|
-
|
90,721,064
|
Materials
|
4,124,755
|
-
|
-
|
4,124,755
|
Preferred Securities
|
||||
Information Technology
|
801,867
|
-
|
-
|
801,867
|
Money Market Funds
|
193,018,250
|
193,018,250
|
-
|
-
|
Total Investments in Securities:
|
7,044,895,598
|
6,692,094,953
|
213,683,672
|
139,116,973
|
Investments in Securities:
|
|||
Common Stocks
|
|||
Beginning Balance
|
$
|
19,413,136
|
|
Net Realized Gain (Loss) on Investment Securities
|
-
|
||
Net Unrealized Gain (Loss) on Investment Securities
|
4,220,803
|
||
Cost of Purchases
|
3,749,900
|
||
Proceeds of Sales
|
-
|
||
Amortization/Accretion
|
-
|
||
Transfers into Level 3
|
-
|
||
Transfers out of Level 3
|
-
|
||
Ending Balance
|
$
|
27,383,839
|
|
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at January 31, 2025
|
$
|
4,220,803
|
|
Convertible Corporate Bonds
|
|||
Beginning Balance
|
$
|
-
|
|
Net Realized Gain (Loss) on Investment Securities
|
(35,680)
|
||
Net Unrealized Gain (Loss) on Investment Securities
|
38,888
|
||
Cost of Purchases
|
147,191
|
||
Proceeds of Sales
|
-
|
||
Amortization/Accretion
|
-
|
||
Transfers into Level 3
|
-
|
||
Transfers out of Level 3
|
-
|
||
Ending Balance
|
$
|
150,399
|
|
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at January 31, 2025
|
$
|
3,209
|
|
Convertible Preferred Stocks
|
|||
Beginning Balance
|
$
|
75,718,771
|
|
Net Realized Gain (Loss) on Investment Securities
|
(1,107,057)
|
||
Net Unrealized Gain (Loss) on Investment Securities
|
12,936,250
|
||
Cost of Purchases
|
23,232,904
|
||
Proceeds of Sales
|
-
|
||
Amortization/Accretion
|
-
|
||
Transfers into Level 3
|
-
|
||
Transfers out of Level 3
|
-
|
||
Ending Balance
|
$
|
110,780,868
|
|
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at January 31, 2025
|
$
|
11,829,193
|
|
Preferred Securities
|
|||
Beginning Balance
|
$
|
871,200
|
|
Net Realized Gain (Loss) on Investment Securities
|
-
|
||
Net Unrealized Gain (Loss) on Investment Securities
|
(118,399)
|
||
Cost of Purchases
|
49,066
|
||
Proceeds of Sales
|
-
|
||
Amortization/Accretion
|
-
|
||
Transfers into Level 3
|
-
|
||
Transfers out of Level 3
|
-
|
||
Ending Balance
|
$
|
801,867
|
|
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at January 31, 2025
|
$
|
(118,399)
|
|
|
The information used in the above reconciliation represents fiscal year to date activity for any Investments in Securities identified as using Level 3 inputs at either the beginning or the end of the current fiscal period. Cost of purchases and proceeds of sales may include securities received and/or delivered through in-kind transactions, corporate actions or exchanges. Transfers into Level 3 were attributable to a lack of observable market data resulting from decreases in market activity, decreases in liquidity, security restructurings or corporate actions. Transfers out of Level 3 were attributable to observable market data becoming available for those securities. Transfers in or out of Level 3 represent the beginning value of any Security or Instrument where a change in the pricing level occurred from the beginning to the end of the period. Realized and unrealized gains (losses) disclosed in the reconciliation are included in Net Gain (Loss) on the Fund's Statement of Operations.
|
|||
Statement of Assets and Liabilities
|
||||
|
As of January 31, 2025 (Unaudited)
|
||||
Assets
|
||||
Investment in securities, at value (including securities loaned of $980,084) - See accompanying schedule:
|
||||
Unaffiliated issuers (cost $3,475,534,676)
|
$
|
6,851,877,348
|
||
Fidelity Central Funds (cost $193,018,250)
|
193,018,250
|
|||
Total Investment in Securities (cost $3,668,552,926)
|
$
|
7,044,895,598
|
||
Foreign currency held at value (cost $139)
|
131
|
|||
Receivable for investments sold
|
32,153,859
|
|||
Receivable for fund shares sold
|
5,773,393
|
|||
Dividends receivable
|
35,728
|
|||
Interest receivable
|
3,230
|
|||
Distributions receivable from Fidelity Central Funds
|
699,113
|
|||
Prepaid expenses
|
5,083
|
|||
Other receivables
|
175,876
|
|||
Total assets
|
7,083,742,011
|
|||
Liabilities
|
||||
Payable for investments purchased
|
$
|
2,505,745
|
||
Payable for fund shares redeemed
|
12,237,892
|
|||
Distributions payable
|
1,129
|
|||
Accrued management fee
|
3,888,272
|
|||
Distribution and service plan fees payable
|
1,243,280
|
|||
Other payables and accrued expenses
|
238,107
|
|||
Collateral on securities loaned
|
1,015,000
|
|||
Total liabilities
|
21,129,425
|
|||
Commitments and contingent liabilities (see Significant Accounting Policies note)
|
||||
Net Assets
|
$
|
7,062,612,586
|
||
Net Assets consist of:
|
||||
Paid in capital
|
$
|
3,529,588,447
|
||
Total accumulated earnings (loss)
|
3,533,024,139
|
|||
Net Assets
|
$
|
7,062,612,586
|
||
Net Asset Value and Maximum Offering Price
|
||||
Class A :
|
||||
Net Asset Value and redemption price per share ($2,649,664,189 ÷ 22,739,224 shares)(a)
|
$
|
116.52
|
||
Maximum offering price per share (100/94.25 of $116.52)
|
$
|
123.63
|
||
Class M :
|
||||
Net Asset Value and redemption price per share ($824,997,022 ÷ 7,865,734 shares)(a)
|
$
|
104.88
|
||
Maximum offering price per share (100/96.50 of $104.88)
|
$
|
108.68
|
||
Class C :
|
||||
Net Asset Value and offering price per share ($371,012,578 ÷ 4,497,640 shares)(a)
|
$
|
82.49
|
||
Class I :
|
||||
Net Asset Value, offering price and redemption price per share ($2,267,957,383 ÷ 17,079,302 shares)
|
$
|
132.79
|
||
Class Z :
|
||||
Net Asset Value, offering price and redemption price per share ($948,981,414 ÷ 7,148,609 shares)
|
$
|
132.75
|
||
(a)Redemption price per share is equal to net asset value less any applicable contingent deferred sales charge.
|
||||
Statement of Operations
|
||||
Six months ended January 31, 2025 (Unaudited)
|
||||
Investment Income
|
||||
Dividends
|
$
|
14,930,947
|
||
Interest
|
3,230
|
|||
Income from Fidelity Central Funds (including $7,668 from security lending)
|
3,575,791
|
|||
Total income
|
18,509,968
|
|||
Expenses
|
||||
Management fee
|
$
|
22,053,888
|
||
Distribution and service plan fees
|
7,127,553
|
|||
Custodian fees and expenses
|
46,374
|
|||
Independent trustees' fees and expenses
|
14,728
|
|||
Registration fees
|
150,414
|
|||
Audit fees
|
29,705
|
|||
Legal
|
5,575
|
|||
Miscellaneous
|
85,705
|
|||
Total expenses before reductions
|
29,513,942
|
|||
Expense reductions
|
(1,251)
|
|||
Total expenses after reductions
|
29,512,691
|
|||
Net Investment income (loss)
|
(11,002,723)
|
|||
Realized and Unrealized Gain (Loss)
|
||||
Net realized gain (loss) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
280,305,681
|
|||
Foreign currency transactions
|
(6,214)
|
|||
Total net realized gain (loss)
|
280,299,467
|
|||
Change in net unrealized appreciation (depreciation) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
238,290,103
|
|||
Assets and liabilities in foreign currencies
|
(1,545)
|
|||
Total change in net unrealized appreciation (depreciation)
|
238,288,558
|
|||
Net gain (loss)
|
518,588,025
|
|||
Net increase (decrease) in net assets resulting from operations
|
$
|
507,585,302
|
||
Statement of Changes in Net Assets
|
||||
Six months ended
January 31, 2025
(Unaudited)
|
Year ended
July 31, 2024
|
|||
Increase (Decrease) in Net Assets
|
||||
Operations
|
||||
Net investment income (loss)
|
$
|
(11,002,723)
|
$
|
(17,161,426)
|
Net realized gain (loss)
|
280,299,467
|
651,904,658
|
||
Change in net unrealized appreciation (depreciation)
|
238,288,558
|
699,495,429
|
||
Net increase (decrease) in net assets resulting from operations
|
507,585,302
|
1,334,238,661
|
||
Distributions to shareholders
|
(529,414,258)
|
(196,415,004)
|
||
Share transactions - net increase (decrease)
|
626,190,114
|
200,670,691
|
||
Total increase (decrease) in net assets
|
604,361,158
|
1,338,494,348
|
||
Net Assets
|
||||
Beginning of period
|
6,458,251,428
|
5,119,757,080
|
||
End of period
|
$
|
7,062,612,586
|
$
|
6,458,251,428
|
Fidelity Advisor® Technology Fund Class A |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
116.35
|
$
|
95.17
|
$
|
75.41
|
$
|
102.43
|
$
|
76.36
|
$
|
52.61
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.23)
|
(.37)
|
(.21)
|
(.37)
|
(.39)
|
(.12)
|
||||||
Net realized and unrealized gain (loss)
|
9.96
|
25.30
|
22.28
|
(13.94)
|
33.48
|
25.35
|
||||||
Total from investment operations
|
9.73
|
24.93
|
22.07
|
(14.31)
|
33.09
|
25.23
|
||||||
Distributions from net realized gain
|
(9.56)
|
(3.75)
|
(2.31)
|
(12.71)
|
(7.02)
|
(1.48)
|
||||||
Total distributions
|
(9.56)
|
(3.75)
|
(2.31)
|
(12.71)
|
(7.02)
|
(1.48)
|
||||||
Net asset value, end of period
|
$
|
116.52
|
$
|
116.35
|
$
|
95.17
|
$
|
75.41
|
$
|
102.43
|
$
|
76.36
|
Total Return C,D,E
|
7.88 % |
27.09%
|
30.51%
|
(16.78)%
|
44.80%
|
48.83%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
.92% H
|
.95%
|
.98%
|
.97%
|
.98%
|
1.01%
|
||||||
Expenses net of fee waivers, if any
|
.92 % H |
.95%
|
.98%
|
.97%
|
.98%
|
1.01%
|
||||||
Expenses net of all reductions
|
.92% H
|
.95%
|
.98%
|
.97%
|
.98%
|
1.01%
|
||||||
Net investment income (loss)
|
(.38)% H
|
(.37)%
|
(.29)%
|
(.41)%
|
(.43)%
|
(.20)%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
2,649,664
|
$
|
2,469,499
|
$
|
1,906,585
|
$
|
1,467,792
|
$
|
1,848,643
|
$
|
1,339,059
|
Portfolio turnover rate I
|
51 % H |
34% J
|
30%
|
20%
|
44%
|
40% J
|
Fidelity Advisor® Technology Fund Class M |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
105.65
|
$
|
86.92
|
$
|
69.25
|
$
|
95.15
|
$
|
71.37
|
$
|
49.28
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.34)
|
(.56)
|
(.36)
|
(.55)
|
(.57)
|
(.25)
|
||||||
Net realized and unrealized gain (loss)
|
9.09
|
23.00
|
20.34
|
(12.76)
|
31.22
|
23.71
|
||||||
Total from investment operations
|
8.75
|
22.44
|
19.98
|
(13.31)
|
30.65
|
23.46
|
||||||
Distributions from net realized gain
|
(9.52)
|
(3.71)
|
(2.31)
|
(12.59)
|
(6.87)
|
(1.37)
|
||||||
Total distributions
|
(9.52)
|
(3.71)
|
(2.31)
|
(12.59)
|
(6.87)
|
(1.37)
|
||||||
Net asset value, end of period
|
$
|
104.88
|
$
|
105.65
|
$
|
86.92
|
$
|
69.25
|
$
|
95.15
|
$
|
71.37
|
Total Return C,D,E
|
7.75 % |
26.77%
|
30.20%
|
(16.99)%
|
44.47%
|
48.44%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
1.17% H
|
1.20%
|
1.22%
|
1.21%
|
1.23%
|
1.26%
|
||||||
Expenses net of fee waivers, if any
|
1.17 % H |
1.19%
|
1.22%
|
1.21%
|
1.23%
|
1.26%
|
||||||
Expenses net of all reductions
|
1.17% H
|
1.19%
|
1.22%
|
1.21%
|
1.22%
|
1.26%
|
||||||
Net investment income (loss)
|
(.63)% H
|
(.61)%
|
(.53)%
|
(.65)%
|
(.68)%
|
(.45)%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
824,997
|
$
|
778,465
|
$
|
624,612
|
$
|
484,293
|
$
|
624,534
|
$
|
464,093
|
Portfolio turnover rate I
|
51 % H |
34% J
|
30%
|
20%
|
44%
|
40% J
|
Fidelity Advisor® Technology Fund Class C |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
85.08
|
$
|
71.04
|
$
|
57.35
|
$
|
80.98
|
$
|
61.67
|
$
|
42.81
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.50)
|
(.83)
|
(.58)
|
(.83)
|
(.85)
|
(.46)
|
||||||
Net realized and unrealized gain (loss)
|
7.43
|
18.58
|
16.58
|
(10.43)
|
26.79
|
20.52
|
||||||
Total from investment operations
|
6.93
|
17.75
|
16.00
|
(11.26)
|
25.94
|
20.06
|
||||||
Distributions from net realized gain
|
(9.52)
|
(3.71)
|
(2.31)
|
(12.37)
|
(6.63)
|
(1.20)
|
||||||
Total distributions
|
(9.52)
|
(3.71)
|
(2.31)
|
(12.37)
|
(6.63)
|
(1.20)
|
||||||
Net asset value, end of period
|
$
|
82.49
|
$
|
85.08
|
$
|
71.04
|
$
|
57.35
|
$
|
80.98
|
$
|
61.67
|
Total Return C,D,E
|
7.48 % |
26.14%
|
29.50%
|
(17.41)%
|
43.73%
|
47.69%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
1.67% H
|
1.70%
|
1.75%
|
1.73%
|
1.75%
|
1.77%
|
||||||
Expenses net of fee waivers, if any
|
1.67 % H |
1.70%
|
1.74%
|
1.73%
|
1.74%
|
1.77%
|
||||||
Expenses net of all reductions
|
1.67% H
|
1.70%
|
1.74%
|
1.73%
|
1.74%
|
1.77%
|
||||||
Net investment income (loss)
|
(1.13)% H
|
(1.12)%
|
(1.05)%
|
(1.17)%
|
(1.20)%
|
(.96)%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
371,013
|
$
|
358,186
|
$
|
313,457
|
$
|
288,008
|
$
|
410,661
|
$
|
343,585
|
Portfolio turnover rate I
|
51 % H |
34% J
|
30%
|
20%
|
44%
|
40% J
|
Fidelity Advisor® Technology Fund Class I |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
131.44
|
$
|
107.03
|
$
|
84.29
|
$
|
112.95
|
$
|
83.56
|
$
|
57.41
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.09)
|
(.13)
|
(.02)
|
(.15)
|
(.17)
|
.04
|
||||||
Net realized and unrealized gain (loss)
|
11.21
|
28.56
|
25.07
|
(15.67)
|
36.76
|
27.72
|
||||||
Total from investment operations
|
11.12
|
28.43
|
25.05
|
(15.82)
|
36.59
|
27.76
|
||||||
Distributions from net realized gain
|
(9.77)
|
(4.02)
|
(2.31)
|
(12.84)
|
(7.20)
|
(1.61)
|
||||||
Total distributions
|
(9.77)
|
(4.02)
|
(2.31)
|
(12.84)
|
(7.20)
|
(1.61)
|
||||||
Net asset value, end of period
|
$
|
132.79
|
$
|
131.44
|
$
|
107.03
|
$
|
84.29
|
$
|
112.95
|
$
|
83.56
|
Total Return C,D
|
8.02 % |
27.42%
|
30.84%
|
(16.56)%
|
45.18%
|
49.22%
|
||||||
Ratios to Average Net Assets B,E,F
|
||||||||||||
Expenses before reductions
|
.67% G
|
.70%
|
.72%
|
.71%
|
.72%
|
.74%
|
||||||
Expenses net of fee waivers, if any
|
.67 % G |
.70%
|
.71%
|
.71%
|
.72%
|
.74%
|
||||||
Expenses net of all reductions
|
.67% G
|
.70%
|
.71%
|
.71%
|
.72%
|
.74%
|
||||||
Net investment income (loss)
|
(.13)% G
|
(.11)%
|
(.03)%
|
(.15)%
|
(.18)%
|
.07%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
2,267,957
|
$
|
2,039,046
|
$
|
1,515,475
|
$
|
1,129,418
|
$
|
1,470,830
|
$
|
1,035,091
|
Portfolio turnover rate H
|
51 % G |
34% I
|
30%
|
20%
|
44%
|
40% I
|
Fidelity Advisor® Technology Fund Class Z |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
131.50
|
$
|
107.07
|
$
|
84.22
|
$
|
112.81
|
$
|
83.44
|
$
|
57.34
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
(.01)
|
.03
|
.08
|
(.04)
|
(.06)
|
.12
|
||||||
Net realized and unrealized gain (loss)
|
11.22
|
28.54
|
25.08
|
(15.63)
|
36.72
|
27.68
|
||||||
Total from investment operations
|
11.21
|
28.57
|
25.16
|
(15.67)
|
36.66
|
27.80
|
||||||
Distributions from net realized gain
|
(9.96)
|
(4.14)
|
(2.31)
|
(12.92)
|
(7.29)
|
(1.70)
|
||||||
Total distributions
|
(9.96)
|
(4.14)
|
(2.31)
|
(12.92)
|
(7.29)
|
(1.70)
|
||||||
Net asset value, end of period
|
$
|
132.75
|
$
|
131.50
|
$
|
107.07
|
$
|
84.22
|
$
|
112.81
|
$
|
83.44
|
Total Return C,D
|
8.08 % |
27.57%
|
31.00%
|
(16.46)%
|
45.37%
|
49.39%
|
||||||
Ratios to Average Net Assets B,E,F
|
||||||||||||
Expenses before reductions
|
.55% G
|
.56%
|
.60%
|
.59%
|
.60%
|
.62%
|
||||||
Expenses net of fee waivers, if any
|
.55 % G |
.56%
|
.59%
|
.59%
|
.60%
|
.62%
|
||||||
Expenses net of all reductions
|
.55% G
|
.56%
|
.59%
|
.59%
|
.60%
|
.62%
|
||||||
Net investment income (loss)
|
(.01)% G
|
.02%
|
.09%
|
(.04)%
|
(.06)%
|
.19%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
948,981
|
$
|
813,055
|
$
|
759,629
|
$
|
462,278
|
$
|
524,383
|
$
|
298,255
|
Portfolio turnover rate H
|
51 % G |
34% I
|
30%
|
20%
|
44%
|
40% I
|
Common Stocks - 93.9%
|
|||
Shares
|
Value ($)
|
||
UNITED STATES - 93.9%
|
|||
Industrials - 0.8%
|
|||
Electrical Equipment - 0.8%
|
|||
GE Vernova Inc
|
24,100
|
8,986,408
|
|
Information Technology - 0.3%
|
|||
Semiconductors & Semiconductor Equipment - 0.3%
|
|||
First Solar Inc (a)
|
23,100
|
3,869,712
|
|
Utilities - 92.8%
|
|||
Electric Utilities - 61.6%
|
|||
American Electric Power Co Inc
|
255,599
|
25,140,718
|
|
Constellation Energy Corp
|
253,965
|
76,184,421
|
|
Duke Energy Corp
|
868,605
|
97,275,074
|
|
Edison International
|
249,109
|
13,451,886
|
|
Entergy Corp
|
643,600
|
52,183,088
|
|
Evergy Inc
|
543,910
|
34,902,705
|
|
Eversource Energy
|
454,679
|
26,225,885
|
|
Exelon Corp
|
1,348,200
|
53,928,000
|
|
FirstEnergy Corp
|
548,768
|
21,840,966
|
|
NextEra Energy Inc
|
1,498,311
|
107,219,135
|
|
NRG Energy Inc
|
116,954
|
11,980,768
|
|
PG&E Corp
|
2,114,098
|
33,085,634
|
|
PPL Corp
|
1,024,034
|
34,407,542
|
|
Southern Co/The
|
488,972
|
41,049,199
|
|
TXNM Energy Inc
|
532,177
|
25,730,758
|
|
Xcel Energy Inc
|
641,718
|
43,123,450
|
|
697,729,229
|
|||
Gas Utilities - 1.9%
|
|||
Southwest Gas Holdings Inc
|
109,658
|
8,189,259
|
|
UGI Corp
|
424,571
|
13,047,067
|
|
21,236,326
|
|||
Independent Power and Renewable Electricity Producers - 7.7%
|
|||
AES Corp/The
|
1,849,240
|
20,341,640
|
|
Talen Energy Corp (a)
|
26,455
|
5,865,867
|
|
Vistra Corp
|
365,435
|
61,404,043
|
|
87,611,550
|
|||
Multi-Utilities - 21.6%
|
|||
Ameren Corp
|
512,703
|
48,296,623
|
|
CenterPoint Energy Inc
|
1,342,287
|
43,718,288
|
|
Consolidated Edison Inc
|
220,000
|
20,622,800
|
|
Dominion Energy Inc
|
214,319
|
11,913,992
|
|
NiSource Inc
|
792,744
|
29,569,351
|
|
Public Service Enterprise Group Inc
|
373,093
|
31,168,189
|
|
Sempra
|
714,348
|
59,240,880
|
|
244,530,123
|
|||
TOTAL UTILITIES
|
1,051,107,228
|
||
TOTAL UNITED STATES
|
1,063,963,348
|
||
|
TOTAL COMMON STOCKS
(Cost $804,664,041)
|
1,063,963,348
|
||
Money Market Funds - 7.3%
|
||||
Yield (%)
|
Shares
|
Value ($)
|
||
Fidelity Cash Central Fund (b)
(Cost $83,386,122)
|
4.37
|
83,369,448
|
83,386,122
|
|
|
TOTAL INVESTMENT IN SECURITIES - 101.2%
(Cost $888,050,163)
|
1,147,349,470
|
NET OTHER ASSETS (LIABILITIES) - (1.2)%
|
(14,013,402)
|
NET ASSETS - 100.0%
|
1,133,336,068
|
(a)
|
Non-income producing
|
(b)
|
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
|
Affiliate
|
Value,
beginning
of period ($)
|
Purchases ($)
|
Sales
Proceeds ($)
|
Dividend
Income ($)
|
Realized
Gain (loss) ($)
|
Change in
Unrealized
appreciation
(depreciation) ($)
|
Value,
end
of period ($)
|
Shares,
end
of period
|
% ownership,
end
of period
|
Fidelity Cash Central Fund
|
29,948,674
|
302,991,502
|
249,554,054
|
546,706
|
-
|
-
|
83,386,122
|
83,369,448
|
0.1%
|
Fidelity Securities Lending Cash Central Fund
|
12,140,825
|
73,558,557
|
85,699,382
|
6,471
|
-
|
-
|
-
|
-
|
0.0%
|
Total
|
42,089,499
|
376,550,059
|
335,253,436
|
553,177
|
-
|
-
|
83,386,122
|
83,369,448
|
|
Valuation Inputs at Reporting Date:
|
||||
Description
|
Total ($)
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Investments in Securities:
|
||||
Common Stocks
|
||||
Industrials
|
8,986,408
|
8,986,408
|
-
|
-
|
Information Technology
|
3,869,712
|
3,869,712
|
-
|
-
|
Utilities
|
1,051,107,228
|
1,051,107,228
|
-
|
-
|
Money Market Funds
|
83,386,122
|
83,386,122
|
-
|
-
|
Total Investments in Securities:
|
1,147,349,470
|
1,147,349,470
|
-
|
-
|
Statement of Assets and Liabilities
|
||||
|
As of January 31, 2025 (Unaudited)
|
||||
Assets
|
||||
Investment in securities, at value - See accompanying schedule:
|
||||
Unaffiliated issuers (cost $804,664,041)
|
$
|
1,063,963,348
|
||
Fidelity Central Funds (cost $83,386,122)
|
83,386,122
|
|||
Total Investment in Securities (cost $888,050,163)
|
$
|
1,147,349,470
|
||
Receivable for investments sold
|
6,129,542
|
|||
Receivable for fund shares sold
|
1,904,945
|
|||
Dividends receivable
|
547,840
|
|||
Distributions receivable from Fidelity Central Funds
|
222,070
|
|||
Prepaid expenses
|
595
|
|||
Total assets
|
1,156,154,462
|
|||
Liabilities
|
||||
Payable for investments purchased
|
$
|
21,232,280
|
||
Payable for fund shares redeemed
|
734,578
|
|||
Accrued management fee
|
638,724
|
|||
Distribution and service plan fees payable
|
178,896
|
|||
Other payables and accrued expenses
|
33,916
|
|||
Total liabilities
|
22,818,394
|
|||
Net Assets
|
$
|
1,133,336,068
|
||
Net Assets consist of:
|
||||
Paid in capital
|
$
|
869,772,581
|
||
Total accumulated earnings (loss)
|
263,563,487
|
|||
Net Assets
|
$
|
1,133,336,068
|
||
Net Asset Value and Maximum Offering Price
|
||||
Class A :
|
||||
Net Asset Value and redemption price per share ($421,380,696 ÷ 9,480,222 shares)(a)
|
$
|
44.45
|
||
Maximum offering price per share (100/94.25 of $44.45)
|
$
|
47.16
|
||
Class M :
|
||||
Net Asset Value and redemption price per share ($75,741,279 ÷ 1,697,590 shares)(a)
|
$
|
44.62
|
||
Maximum offering price per share (100/96.50 of $44.62)
|
$
|
46.24
|
||
Class C :
|
||||
Net Asset Value and offering price per share ($73,501,260 ÷ 1,699,865 shares)(a)
|
$
|
43.24
|
||
Class I :
|
||||
Net Asset Value, offering price and redemption price per share ($437,600,996 ÷ 9,585,503 shares)
|
$
|
45.65
|
||
Class Z :
|
||||
Net Asset Value, offering price and redemption price per share ($125,111,837 ÷ 2,741,947 shares)
|
$
|
45.63
|
||
(a)Redemption price per share is equal to net asset value less any applicable contingent deferred sales charge.
|
||||
Statement of Operations
|
||||
Six months ended January 31, 2025 (Unaudited)
|
||||
Investment Income
|
||||
Dividends
|
$
|
12,697,404
|
||
Income from Fidelity Central Funds (including $6,471 from security lending)
|
553,177
|
|||
Total income
|
13,250,581
|
|||
Expenses
|
||||
Management fee
|
$
|
3,477,973
|
||
Distribution and service plan fees
|
1,013,285
|
|||
Custodian fees and expenses
|
5,001
|
|||
Independent trustees' fees and expenses
|
2,016
|
|||
Registration fees
|
81,698
|
|||
Audit fees
|
25,680
|
|||
Legal
|
720
|
|||
Miscellaneous
|
26,086
|
|||
Total expenses before reductions
|
4,632,459
|
|||
Expense reductions
|
(804)
|
|||
Total expenses after reductions
|
4,631,655
|
|||
Net Investment income (loss)
|
8,618,926
|
|||
Realized and Unrealized Gain (Loss)
|
||||
Net realized gain (loss) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
14,807,288
|
|||
Foreign currency transactions
|
2,514
|
|||
Total net realized gain (loss)
|
14,809,802
|
|||
Change in net unrealized appreciation (depreciation) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
68,148,124
|
|||
Assets and liabilities in foreign currencies
|
(919)
|
|||
Total change in net unrealized appreciation (depreciation)
|
68,147,205
|
|||
Net gain (loss)
|
82,957,007
|
|||
Net increase (decrease) in net assets resulting from operations
|
$
|
91,575,933
|
||
Statement of Changes in Net Assets
|
||||
Six months ended
January 31, 2025
(Unaudited)
|
Year ended
July 31, 2024
|
|||
Increase (Decrease) in Net Assets
|
||||
Operations
|
||||
Net investment income (loss)
|
$
|
8,618,926
|
$
|
14,691,657
|
Net realized gain (loss)
|
14,809,802
|
37,078,896
|
||
Change in net unrealized appreciation (depreciation)
|
68,147,205
|
47,869,079
|
||
Net increase (decrease) in net assets resulting from operations
|
91,575,933
|
99,639,632
|
||
Distributions to shareholders
|
(48,619,679)
|
(23,696,221)
|
||
Share transactions - net increase (decrease)
|
270,662,988
|
(74,826,763)
|
||
Total increase (decrease) in net assets
|
313,619,242
|
1,116,648
|
||
Net Assets
|
||||
Beginning of period
|
819,716,826
|
818,600,178
|
||
End of period
|
$
|
1,133,336,068
|
$
|
819,716,826
|
Fidelity Advisor® Utilities Fund Class A |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
41.94
|
$
|
37.27
|
$
|
39.71
|
$
|
34.53
|
$
|
30.67
|
$
|
31.73
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.37
|
.75
|
.64
|
.52
|
.56
|
.60
|
||||||
Net realized and unrealized gain (loss)
|
4.20
|
5.18
|
(1.29)
|
5.84
|
3.98
|
(1.03)
|
||||||
Total from investment operations
|
4.57
|
5.93
|
(.65)
|
6.36
|
4.54
|
(.43)
|
||||||
Distributions from net investment income
|
(.42)
|
(.77)
|
(.64)
|
(.67)
|
(.68)
|
(.62)
|
||||||
Distributions from net realized gain
|
(1.64)
|
(.49)
|
(1.15)
|
(.51)
|
-
|
- C
|
||||||
Total distributions
|
(2.06)
|
(1.26)
|
(1.79)
|
(1.18)
|
(.68)
|
(.63) D
|
||||||
Net asset value, end of period
|
$
|
44.45
|
$
|
41.94
|
$
|
37.27
|
$
|
39.71
|
$
|
34.53
|
$
|
30.67
|
Total Return E,F,G
|
10.95 % |
16.48%
|
(1.58)%
|
18.70%
|
14.95%
|
(1.56)%
|
||||||
Ratios to Average Net Assets B,H,I
|
||||||||||||
Expenses before reductions
|
.99% J
|
1.01%
|
1.01%
|
1.02%
|
1.05%
|
1.06%
|
||||||
Expenses net of fee waivers, if any
|
.99 % J |
1.00%
|
1.01%
|
1.02%
|
1.04%
|
1.06%
|
||||||
Expenses net of all reductions
|
.99% J
|
1.00%
|
1.01%
|
1.02%
|
1.03%
|
1.05%
|
||||||
Net investment income (loss)
|
1.64% J
|
2.04%
|
1.71%
|
1.41%
|
1.70%
|
1.88%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
421,381
|
$
|
348,276
|
$
|
327,807
|
$
|
322,060
|
$
|
254,388
|
$
|
249,158
|
Portfolio turnover rate K
|
82 % J |
84%
|
66%
|
36%
|
45%
|
80% L
|
Fidelity Advisor® Utilities Fund Class M |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
42.07
|
$
|
37.37
|
$
|
39.81
|
$
|
34.57
|
$
|
30.71
|
$
|
31.77
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.31
|
.66
|
.54
|
.42
|
.47
|
.51
|
||||||
Net realized and unrealized gain (loss)
|
4.21
|
5.20
|
(1.29)
|
5.85
|
3.99
|
(1.03)
|
||||||
Total from investment operations
|
4.52
|
5.86
|
(.75)
|
6.27
|
4.46
|
(.52)
|
||||||
Distributions from net investment income
|
(.33)
|
(.67)
|
(.54)
|
(.51)
|
(.60)
|
(.53)
|
||||||
Distributions from net realized gain
|
(1.64)
|
(.49)
|
(1.15)
|
(.51)
|
-
|
- C
|
||||||
Total distributions
|
(1.97)
|
(1.16)
|
(1.69)
|
(1.03) D
|
(.60)
|
(.54) D
|
||||||
Net asset value, end of period
|
$
|
44.62
|
$
|
42.07
|
$
|
37.37
|
$
|
39.81
|
$
|
34.57
|
$
|
30.71
|
Total Return E,F,G
|
10.81 % |
16.19%
|
(1.85)%
|
18.37%
|
14.63%
|
(1.82)%
|
||||||
Ratios to Average Net Assets B,H,I
|
||||||||||||
Expenses before reductions
|
1.24% J
|
1.27%
|
1.28%
|
1.30%
|
1.32%
|
1.33%
|
||||||
Expenses net of fee waivers, if any
|
1.24 % J |
1.27%
|
1.27%
|
1.29%
|
1.32%
|
1.33%
|
||||||
Expenses net of all reductions
|
1.24% J
|
1.27%
|
1.27%
|
1.29%
|
1.31%
|
1.33%
|
||||||
Net investment income (loss)
|
1.38% J
|
1.78%
|
1.45%
|
1.14%
|
1.42%
|
1.60%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
75,741
|
$
|
70,288
|
$
|
68,733
|
$
|
71,690
|
$
|
58,065
|
$
|
58,773
|
Portfolio turnover rate K
|
82 % J |
84%
|
66%
|
36%
|
45%
|
80% L
|
Fidelity Advisor® Utilities Fund Class C |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
40.83
|
$
|
36.30
|
$
|
38.73
|
$
|
33.60
|
$
|
29.83
|
$
|
30.90
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.19
|
.47
|
.35
|
.24
|
.30
|
.35
|
||||||
Net realized and unrealized gain (loss)
|
4.08
|
5.05
|
(1.26)
|
5.67
|
3.88
|
(1.01)
|
||||||
Total from investment operations
|
4.27
|
5.52
|
(.91)
|
5.91
|
4.18
|
(.66)
|
||||||
Distributions from net investment income
|
(.22)
|
(.50)
|
(.37)
|
(.27)
|
(.41)
|
(.40)
|
||||||
Distributions from net realized gain
|
(1.64)
|
(.49)
|
(1.15)
|
(.51)
|
-
|
- C
|
||||||
Total distributions
|
(1.86)
|
(.99)
|
(1.52)
|
(.78)
|
(.41)
|
(.41) D
|
||||||
Net asset value, end of period
|
$
|
43.24
|
$
|
40.83
|
$
|
36.30
|
$
|
38.73
|
$
|
33.60
|
$
|
29.83
|
Total Return E,F,G
|
10.52 % |
15.64%
|
(2.34)%
|
17.78%
|
14.10%
|
(2.28)%
|
||||||
Ratios to Average Net Assets B,H,I
|
||||||||||||
Expenses before reductions
|
1.74% J
|
1.76%
|
1.77%
|
1.78%
|
1.80%
|
1.81%
|
||||||
Expenses net of fee waivers, if any
|
1.74 % J |
1.75%
|
1.76%
|
1.78%
|
1.80%
|
1.81%
|
||||||
Expenses net of all reductions
|
1.74% J
|
1.75%
|
1.76%
|
1.78%
|
1.79%
|
1.80%
|
||||||
Net investment income (loss)
|
.88% J
|
1.30%
|
.96%
|
.65%
|
.94%
|
1.12%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
73,501
|
$
|
56,100
|
$
|
58,042
|
$
|
61,087
|
$
|
49,312
|
$
|
63,458
|
Portfolio turnover rate K
|
82 % J |
84%
|
66%
|
36%
|
45%
|
80% L
|
Fidelity Advisor® Utilities Fund Class I |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
43.06
|
$
|
38.22
|
$
|
40.68
|
$
|
35.39
|
$
|
31.40
|
$
|
32.47
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.44
|
.88
|
.76
|
.64
|
.66
|
.71
|
||||||
Net realized and unrealized gain (loss)
|
4.31
|
5.32
|
(1.33)
|
5.98
|
4.10
|
(1.07)
|
||||||
Total from investment operations
|
4.75
|
6.20
|
(.57)
|
6.62
|
4.76
|
(.36)
|
||||||
Distributions from net investment income
|
(.52)
|
(.87)
|
(.74)
|
(.81)
|
(.77)
|
(.71)
|
||||||
Distributions from net realized gain
|
(1.64)
|
(.49)
|
(1.15)
|
(.51)
|
-
|
- C
|
||||||
Total distributions
|
(2.16)
|
(1.36)
|
(1.89)
|
(1.33) D
|
(.77)
|
(.71)
|
||||||
Net asset value, end of period
|
$
|
45.65
|
$
|
43.06
|
$
|
38.22
|
$
|
40.68
|
$
|
35.39
|
$
|
31.40
|
Total Return E,F
|
11.08 % |
16.82%
|
(1.34)%
|
19.00%
|
15.30%
|
(1.30)%
|
||||||
Ratios to Average Net Assets B,G,H
|
||||||||||||
Expenses before reductions
|
.72% I
|
.74%
|
.75%
|
.76%
|
.77%
|
.79%
|
||||||
Expenses net of fee waivers, if any
|
.72 % I |
.73%
|
.74%
|
.75%
|
.77%
|
.78%
|
||||||
Expenses net of all reductions
|
.72% I
|
.73%
|
.74%
|
.75%
|
.76%
|
.78%
|
||||||
Net investment income (loss)
|
1.91% I
|
2.31%
|
1.98%
|
1.68%
|
1.97%
|
2.15%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
437,601
|
$
|
270,962
|
$
|
255,201
|
$
|
269,667
|
$
|
143,582
|
$
|
187,833
|
Portfolio turnover rate J
|
82 % I |
84%
|
66%
|
36%
|
45%
|
80% K
|
Fidelity Advisor® Utilities Fund Class Z |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
43.04
|
$
|
38.20
|
$
|
40.66
|
$
|
35.38
|
$
|
31.42
|
$
|
32.48
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.47
|
.93
|
.81
|
.69
|
.71
|
.74
|
||||||
Net realized and unrealized gain (loss)
|
4.30
|
5.31
|
(1.33)
|
5.98
|
4.08
|
(1.04)
|
||||||
Total from investment operations
|
4.77
|
6.24
|
(.52)
|
6.67
|
4.79
|
(.30)
|
||||||
Distributions from net investment income
|
(.54)
|
(.92)
|
(.79)
|
(.88)
|
(.83)
|
(.75)
|
||||||
Distributions from net realized gain
|
(1.64)
|
(.49)
|
(1.15)
|
(.51)
|
-
|
- C
|
||||||
Total distributions
|
(2.18)
|
(1.40) D
|
(1.94)
|
(1.39)
|
(.83)
|
(.76) D
|
||||||
Net asset value, end of period
|
$
|
45.63
|
$
|
43.04
|
$
|
38.20
|
$
|
40.66
|
$
|
35.38
|
$
|
31.42
|
Total Return E,F
|
11.14 % |
16.97%
|
(1.21)%
|
19.17%
|
15.41%
|
(1.15)%
|
||||||
Ratios to Average Net Assets A,G,H
|
||||||||||||
Expenses before reductions
|
.60% I
|
.58%
|
.62%
|
.63%
|
.64%
|
.65%
|
||||||
Expenses net of fee waivers, if any
|
.60 % I |
.57%
|
.62%
|
.63%
|
.64%
|
.65%
|
||||||
Expenses net of all reductions
|
.60% I
|
.57%
|
.62%
|
.63%
|
.63%
|
.64%
|
||||||
Net investment income (loss)
|
2.03% I
|
2.48%
|
2.10%
|
1.81%
|
2.10%
|
2.29%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
125,112
|
$
|
74,091
|
$
|
108,817
|
$
|
106,266
|
$
|
54,746
|
$
|
52,034
|
Portfolio turnover rate J
|
82 % I |
84%
|
66%
|
36%
|
45%
|
80% K
|
Fidelity Central Fund
|
Investment Manager
|
Investment Objective
|
Investment Practices
|
Expense RatioA
|
Fidelity Money Market Central Funds
|
Fidelity Management & Research Company LLC (FMR)
|
Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity.
|
Short-term Investments
|
Less than .005%
|
Asset Type
|
Fair Value
|
Valuation Technique(s)
|
Unobservable Input
|
Amount or Range/Weighted Average
|
Impact to Valuation from an Increase in InputA
|
Common Stocks
|
$7
|
Recovery value
|
Recovery value
|
$0.00
|
Increase
|
Convertible Corporate Bonds
|
$885,016
|
Market approach
|
Transaction price
|
$100.00
|
Increase
|
Discount rate
|
23.5%
|
Decrease
|
|||
Probability rate
|
0.0% - 50.0% / 25.0%
|
Increase
|
|||
Convertible Preferred Stocks
|
$30,100,135
|
Market approach
|
Transaction price
|
$1.13 - $8.61 / $4.09
|
Increase
|
Discount rate
|
10.0% - 80.0% / 46.1%
|
Decrease
|
|||
Premium rate
|
15.0%
|
Increase
|
|||
Recovery value
|
Recovery value
|
$0.00
|
Increase
|
||
Black scholes
|
Volatility
|
75.0% - 90.0% / 82.7%
|
Increase
|
||
Discount rate
|
4.3% - 4.4% / 4.3%
|
Increase
|
|||
Term
|
2.0 - 3.0 / 2.9
|
Increase
|
Asset Type
|
Fair Value
|
Valuation Technique(s)
|
Unobservable Input
|
Amount or Range/Weighted Average
|
Impact to Valuation from an Increase in InputA
|
Common Stocks
|
$3,284,900
|
Market comparable
|
Enterprise value/Revenue multiple (EV/R)
|
5.5
|
Increase
|
Market approach
|
Transaction price
|
$33.33
|
Increase
|
||
Black scholes
|
Volatility
|
70.0%
|
Increase
|
||
Discount rate
|
4.5%
|
Increase
|
|||
Term
|
5.0
|
Increase
|
|||
Convertible Corporate Bonds
|
$5,830,245
|
Market comparable
|
Enterprise value/Revenue multiple (EV/R)
|
6.5 - 7.0 / 6.7
|
Increase
|
Discount rate
|
25.0% - 32.4% / 28.4%
|
Decrease
|
|||
Probability rate
|
0.0% - 50.0% / 21.3%
|
Increase
|
|||
Market approach
|
Transaction price
|
$100.00
|
Increase
|
||
Discount rate
|
23.5%
|
Decrease
|
|||
Probability rate
|
0.0% - 50.0% / 25.0%
|
Increase
|
|||
Black scholes
|
Volatility
|
55.0%
|
Increase
|
||
Discount rate
|
4.3%
|
Increase
|
|||
Term
|
0.6
|
Increase
|
|||
Convertible Preferred Stocks
|
$74,959,527
|
Market comparable
|
Enterprise value/Revenue multiple (EV/R)
|
1.4 - 13.5 / 4.6
|
Increase
|
Market approach
|
Transaction price
|
$1.20 - $33.33 / $13.29
|
Increase
|
||
Discount rate
|
10.0% - 70.0% / 23.8%
|
Decrease
|
|||
Black scholes
|
Volatility
|
45.0% - 90.0% / 66.6%
|
Increase
|
||
Discount rate
|
4.2% - 4.5% / 4.3%
|
Increase
|
|||
Term
|
1.5 - 5.0 / 2.8
|
Increase
|
|||
Preferred Securities
|
$7,928,979
|
Market approach
|
Transaction price
|
$100.00
|
Increase
|
Discount rate
|
36.1%
|
Decrease
|
|||
Probability rate
|
0.0% - 50.0% / 25.0%
|
Increase
|
|||
Black scholes
|
Volatility
|
70.0%
|
Increase
|
||
Discount rate
|
4.3%
|
Increase
|
|||
Term
|
0.4
|
Increase
|
Asset Type
|
Fair Value
|
Valuation Technique(s)
|
Unobservable Input
|
Amount or Range/Weighted Average
|
Impact to Valuation from an Increase in InputA
|
Common Stocks
|
$27,383,839
|
Market comparable
|
Enterprise value/Revenue multiple (EV/R)
|
13.3 - 19.1 / 18.5
|
Increase
|
Market approach
|
Transaction price
|
$8.00
|
Increase
|
||
Recovery value
|
Recovery value
|
$0.00
|
Increase
|
||
Black scholes
|
Volatility
|
70.0%
|
Increase
|
||
Discount rate
|
4.4%
|
Increase
|
|||
Term
|
3.0
|
Increase
|
|||
Convertible Corporate Bonds
|
$150,399
|
Market approach
|
Transaction price
|
$100.00
|
Increase
|
Discount rate
|
21.70%
|
Decrease
|
|||
Probability rate
|
0.0% - 60.0% / 25.0%
|
Increase
|
|||
Black scholes
|
Volatility
|
100.0%
|
Increase
|
||
Discount rate
|
5.0%
|
Increase
|
|||
Term
|
0.3
|
Increase
|
|||
Convertible Preferred Stocks
|
$110,780,868
|
Market comparable
|
Enterprise value/Revenue multiple (EV/R)
|
0.9 - 51.0 / 16.7
|
Increase
|
Market approach
|
Transaction price
|
$1.10 - $8.00 / $4.11
|
Increase
|
||
Discount rate
|
60.0%
|
Decrease
|
|||
Premium rate
|
25.0%
|
Increase
|
|||
Black scholes
|
Volatility
|
50.0% - 100.0% / 67.0%
|
Increase
|
||
Discount rate
|
4.3% - 4.5% / 4.3%
|
Increase
|
|||
Term
|
2.0 - 5.0 / 2.9
|
Increase
|
|||
Preferred Securities
|
$801,867
|
Market approach
|
Transaction price
|
$100.00
|
Increase
|
Discount rate
|
35.4% - 37.9% / 36.4%
|
Decrease
|
|||
Probability rate
|
0.0% - 50.0% / 30.2%
|
Increase
|
|||
Black scholes
|
Volatility
|
50.0% - 100.0% / 79.2%
|
Increase
|
||
Discount rate
|
4.3% - 5.0% / 4.7%
|
Increase
|
|||
Term
|
0.1 - 0.4 / 0.2
|
Increase
|
Fidelity Advisor Energy Fund
|
109,516
|
Fidelity Advisor Technology Fund
|
175,876
|
Tax cost ($)
|
Gross unrealized appreciation ($)
|
Gross unrealized depreciation ($)
|
Net unrealized appreciation (depreciation)($)
|
|
Fidelity Advisor Biotechnology Fund
|
1,175,234,662
|
567,374,551
|
(81,561,762)
|
485,812,789
|
Fidelity Advisor Consumer Discretionary Fund
|
237,353,352
|
311,491,356
|
(10,634,106)
|
300,857,250
|
Fidelity Advisor Energy Fund
|
718,871,054
|
455,318,727
|
(28,621,500)
|
426,697,227
|
Fidelity Advisor Financials Fund
|
468,008,558
|
214,862,651
|
(6,282,843)
|
208,579,808
|
Fidelity Advisor Health Care Fund
|
2,647,152,714
|
1,853,045,147
|
(233,142,776)
|
1,619,902,371
|
Fidelity Advisor Industrials Fund
|
472,417,272
|
215,511,541
|
(7,940,121)
|
207,571,420
|
Fidelity Advisor Semiconductors Fund
|
1,813,443,669
|
1,235,456,580
|
(109,884,981)
|
1,125,571,599
|
Fidelity Advisor Technology Fund
|
3,677,650,014
|
3,629,150,355
|
(261,904,771)
|
3,367,245,584
|
Fidelity Advisor Utilities Fund
|
889,783,214
|
270,847,701
|
(13,281,445)
|
257,566,256
|
Short-term ($)
|
Long-term ($)
|
Total capital loss carryforward ($)
|
|
Fidelity Advisor Energy Fund
|
(191,455,812)
|
-
|
(191,455,812)
|
Ordinary losses ($)
|
|
Fidelity Advisor Consumer Discretionary Fund
|
(563,892)
|
Fidelity Advisor Health Care Fund
|
(6,688,745)
|
Fidelity Advisor Semiconductors Fund
|
(4,933,502)
|
Fidelity Advisor Technology Fund
|
(17,165,728)
|
Amount ($)
|
% of Net Assets
|
|
Fidelity Advisor Health Care Fund
|
1,480,711
|
.04
|
Investment to be Acquired
|
Commitment Amount ($)
|
Unrealized Appreciation (Depreciation)($)
|
|
Fidelity Advisor Biotechnology Fund
|
Crescent Biopharma
|
3,320,670
|
2,710,312
|
Fidelity Advisor Biotechnology Fund
|
Jade Biosciences
|
783,600
|
(40,187)
|
Fidelity Advisor Health Care Fund
|
Jade Biosciences
|
1,905,603
|
(97,730)
|
Fidelity Advisor Technology Fund
|
Revolut Group Holdings, Ltd.
|
7,140,580
|
-
|
Purchases ($)
|
Sales ($)
|
|
Fidelity Advisor Biotechnology Fund
|
414,007,154
|
496,845,908
|
Fidelity Advisor Consumer Discretionary Fund
|
58,718,818
|
93,677,285
|
Fidelity Advisor Energy Fund
|
88,728,280
|
160,749,885
|
Fidelity Advisor Financials Fund
|
191,048,028
|
125,781,372
|
Fidelity Advisor Health Care Fund
|
1,076,522,766
|
1,652,796,145
|
Fidelity Advisor Industrials Fund
|
131,645,426
|
96,625,780
|
Fidelity Advisor Semiconductors Fund
|
919,189,335
|
735,046,672
|
Fidelity Advisor Technology Fund
|
1,825,995,769
|
1,676,195,979
|
Fidelity Advisor Utilities Fund
|
603,670,747
|
403,048,013
|
Shares
|
Total net realized gain or loss ($)
|
Total Proceeds ($)
|
|
Fidelity Advisor Consumer Discretionary Fund
|
493,122
|
15,311,646
|
19,147,937
|
Fidelity Advisor Energy Fund
|
1,253,395
|
42,342,401
|
57,668,686
|
Fidelity Advisor Financials Fund
|
629,921
|
7,051,602
|
15,955,906
|
Fidelity Advisor Industrials Fund
|
553,097
|
11,201,399
|
22,245,575
|
Fidelity Advisor Technology Fund
|
1,690,112
|
75,184,814
|
169,535,169
|
Maximum management Fee Rate%
|
|
Fidelity Advisor Biotechnology Fund
|
|
Class A
|
.71
|
Class M
|
.72
|
Class C
|
.72
|
Class I
|
.69
|
Class Z
|
.56
|
Fidelity Advisor Consumer Discretionary Fund
|
|
Class A
|
.70
|
Class M
|
.72
|
Class C
|
.71
|
Class I
|
.69
|
Class Z
|
.56
|
Fidelity Advisor Energy Fund
|
|
Class A
|
.72
|
Class M
|
.72
|
Class C
|
.71
|
Class I
|
.69
|
Class Z
|
.56
|
Fidelity Advisor Financials Fund
|
|
Class A
|
.72
|
Class M
|
.71
|
Class C
|
.71
|
Class I
|
.69
|
Class Z
|
.56
|
Fidelity Advisor Health Care Fund
|
|
Class A
|
.69
|
Class M
|
.69
|
Class C
|
.69
|
Class I
|
.68
|
Class Z
|
.55
|
Fidelity Advisor Industrials Fund
|
|
Class A
|
.70
|
Class M
|
.70
|
Class C
|
.71
|
Class I
|
.68
|
Class Z
|
.56
|
Fidelity Advisor Semiconductors Fund
|
|
Class A
|
.69
|
Class M
|
.68
|
Class C
|
.70
|
Class I
|
.69
|
Class Z
|
.56
|
Fidelity Advisor Technology Fund
|
|
Class A
|
.68
|
Class M
|
.67
|
Class C
|
.69
|
Class I
|
.67
|
Class Z
|
.55
|
Fidelity Advisor Utilities Fund
|
|
Class A
|
.71
|
Class M
|
.72
|
Class C
|
.71
|
Class I
|
.69
|
Class Z
|
.57
|
Total Management Fee Rate %
|
|
Fidelity Advisor Biotechnology Fund
|
|
Class A
|
.68
|
Class M
|
.69
|
Class C
|
.68
|
Class I
|
.69
|
Class Z
|
.56
|
Fidelity Advisor Consumer Discretionary Fund
|
|
Class A
|
.70
|
Class M
|
.72
|
Class C
|
.71
|
Class I
|
.69
|
Class Z
|
.56
|
Fidelity Advisor Energy Fund
|
|
Class A
|
.70
|
Class M
|
.70
|
Class C
|
.70
|
Class I
|
.69
|
Class Z
|
.56
|
Fidelity Advisor Financials Fund
|
|
Class A
|
.72
|
Class M
|
.71
|
Class C
|
.71
|
Class I
|
.69
|
Class Z
|
.56
|
Fidelity Advisor Health Care Fund
|
|
Class A
|
.66
|
Class M
|
.66
|
Class C
|
.66
|
Class I
|
.66
|
Class Z
|
.55
|
Fidelity Advisor Industrials Fund
|
|
Class A
|
.70
|
Class M
|
.70
|
Class C
|
.71
|
Class I
|
.68
|
Class Z
|
.56
|
Fidelity Advisor Semiconductors Fund
|
|
Class A
|
.67
|
Class M
|
.67
|
Class C
|
.67
|
Class I
|
.67
|
Class Z
|
.55
|
Fidelity Advisor Technology Fund
|
|
Class A
|
.66
|
Class M
|
.66
|
Class C
|
.66
|
Class I
|
.66
|
Class Z
|
.54
|
Fidelity Advisor Utilities Fund
|
|
Class A
|
.71
|
Class M
|
.71
|
Class C
|
.71
|
Class I
|
.69
|
Class Z
|
.57
|
Distribution Fee
|
Service Fee
|
Total Fees ($)
|
Retained by FDC ($)
|
|
Fidelity Advisor Biotechnology Fund
|
||||
Class A
|
- %
|
.25%
|
880,400
|
1,129
|
Class M
|
.25%
|
.25%
|
314,772
|
-
|
Class C
|
.75%
|
.25%
|
414,881
|
22,972
|
1,610,053
|
24,101
|
|||
Fidelity Advisor Consumer Discretionary Fund
|
||||
Class A
|
- %
|
.25%
|
286,876
|
1,080
|
Class M
|
.25%
|
.25%
|
93,962
|
-
|
Class C
|
.75%
|
.25%
|
159,157
|
10,082
|
539,995
|
11,162
|
|||
Fidelity Advisor Energy Fund
|
||||
Class A
|
- %
|
.25%
|
453,686
|
6,832
|
Class M
|
.25%
|
.25%
|
257,030
|
-
|
Class C
|
.75%
|
.25%
|
372,495
|
53,912
|
1,083,211
|
60,744
|
|||
Fidelity Advisor Financials Fund
|
||||
Class A
|
- %
|
.25%
|
276,340
|
3,352
|
Class M
|
.25%
|
.25%
|
205,924
|
-
|
Class C
|
.75%
|
.25%
|
194,013
|
22,267
|
676,277
|
25,619
|
|||
Fidelity Advisor Health Care Fund
|
||||
Class A
|
- %
|
.25%
|
1,804,930
|
2,270
|
Class M
|
.25%
|
.25%
|
752,398
|
-
|
Class C
|
.75%
|
.25%
|
1,270,313
|
55,111
|
3,827,641
|
57,381
|
|||
Fidelity Advisor Industrials Fund
|
||||
Class A
|
- %
|
.25%
|
358,173
|
3,462
|
Class M
|
.25%
|
.25%
|
172,549
|
-
|
Class C
|
.75%
|
.25%
|
175,840
|
22,398
|
706,562
|
25,860
|
|||
Fidelity Advisor Semiconductors Fund
|
||||
Class A
|
- %
|
.25%
|
1,395,101
|
32,032
|
Class M
|
.25%
|
.25%
|
454,288
|
-
|
Class C
|
.75%
|
.25%
|
1,137,501
|
322,938
|
2,986,890
|
354,970
|
|||
Fidelity Advisor Technology Fund
|
||||
Class A
|
- %
|
.25%
|
3,248,986
|
31,669
|
Class M
|
.25%
|
.25%
|
2,028,858
|
-
|
Class C
|
.75%
|
.25%
|
1,849,709
|
258,931
|
7,127,553
|
290,600
|
|||
Fidelity Advisor Utilities Fund
|
||||
Class A
|
- %
|
.25%
|
496,896
|
10,346
|
Class M
|
.25%
|
.25%
|
189,102
|
-
|
Class C
|
.75%
|
.25%
|
327,287
|
74,195
|
1,013,285
|
84,541
|
Retained by FDC ($)
|
|
Fidelity Advisor Biotechnology Fund
|
|
Class A
|
48,847
|
Class M
|
5,037
|
53,884
|
|
Fidelity Advisor Consumer Discretionary Fund
|
|
Class A
|
12,634
|
Class M
|
1,315
|
Class C A
|
36
|
13,985
|
|
Fidelity Advisor Energy Fund
|
|
Class A
|
74,649
|
Class M
|
3,358
|
Class C A
|
710
|
78,717
|
|
Fidelity Advisor Financials Fund
|
|
Class A
|
46,424
|
Class M
|
1,491
|
Class C A
|
184
|
48,099
|
|
Fidelity Advisor Health Care Fund
|
|
Class A
|
75,406
|
Class M
|
8,732
|
Class C A
|
560
|
84,698
|
|
Fidelity Advisor Industrials Fund
|
|
Class A
|
35,007
|
Class M
|
1,483
|
Class C A
|
61
|
36,551
|
|
Fidelity Advisor Semiconductors Fund
|
|
Class A
|
672,570
|
Class M
|
15,934
|
Class C A
|
2,921
|
691,425
|
|
Fidelity Advisor Technology Fund
|
|
Class A
|
461,543
|
Class M
|
19,862
|
Class C A
|
4,457
|
485,862
|
|
Fidelity Advisor Utilities Fund
|
|
Class A
|
180,980
|
Class M
|
4,463
|
Class C A
|
219
|
185,662
|
Amount ($)
|
|
Fidelity Advisor Biotechnology Fund
|
25,594
|
Fidelity Advisor Consumer Discretionary Fund
|
1,095
|
Fidelity Advisor Energy Fund
|
4,165
|
Fidelity Advisor Financials Fund
|
3,621
|
Fidelity Advisor Health Care Fund
|
22,227
|
Fidelity Advisor Industrials Fund
|
1,172
|
Fidelity Advisor Semiconductors Fund
|
9,386
|
Fidelity Advisor Technology Fund
|
15,965
|
Fidelity Advisor Utilities Fund
|
8,953
|
Borrower or Lender
|
Average Loan Balance ($)
|
Weighted Average Interest Rate
|
Interest Expense ($)
|
|
Fidelity Advisor Health Care Fund
|
Borrower
|
14,332,840
|
4.72%
|
46,923
|
Purchases ($)
|
Sales ($)
|
Realized Gain (Loss) ($)
|
|
Fidelity Advisor Biotechnology Fund
|
12,455,211
|
44,247,845
|
6,252,681
|
Fidelity Advisor Consumer Discretionary Fund
|
8,436,501
|
7,221,953
|
3,663,513
|
Fidelity Advisor Energy Fund
|
3,889,721
|
9,181,531
|
2,646,092
|
Fidelity Advisor Financials Fund
|
15,737,042
|
6,069,922
|
1,335,796
|
Fidelity Advisor Health Care Fund
|
83,939,814
|
185,408,525
|
43,156,351
|
Fidelity Advisor Industrials Fund
|
9,043,502
|
3,873,571
|
886,128
|
Fidelity Advisor Semiconductors Fund
|
91,391,860
|
126,898,191
|
(4,126,796)
|
Fidelity Advisor Technology Fund
|
209,131,233
|
179,969,027
|
58,444,018
|
Fidelity Advisor Utilities Fund
|
8,979,459
|
24,111,652
|
456,473
|
Amount ($)
|
|
Fidelity Advisor Biotechnology Fund
|
1,153
|
Fidelity Advisor Consumer Discretionary Fund
|
310
|
Fidelity Advisor Energy Fund
|
781
|
Fidelity Advisor Financials Fund
|
354
|
Fidelity Advisor Health Care Fund
|
2,960
|
Fidelity Advisor Industrials Fund
|
386
|
Fidelity Advisor Semiconductors Fund
|
1,799
|
Fidelity Advisor Technology Fund
|
4,338
|
Fidelity Advisor Utilities Fund
|
611
|
Total Security Lending Fees Paid to NFS ($)
|
Security Lending Income From Securities Loaned to NFS ($)
|
Value of Securities Loaned to NFS at Period End ($)
|
|
Fidelity Advisor Biotechnology Fund
|
35,270
|
9,076
|
11,358
|
Fidelity Advisor Consumer Discretionary Fund
|
247
|
-
|
-
|
Fidelity Advisor Energy Fund
|
3,962
|
-
|
-
|
Fidelity Advisor Financials Fund
|
301
|
-
|
-
|
Fidelity Advisor Health Care Fund
|
51,642
|
1,516
|
-
|
Fidelity Advisor Industrials Fund
|
408
|
2
|
-
|
Fidelity Advisor Semiconductors Fund
|
21,447
|
33,353
|
-
|
Fidelity Advisor Technology Fund
|
810
|
-
|
-
|
Fidelity Advisor Utilities Fund
|
704
|
-
|
-
|
Custodian credits ($)
|
|
Fidelity Advisor Biotechnology Fund
|
6,240
|
Fidelity Advisor Semiconductors Fund
|
1,218
|
Fidelity Advisor Technology Fund
|
1,251
|
Fidelity Advisor Utilities Fund
|
804
|
Six months ended
January 31, 2025
|
Year ended
July 31, 2024
|
|
Fidelity Advisor Biotechnology Fund
|
||
Distributions to shareholders
|
||
Class A
|
$35,680,739
|
$7,399,425
|
Class M
|
6,875,045
|
1,088,438
|
Class C
|
4,545,928
|
-
|
Class I
|
36,584,307
|
9,290,645
|
Class Z
|
4,140,434
|
1,038,552
|
Total
|
$87,826,453
|
$18,817,060
|
Fidelity Advisor Consumer Discretionary Fund
|
||
Distributions to shareholders
|
||
Class A
|
$13,465,528
|
$-
|
Class M
|
2,435,918
|
-
|
Class C
|
2,511,046
|
-
|
Class I
|
7,553,763
|
-
|
Class Z
|
2,568,813
|
-
|
Total
|
$28,535,068
|
$-
|
Fidelity Advisor Energy Fund
|
||
Distributions to shareholders
|
||
Class A
|
$3,226,132
|
$ 7,318,255
|
Class M
|
783,404
|
1,764,969
|
Class C
|
544,010
|
1,178,876
|
Class I
|
5,024,795
|
11,020,177
|
Class Z
|
1,034,492
|
2,232,106
|
Total
|
$10,612,833
|
$23,514,383
|
Fidelity Advisor Financials Fund
|
||
Distributions to shareholders
|
||
Class A
|
$10,714,275
|
$3,936,144
|
Class M
|
3,846,473
|
1,359,712
|
Class C
|
1,771,962
|
580,285
|
Class I
|
8,847,671
|
2,558,939
|
Class Z
|
4,139,540
|
547,015
|
Total
|
$29,319,921
|
$8,982,095
|
Fidelity Advisor Health Care Fund
|
||
Distributions to shareholders
|
||
Class A
|
$148,445,325
|
$-
|
Class M
|
33,846,903
|
-
|
Class C
|
34,204,550
|
-
|
Class I
|
177,175,436
|
-
|
Class Z
|
47,864,866
|
-
|
Total
|
$441,537,080
|
$-
|
Fidelity Advisor Industrials Fund
|
||
Distributions to shareholders
|
||
Class A
|
$11,007,825
|
$19,091,663
|
Class M
|
2,622,510
|
4,801,657
|
Class C
|
1,569,587
|
3,163,271
|
Class I
|
7,029,076
|
9,988,265
|
Class Z
|
2,251,680
|
2,725,506
|
Total
|
$24,480,678
|
$39,770,362
|
Fidelity Advisor Semiconductors Fund
|
||
Distributions to shareholders
|
||
Class A
|
$77,150,691
|
$21,083,648
|
Class M
|
13,426,839
|
3,540,848
|
Class C
|
19,503,344
|
5,533,444
|
Class I
|
68,152,310
|
18,203,721
|
Class Z
|
15,721,265
|
3,470,629
|
Total
|
$193,954,449
|
$51,832,290
|
Fidelity Advisor Technology Fund
|
||
Distributions to shareholders
|
||
Class A
|
$202,060,752
|
$75,972,488
|
Class M
|
68,808,724
|
26,864,038
|
Class C
|
38,811,439
|
15,432,543
|
Class I
|
154,730,219
|
58,230,400
|
Class Z
|
65,003,124
|
19,915,535
|
Total
|
$529,414,258
|
$196,415,004
|
Fidelity Advisor Utilities Fund
|
||
Distributions to shareholders
|
||
Class A
|
$18,378,538
|
$10,455,083
|
Class M
|
3,243,741
|
2,004,102
|
Class C
|
2,919,055
|
1,433,195
|
Class I
|
18,576,755
|
7,152,393
|
Class Z
|
5,501,590
|
2,651,448
|
Total
|
$48,619,679
|
$23,696,221
|
Shares
|
Shares
|
Dollars
|
Dollars
|
|
Six months ended
January 31, 2025
|
Year ended
July 31, 2024
|
Six months ended
January 31, 2025
|
Year ended
July 31, 2024
|
|
Fidelity Advisor Biotechnology Fund
|
||||
Class A
|
||||
Shares sold
|
954,913
|
2,649,700
|
$29,624,424
|
$72,502,956
|
Reinvestment of distributions
|
1,198,369
|
273,310
|
33,446,486
|
6,909,269
|
Shares redeemed
|
(2,436,261)
|
(5,241,119)
|
(73,985,956)
|
(139,324,676)
|
Net increase (decrease)
|
(282,979)
|
(2,318,109)
|
$(10,915,046)
|
$(59,912,451)
|
Class M
|
||||
Shares sold
|
172,626
|
306,124
|
$5,010,851
|
$7,730,359
|
Reinvestment of distributions
|
267,639
|
46,475
|
6,795,345
|
1,075,432
|
Shares redeemed
|
(371,837)
|
(853,680)
|
(10,326,321)
|
(21,109,524)
|
Net increase (decrease)
|
68,428
|
(501,081)
|
$1,479,875
|
$(12,303,733)
|
Class C
|
||||
Shares sold
|
154,597
|
291,630
|
$3,638,423
|
$6,284,802
|
Reinvestment of distributions
|
203,344
|
-
|
4,394,259
|
-
|
Shares redeemed
|
(770,021)
|
(2,724,748)
|
(18,364,318)
|
(56,457,308)
|
Net increase (decrease)
|
(412,080)
|
(2,433,118)
|
$(10,331,636)
|
$(50,172,506)
|
Class I
|
||||
Shares sold
|
3,064,789
|
4,210,816
|
$105,353,475
|
$128,411,204
|
Reinvestment of distributions
|
999,488
|
282,262
|
30,634,295
|
7,793,263
|
Shares redeemed
|
(3,719,872)
|
(8,100,490)
|
(123,999,014)
|
(236,749,589)
|
Net increase (decrease)
|
344,405
|
(3,607,412)
|
$11,988,756
|
$(100,545,122)
|
Class Z
|
||||
Shares sold
|
332,376
|
906,906
|
$11,307,698
|
$26,839,138
|
Reinvestment of distributions
|
116,255
|
32,151
|
3,569,030
|
889,286
|
Shares redeemed
|
(487,803)
|
(757,301)
|
(15,857,138)
|
(21,811,755)
|
Net increase (decrease)
|
(39,172)
|
181,756
|
$(980,410)
|
$5,916,669
|
Fidelity Advisor Consumer Discretionary Fund
|
||||
Class A
|
||||
Shares sold
|
230,619
|
751,655
|
$10,700,190
|
$29,127,454
|
Reinvestment of distributions
|
264,932
|
-
|
13,063,817
|
-
|
Shares redeemed
|
(617,637)
|
(959,120)
|
(28,030,340)
|
(37,712,464)
|
Net increase (decrease)
|
(122,086)
|
(207,465)
|
$(4,266,333)
|
$(8,585,010)
|
Class M
|
||||
Shares sold
|
19,794
|
65,698
|
$833,176
|
$2,328,548
|
Reinvestment of distributions
|
54,024
|
-
|
2,409,471
|
-
|
Shares redeemed
|
(68,268)
|
(188,451)
|
(2,834,699)
|
(6,523,190)
|
Net increase (decrease)
|
5,550
|
(122,753)
|
$407,948
|
$(4,194,642)
|
Class C
|
||||
Shares sold
|
61,098
|
106,037
|
$2,081,372
|
$3,101,374
|
Reinvestment of distributions
|
69,116
|
-
|
2,488,855
|
-
|
Shares redeemed
|
(162,719)
|
(651,288)
|
(5,485,696)
|
(18,972,585)
|
Net increase (decrease)
|
(32,505)
|
(545,251)
|
$(915,469)
|
$(15,871,211)
|
Class I
|
||||
Shares sold
|
363,145
|
1,605,539
|
$18,609,181
|
$67,012,895
|
Reinvestment of distributions
|
128,633
|
-
|
7,068,361
|
-
|
Shares redeemed
|
(628,583)
|
(1,903,546)
|
(30,929,539)
|
(79,673,073)
|
Net increase (decrease)
|
(136,805)
|
(298,007)
|
$(5,251,997)
|
$(12,660,178)
|
Class Z
|
||||
Shares sold
|
192,027
|
388,498
|
$9,986,176
|
$16,440,384
|
Reinvestment of distributions
|
42,975
|
-
|
2,378,213
|
-
|
Shares redeemed
|
(90,723)
|
(1,574,354)
|
(4,615,663)
|
(61,888,489)
|
Net increase (decrease)
|
144,279
|
(1,185,856)
|
$7,748,726
|
$(45,448,105)
|
Fidelity Advisor Energy Fund
|
||||
Class A
|
||||
Shares sold
|
814,552
|
1,802,738
|
$37,487,143
|
$83,797,509
|
Reinvestment of distributions
|
73,675
|
167,879
|
3,128,958
|
7,094,565
|
Shares redeemed
|
(1,267,710)
|
(2,315,640)
|
(58,257,210)
|
(105,057,379)
|
Net increase (decrease)
|
(379,483)
|
(345,023)
|
$(17,641,109)
|
$(14,165,305)
|
Class M
|
||||
Shares sold
|
161,848
|
361,787
|
$7,655,625
|
$17,332,099
|
Reinvestment of distributions
|
17,556
|
39,715
|
767,017
|
1,727,981
|
Shares redeemed
|
(240,895)
|
(554,617)
|
(11,366,426)
|
(25,806,670)
|
Net increase (decrease)
|
(61,491)
|
(153,115)
|
$(2,943,784)
|
$(6,746,590)
|
Class C
|
||||
Shares sold
|
274,281
|
340,034
|
$11,486,657
|
$14,247,108
|
Reinvestment of distributions
|
13,557
|
29,115
|
523,588
|
1,125,303
|
Shares redeemed
|
(337,915)
|
(864,275)
|
(14,087,152)
|
(35,707,272)
|
Net increase (decrease)
|
(50,077)
|
(495,126)
|
$(2,076,907)
|
$(20,334,861)
|
Class I
|
||||
Shares sold
|
1,641,804
|
7,331,050
|
$80,351,758
|
$360,535,890
|
Reinvestment of distributions
|
104,013
|
226,380
|
4,696,194
|
10,144,089
|
Shares redeemed
|
(3,486,876)
|
(6,596,082)
|
(169,643,994)
|
(313,054,267)
|
Net increase (decrease)
|
(1,741,059)
|
961,348
|
$(84,596,042)
|
$57,625,712
|
Class Z
|
||||
Shares sold
|
558,095
|
1,885,365
|
$27,377,926
|
$93,387,839
|
Reinvestment of distributions
|
21,238
|
42,781
|
957,615
|
1,913,609
|
Shares redeemed
|
(568,101)
|
(5,380,884)
|
(27,678,044)
|
(257,774,216)
|
Net increase (decrease)
|
11,232
|
(3,452,738)
|
$657,497
|
$(162,472,768)
|
Fidelity Advisor Financials Fund
|
||||
Class A
|
||||
Shares sold
|
850,909
|
818,003
|
$30,817,325
|
$22,800,145
|
Reinvestment of distributions
|
295,742
|
136,530
|
10,350,952
|
3,770,958
|
Shares redeemed
|
(536,095)
|
(1,321,630)
|
(18,878,927)
|
(36,117,669)
|
Net increase (decrease)
|
610,556
|
(367,097)
|
$22,289,350
|
$(9,546,566)
|
Class M
|
||||
Shares sold
|
236,377
|
257,400
|
$8,355,321
|
$7,324,391
|
Reinvestment of distributions
|
109,721
|
49,122
|
3,788,667
|
1,340,046
|
Shares redeemed
|
(190,847)
|
(477,488)
|
(6,477,822)
|
(12,892,718)
|
Net increase (decrease)
|
155,251
|
(170,966)
|
$5,666,166
|
$(4,228,281)
|
Class C
|
||||
Shares sold
|
299,304
|
89,000
|
$10,144,853
|
$2,319,425
|
Reinvestment of distributions
|
54,581
|
22,503
|
1,767,319
|
577,888
|
Shares redeemed
|
(263,598)
|
(652,906)
|
(8,736,529)
|
(16,390,802)
|
Net increase (decrease)
|
90,287
|
(541,403)
|
$3,175,643
|
$(13,493,489)
|
Class I
|
||||
Shares sold
|
2,156,068
|
1,755,800
|
$79,509,221
|
$49,634,580
|
Reinvestment of distributions
|
230,998
|
87,544
|
8,380,618
|
2,502,894
|
Shares redeemed
|
(680,458)
|
(2,313,168)
|
(24,874,540)
|
(63,481,344)
|
Net increase (decrease)
|
1,706,608
|
(469,824)
|
$63,015,299
|
$(11,343,870)
|
Class Z
|
||||
Shares sold
|
704,661
|
1,757,445
|
$25,972,503
|
$51,626,690
|
Reinvestment of distributions
|
95,736
|
14,544
|
3,468,532
|
415,095
|
Shares redeemed
|
(805,602)
|
(3,095,014)
|
(30,288,179)
|
(80,266,238)
|
Net increase (decrease)
|
(5,205)
|
(1,323,025)
|
$(847,144)
|
$(28,224,453)
|
Fidelity Advisor Health Care Fund
|
||||
Class A
|
||||
Shares sold
|
876,729
|
2,311,559
|
$55,701,394
|
$136,317,319
|
Reinvestment of distributions
|
2,481,709
|
-
|
140,762,512
|
-
|
Shares redeemed
|
(2,359,574)
|
(5,454,640)
|
(148,537,074)
|
(322,642,152)
|
Net increase (decrease)
|
998,864
|
(3,143,081)
|
$47,926,832
|
$(186,324,833)
|
Class M
|
||||
Shares sold
|
98,500
|
223,594
|
$5,705,799
|
$12,194,685
|
Reinvestment of distributions
|
650,227
|
-
|
33,181,084
|
-
|
Shares redeemed
|
(471,133)
|
(824,131)
|
(27,117,062)
|
(44,498,389)
|
Net increase (decrease)
|
277,594
|
(600,537)
|
$11,769,821
|
$(32,303,704)
|
Class C
|
||||
Shares sold
|
134,708
|
348,702
|
$6,135,571
|
$15,349,798
|
Reinvestment of distributions
|
835,920
|
-
|
33,236,165
|
-
|
Shares redeemed
|
(1,134,238)
|
(2,928,311)
|
(51,858,411)
|
(127,438,226)
|
Net increase (decrease)
|
(163,610)
|
(2,579,609)
|
$(12,486,675)
|
$(112,088,428)
|
Class I
|
||||
Shares sold
|
1,717,554
|
4,486,201
|
$121,116,223
|
$294,961,288
|
Reinvestment of distributions
|
2,428,828
|
-
|
155,566,402
|
-
|
Shares redeemed
|
(5,880,642)
|
(14,948,048)
|
(414,202,611)
|
(974,268,206)
|
Net increase (decrease)
|
(1,734,260)
|
(10,461,847)
|
$(137,519,986)
|
$(679,306,918)
|
Class Z
|
||||
Shares sold
|
711,560
|
2,694,277
|
$51,279,906
|
$178,292,993
|
Reinvestment of distributions
|
566,654
|
-
|
36,475,541
|
-
|
Shares redeemed
|
(2,022,294)
|
(7,519,316)
|
(146,570,418)
|
(481,983,286)
|
Net increase (decrease)
|
(744,080)
|
(4,825,039)
|
$(58,814,971)
|
$(303,690,293)
|
Fidelity Advisor Industrials Fund
|
||||
Class A
|
||||
Shares sold
|
532,165
|
691,375
|
$25,773,706
|
$27,779,266
|
Reinvestment of distributions
|
227,321
|
476,634
|
10,461,330
|
18,093,011
|
Shares redeemed
|
(523,964)
|
(905,850)
|
(24,794,731)
|
(36,408,194)
|
Net increase (decrease)
|
235,522
|
262,159
|
$11,440,305
|
$9,464,083
|
Class M
|
||||
Shares sold
|
122,881
|
218,666
|
$5,708,369
|
$8,638,732
|
Reinvestment of distributions
|
58,827
|
130,912
|
2,592,490
|
4,766,508
|
Shares redeemed
|
(172,243)
|
(241,457)
|
(7,617,122)
|
(9,358,794)
|
Net increase (decrease)
|
9,465
|
108,121
|
$683,737
|
$4,046,446
|
Class C
|
||||
Shares sold
|
206,087
|
133,579
|
$8,172,539
|
$4,409,475
|
Reinvestment of distributions
|
42,220
|
101,765
|
1,553,692
|
3,132,328
|
Shares redeemed
|
(206,792)
|
(340,007)
|
(8,054,793)
|
(11,096,876)
|
Net increase (decrease)
|
41,515
|
(104,663)
|
$1,671,438
|
$(3,555,073)
|
Class I
|
||||
Shares sold
|
1,120,891
|
1,502,930
|
$58,956,809
|
$65,003,554
|
Reinvestment of distributions
|
127,458
|
219,293
|
6,421,349
|
9,085,300
|
Shares redeemed
|
(577,569)
|
(1,877,502)
|
(29,594,597)
|
(79,570,258)
|
Net increase (decrease)
|
670,780
|
(155,279)
|
$35,783,561
|
$(5,481,404)
|
Class Z
|
||||
Shares sold
|
352,682
|
600,142
|
$18,909,916
|
$26,252,508
|
Reinvestment of distributions
|
40,688
|
62,886
|
2,047,836
|
2,604,125
|
Shares redeemed
|
(204,703)
|
(2,156,935)
|
(10,806,611)
|
(88,761,038)
|
Net increase (decrease)
|
188,667
|
(1,493,907)
|
$10,151,141
|
$(59,904,405)
|
Fidelity Advisor Semiconductors Fund
|
||||
Class A
|
||||
Shares sold
|
2,378,400
|
4,838,303
|
$200,255,590
|
$343,697,111
|
Reinvestment of distributions
|
893,362
|
344,846
|
76,516,486
|
20,876,979
|
Shares redeemed
|
(1,351,683)
|
(1,933,905)
|
(113,017,684)
|
(133,711,892)
|
Net increase (decrease)
|
1,920,079
|
3,249,244
|
$163,754,392
|
$230,862,198
|
Class M
|
||||
Shares sold
|
319,229
|
791,906
|
$24,894,316
|
$53,531,235
|
Reinvestment of distributions
|
165,294
|
61,148
|
13,129,289
|
3,458,547
|
Shares redeemed
|
(204,537)
|
(212,743)
|
(15,695,823)
|
(13,778,612)
|
Net increase (decrease)
|
279,986
|
640,311
|
$22,327,782
|
$43,211,170
|
Class C
|
||||
Shares sold
|
482,328
|
1,308,621
|
$32,403,541
|
$75,362,622
|
Reinvestment of distributions
|
290,329
|
113,850
|
19,449,141
|
5,527,405
|
Shares redeemed
|
(434,703)
|
(676,236)
|
(29,144,649)
|
(37,788,799)
|
Net increase (decrease)
|
337,954
|
746,235
|
$22,708,033
|
$43,101,228
|
Class I
|
||||
Shares sold
|
2,461,213
|
5,918,967
|
$222,773,525
|
$451,679,642
|
Reinvestment of distributions
|
718,671
|
273,927
|
67,037,659
|
17,923,026
|
Shares redeemed
|
(1,620,251)
|
(2,919,636)
|
(146,709,020)
|
(224,521,109)
|
Net increase (decrease)
|
1,559,633
|
3,273,258
|
$143,102,164
|
$245,081,559
|
Class Z
|
||||
Shares sold
|
737,285
|
1,603,015
|
$67,993,637
|
$127,452,494
|
Reinvestment of distributions
|
136,323
|
44,183
|
12,755,769
|
2,895,741
|
Shares redeemed
|
(434,062)
|
(585,589)
|
(39,533,458)
|
(42,801,386)
|
Net increase (decrease)
|
439,546
|
1,061,609
|
$41,215,948
|
$87,546,849
|
Fidelity Advisor Technology Fund
|
||||
Class A
|
||||
Shares sold
|
1,562,660
|
3,228,116
|
$190,430,571
|
$326,552,310
|
Reinvestment of distributions
|
1,562,743
|
764,250
|
193,467,550
|
72,565,432
|
Shares redeemed
|
(1,611,652)
|
(2,801,337)
|
(194,594,115)
|
(282,697,295)
|
Net increase (decrease)
|
1,513,751
|
1,191,029
|
$189,304,006
|
$116,420,447
|
Class M
|
||||
Shares sold
|
385,736
|
1,078,923
|
$42,261,609
|
$98,350,142
|
Reinvestment of distributions
|
609,621
|
307,073
|
67,948,398
|
26,518,839
|
Shares redeemed
|
(497,668)
|
(1,204,017)
|
(54,113,188)
|
(111,499,551)
|
Net increase (decrease)
|
497,689
|
181,979
|
$56,096,819
|
$13,369,430
|
Class C
|
||||
Shares sold
|
408,308
|
823,369
|
$36,148,499
|
$61,716,478
|
Reinvestment of distributions
|
434,552
|
217,843
|
38,114,531
|
15,194,548
|
Shares redeemed
|
(555,276)
|
(1,243,391)
|
(49,212,497)
|
(91,783,163)
|
Net increase (decrease)
|
287,584
|
(202,179)
|
$25,050,533
|
$(14,872,137)
|
Class I
|
||||
Shares sold
|
2,419,646
|
7,101,062
|
$332,232,190
|
$783,888,507
|
Reinvestment of distributions
|
1,036,654
|
518,428
|
146,220,064
|
55,528,866
|
Shares redeemed
|
(1,889,780)
|
(6,265,629)
|
(256,885,418)
|
(699,659,492)
|
Net increase (decrease)
|
1,566,520
|
1,353,861
|
$221,566,836
|
$139,757,881
|
Class Z
|
||||
Shares sold
|
1,459,778
|
3,570,966
|
$200,745,633
|
$412,531,561
|
Reinvestment of distributions
|
389,691
|
147,530
|
54,942,466
|
15,797,497
|
Shares redeemed
|
(883,809)
|
(4,630,106)
|
(121,516,179)
|
(482,333,988)
|
Net increase (decrease)
|
965,660
|
(911,610)
|
$134,171,920
|
$(54,004,930)
|
Fidelity Advisor Utilities Fund
|
||||
Class A
|
||||
Shares sold
|
1,480,320
|
1,280,858
|
$67,513,110
|
$48,456,309
|
Reinvestment of distributions
|
405,630
|
279,588
|
17,881,934
|
10,124,466
|
Shares redeemed
|
(709,009)
|
(2,053,712)
|
(32,146,592)
|
(74,697,612)
|
Net increase (decrease)
|
1,176,941
|
(493,266)
|
$53,248,452
|
$(16,116,837)
|
Class M
|
||||
Shares sold
|
83,403
|
140,983
|
$3,836,715
|
$5,275,029
|
Reinvestment of distributions
|
72,228
|
54,023
|
3,192,597
|
1,961,658
|
Shares redeemed
|
(128,771)
|
(363,636)
|
(5,876,812)
|
(13,403,536)
|
Net increase (decrease)
|
26,860
|
(168,630)
|
$1,152,500
|
$(6,166,849)
|
Class C
|
||||
Shares sold
|
422,830
|
292,050
|
$18,905,736
|
$10,544,703
|
Reinvestment of distributions
|
68,219
|
40,395
|
2,915,828
|
1,423,265
|
Shares redeemed
|
(165,239)
|
(557,312)
|
(7,240,660)
|
(19,899,030)
|
Net increase (decrease)
|
325,810
|
(224,867)
|
$14,580,904
|
$(7,931,062)
|
Class I
|
||||
Shares sold
|
4,696,529
|
3,105,540
|
$220,319,255
|
$124,002,559
|
Reinvestment of distributions
|
402,790
|
187,848
|
18,245,597
|
6,984,725
|
Shares redeemed
|
(1,806,479)
|
(3,677,678)
|
(84,001,287)
|
(136,341,969)
|
Net increase (decrease)
|
3,292,840
|
(384,290)
|
$154,563,565
|
$(5,354,685)
|
Class Z
|
||||
Shares sold
|
1,608,517
|
1,408,595
|
$75,111,792
|
$53,605,471
|
Reinvestment of distributions
|
106,307
|
58,601
|
4,814,844
|
2,156,332
|
Shares redeemed
|
(694,511)
|
(2,594,297)
|
(32,809,069)
|
(95,019,133)
|
Net increase (decrease)
|
1,020,313
|
(1,127,101)
|
$47,117,567
|
$(39,257,330)
|
![]() |


Contents
Common Stocks - 99.9%
|
|||
Shares
|
Value ($)
|
||
UNITED STATES - 99.9%
|
|||
Real Estate - 99.9%
|
|||
Health Care REITs - 10.4%
|
|||
Ventas Inc
|
205,905
|
12,440,780
|
|
Welltower Inc
|
59,700
|
8,147,856
|
|
20,588,636
|
|||
Hotel & Resort REITs - 1.7%
|
|||
Ryman Hospitality Properties Inc
|
31,200
|
3,271,008
|
|
Industrial REITs - 13.5%
|
|||
Americold Realty Trust Inc
|
73,100
|
1,597,235
|
|
EastGroup Properties Inc
|
10,800
|
1,831,896
|
|
Prologis Inc
|
150,416
|
17,937,108
|
|
Rexford Industrial Realty Inc
|
38,900
|
1,581,674
|
|
Terreno Realty Corp
|
56,400
|
3,689,688
|
|
26,637,601
|
|||
Office REITs - 1.9%
|
|||
Douglas Emmett Inc (a)
|
206,500
|
3,791,340
|
|
Real Estate Management & Development - 11.0%
|
|||
CBRE Group Inc Class A (b)
|
95,700
|
13,851,618
|
|
CoStar Group Inc (b)
|
34,500
|
2,642,700
|
|
Zillow Group Inc Class C (b)
|
63,700
|
5,237,414
|
|
21,731,732
|
|||
Residential REITs - 13.8%
|
|||
Essex Property Trust Inc
|
21,047
|
5,989,345
|
|
Invitation Homes Inc
|
171,600
|
5,345,340
|
|
Mid-America Apartment Communities Inc
|
32,400
|
4,943,592
|
|
Sun Communities Inc
|
54,200
|
6,856,300
|
|
UDR Inc
|
100,400
|
4,190,696
|
|
27,325,273
|
|||
Retail REITs - 13.4%
|
|||
Curbline Properties Corp
|
165,550
|
4,051,009
|
|
Federal Realty Investment Trust
|
29,600
|
3,215,448
|
|
Macerich Co/The
|
202,600
|
4,210,028
|
|
NNN REIT Inc
|
119,800
|
4,718,922
|
|
SITE Centers Corp
|
79,375
|
1,189,037
|
|
Tanger Inc
|
159,700
|
5,241,354
|
|
Urban Edge Properties
|
189,400
|
3,852,396
|
|
26,478,194
|
|||
Specialized REITs - 34.2%
|
|||
American Tower Corp
|
75,800
|
14,019,210
|
|
Crown Castle Inc
|
81,100
|
7,240,608
|
|
CubeSmart
|
159,900
|
6,667,830
|
|
Digital Realty Trust Inc
|
26,300
|
4,309,518
|
|
Equinix Inc
|
20,000
|
18,273,200
|
|
Four Corners Property Trust Inc
|
242,100
|
6,640,803
|
|
Lamar Advertising Co Class A
|
18,200
|
2,300,844
|
|
Public Storage Operating Co
|
26,700
|
7,969,416
|
|
67,421,429
|
|||
TOTAL REAL ESTATE
|
197,245,213
|
||
|
TOTAL COMMON STOCKS
(Cost $149,982,409)
|
197,245,213
|
||
Money Market Funds - 1.2%
|
||||
Yield (%)
|
Shares
|
Value ($)
|
||
Fidelity Cash Central Fund (c)
|
4.37
|
825,742
|
825,907
|
|
Fidelity Securities Lending Cash Central Fund (c)(d)
|
4.37
|
1,625,462
|
1,625,625
|
|
|
TOTAL MONEY MARKET FUNDS
(Cost $2,451,531)
|
2,451,532
|
|||
|
TOTAL INVESTMENT IN SECURITIES - 101.1%
(Cost $152,433,940)
|
199,696,745
|
NET OTHER ASSETS (LIABILITIES) - (1.1)%
|
(2,192,567)
|
NET ASSETS - 100.0%
|
197,504,178
|
(a)
|
Security or a portion of the security is on loan at period end.
|
(b)
|
Non-income producing
|
(c)
|
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
|
(d)
|
Investment made with cash collateral received from securities on loan.
|
Affiliate
|
Value,
beginning
of period ($)
|
Purchases ($)
|
Sales
Proceeds ($)
|
Dividend
Income ($)
|
Realized
Gain (loss) ($)
|
Change in
Unrealized
appreciation
(depreciation) ($)
|
Value,
end
of period ($)
|
Shares,
end
of period
|
% ownership,
end
of period
|
Fidelity Cash Central Fund
|
2,431,246
|
18,584,295
|
20,189,634
|
24,321
|
-
|
-
|
825,907
|
825,742
|
0.0%
|
Fidelity Securities Lending Cash Central Fund
|
2,412,825
|
3,707,300
|
4,494,500
|
628
|
-
|
-
|
1,625,625
|
1,625,462
|
0.0%
|
Total
|
4,844,071
|
22,291,595
|
24,684,134
|
24,949
|
-
|
-
|
2,451,532
|
2,451,204
|
|
Valuation Inputs at Reporting Date:
|
||||
Description
|
Total ($)
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Investments in Securities:
|
||||
Common Stocks
|
||||
Real Estate
|
197,245,213
|
197,245,213
|
-
|
-
|
Money Market Funds
|
2,451,532
|
2,451,532
|
-
|
-
|
Total Investments in Securities:
|
199,696,745
|
199,696,745
|
-
|
-
|
Statement of Assets and Liabilities
|
||||
|
As of January 31, 2025 (Unaudited)
|
||||
Assets
|
||||
Investment in securities, at value (including securities loaned of $1,591,812) - See accompanying schedule:
|
||||
Unaffiliated issuers (cost $149,982,409)
|
$
|
197,245,213
|
||
Fidelity Central Funds (cost $2,451,531)
|
2,451,532
|
|||
Total Investment in Securities (cost $152,433,940)
|
$
|
199,696,745
|
||
Receivable for investments sold
|
98,745
|
|||
Receivable for fund shares sold
|
76,874
|
|||
Dividends receivable
|
236,521
|
|||
Distributions receivable from Fidelity Central Funds
|
1,363
|
|||
Prepaid expenses
|
239
|
|||
Other receivables
|
112,512
|
|||
Total assets
|
200,222,999
|
|||
Liabilities
|
||||
Payable for investments purchased
|
$
|
97,580
|
||
Payable for fund shares redeemed
|
678,515
|
|||
Accrued management fee
|
115,054
|
|||
Distribution and service plan fees payable
|
51,930
|
|||
Other payables and accrued expenses
|
150,117
|
|||
Collateral on securities loaned
|
1,625,625
|
|||
Total liabilities
|
2,718,821
|
|||
Net Assets
|
$
|
197,504,178
|
||
Net Assets consist of:
|
||||
Paid in capital
|
$
|
147,936,464
|
||
Total accumulated earnings (loss)
|
49,567,714
|
|||
Net Assets
|
$
|
197,504,178
|
||
Net Asset Value and Maximum Offering Price
|
||||
Class A :
|
||||
Net Asset Value and redemption price per share ($81,555,917 ÷ 4,867,930 shares)(a)
|
$
|
16.75
|
||
Maximum offering price per share (100/94.25 of $16.75)
|
$
|
17.77
|
||
Class M :
|
||||
Net Asset Value and redemption price per share ($76,082,295 ÷ 4,566,887 shares)(a)
|
$
|
16.66
|
||
Maximum offering price per share (100/96.50 of $16.66)
|
$
|
17.26
|
||
Class C :
|
||||
Net Asset Value and offering price per share ($4,850,742 ÷ 307,387 shares)(a)
|
$
|
15.78
|
||
Class I :
|
||||
Net Asset Value, offering price and redemption price per share ($28,646,052 ÷ 1,674,707 shares)
|
$
|
17.11
|
||
Class Z :
|
||||
Net Asset Value, offering price and redemption price per share ($6,369,172 ÷ 373,339 shares)
|
$
|
17.06
|
||
(a)Redemption price per share is equal to net asset value less any applicable contingent deferred sales charge.
|
||||
Statement of Operations
|
||||
Six months ended January 31, 2025 (Unaudited)
|
||||
Investment Income
|
||||
Dividends
|
$
|
2,569,597
|
||
Income from Fidelity Central Funds (including $628 from security lending)
|
24,949
|
|||
Total income
|
2,594,546
|
|||
Expenses
|
||||
Management fee
|
$
|
773,559
|
||
Distribution and service plan fees
|
333,390
|
|||
Custodian fees and expenses
|
8,908
|
|||
Independent trustees' fees and expenses
|
497
|
|||
Registration fees
|
46,048
|
|||
Audit fees
|
27,715
|
|||
Legal
|
370
|
|||
Miscellaneous
|
5,081
|
|||
Total expenses
|
1,195,568
|
|||
Net Investment income (loss)
|
1,398,978
|
|||
Realized and Unrealized Gain (Loss)
|
||||
Net realized gain (loss) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
18,258,403
|
|||
Total net realized gain (loss)
|
18,258,403
|
|||
Change in net unrealized appreciation (depreciation) on investment securities
|
(10,525,967)
|
|||
Net gain (loss)
|
7,732,436
|
|||
Net increase (decrease) in net assets resulting from operations
|
$
|
9,131,414
|
||
Statement of Changes in Net Assets
|
||||
Six months ended
January 31, 2025
(Unaudited)
|
Year ended
July 31, 2024
|
|||
Increase (Decrease) in Net Assets
|
||||
Operations
|
||||
Net investment income (loss)
|
$
|
1,398,978
|
$
|
4,862,065
|
Net realized gain (loss)
|
18,258,403
|
4,967,987
|
||
Change in net unrealized appreciation (depreciation)
|
(10,525,967)
|
11,235,336
|
||
Net increase (decrease) in net assets resulting from operations
|
9,131,414
|
21,065,388
|
||
Distributions to shareholders
|
(15,113,849)
|
(4,738,172)
|
||
Share transactions - net increase (decrease)
|
(33,518,905)
|
(37,939,622)
|
||
Total increase (decrease) in net assets
|
(39,501,340)
|
(21,612,406)
|
||
Net Assets
|
||||
Beginning of period
|
237,005,518
|
258,617,924
|
||
End of period
|
$
|
197,504,178
|
$
|
237,005,518
|
Fidelity Advisor® Real Estate Fund Class A |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
17.53
|
$
|
16.24
|
$
|
21.95
|
$
|
24.66
|
$
|
19.62
|
$
|
22.91
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.12
|
.33
|
.34
|
.22
|
.26
|
.41
|
||||||
Net realized and unrealized gain (loss)
|
.43
|
1.28
|
(3.09)
|
(1.47)
|
5.50
|
(1.91)
|
||||||
Total from investment operations
|
.55
|
1.61
|
(2.75)
|
(1.25)
|
5.76
|
(1.50)
|
||||||
Distributions from net investment income
|
(.26)
|
(.32)
|
(.26)
|
(.17)
|
(.24)
|
(.38)
|
||||||
Distributions from net realized gain
|
(1.08)
|
-
|
(2.69)
|
(1.30)
|
(.48)
|
(1.41)
|
||||||
Total distributions
|
(1.33) C
|
(.32)
|
(2.96) C
|
(1.46) C
|
(.72)
|
(1.79)
|
||||||
Net asset value, end of period
|
$
|
16.75
|
$
|
17.53
|
$
|
16.24
|
$
|
21.95
|
$
|
24.66
|
$
|
19.62
|
Total Return D,E,F
|
3.24 % |
10.10%
|
(11.70)%
|
(5.65)%
|
30.38%
|
(7.21)%
|
||||||
Ratios to Average Net Assets B,G,H
|
||||||||||||
Expenses before reductions
|
1.05% I
|
1.07%
|
1.11%
|
1.07%
|
1.09%
|
1.10%
|
||||||
Expenses net of fee waivers, if any
|
1.05 % I |
1.07%
|
1.10%
|
1.07%
|
1.09%
|
1.10%
|
||||||
Expenses net of all reductions
|
1.05% I
|
1.07%
|
1.10%
|
1.07%
|
1.08%
|
1.09%
|
||||||
Net investment income (loss)
|
1.33% I
|
2.11%
|
1.96%
|
.95%
|
1.24%
|
1.93%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
81,556
|
$
|
83,618
|
$
|
91,784
|
$
|
122,949
|
$
|
138,134
|
$
|
115,736
|
Portfolio turnover rate J
|
49 % I |
24%
|
31%
|
48%
|
53%
|
56%
|
Fidelity Advisor® Real Estate Fund Class M |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
17.44
|
$
|
16.16
|
$
|
21.87
|
$
|
24.59
|
$
|
19.58
|
$
|
22.87
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.10
|
.29
|
.30
|
.17
|
.21
|
.36
|
||||||
Net realized and unrealized gain (loss)
|
.42
|
1.28
|
(3.08)
|
(1.46)
|
5.49
|
(1.90)
|
||||||
Total from investment operations
|
.52
|
1.57
|
(2.78)
|
(1.29)
|
5.70
|
(1.54)
|
||||||
Distributions from net investment income
|
(.23)
|
(.29)
|
(.24)
|
(.13)
|
(.22)
|
(.34)
|
||||||
Distributions from net realized gain
|
(1.08)
|
-
|
(2.69)
|
(1.30)
|
(.48)
|
(1.41)
|
||||||
Total distributions
|
(1.30) C
|
(.29)
|
(2.93)
|
(1.43)
|
(.69) C
|
(1.75)
|
||||||
Net asset value, end of period
|
$
|
16.66
|
$
|
17.44
|
$
|
16.16
|
$
|
21.87
|
$
|
24.59
|
$
|
19.58
|
Total Return D,E,F
|
3.09 % |
9.85%
|
(11.87)%
|
(5.83)%
|
30.14%
|
(7.42)%
|
||||||
Ratios to Average Net Assets B,G,H
|
||||||||||||
Expenses before reductions
|
1.30% I
|
1.31%
|
1.31%
|
1.29%
|
1.31%
|
1.31%
|
||||||
Expenses net of fee waivers, if any
|
1.30 % I |
1.30%
|
1.31%
|
1.28%
|
1.31%
|
1.31%
|
||||||
Expenses net of all reductions
|
1.30% I
|
1.30%
|
1.31%
|
1.28%
|
1.30%
|
1.30%
|
||||||
Net investment income (loss)
|
1.08% I
|
1.88%
|
1.75%
|
.73%
|
1.03%
|
1.71%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
76,082
|
$
|
81,022
|
$
|
84,126
|
$
|
100,892
|
$
|
118,778
|
$
|
98,724
|
Portfolio turnover rate J
|
49 % I |
24%
|
31%
|
48%
|
53%
|
56%
|
Fidelity Advisor® Real Estate Fund Class C |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
16.58
|
$
|
15.38
|
$
|
21.00
|
$
|
23.74
|
$
|
18.97
|
$
|
22.26
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.05
|
.20
|
.20
|
.03
|
.09
|
.23
|
||||||
Net realized and unrealized gain (loss)
|
.41
|
1.21
|
(2.97)
|
(1.39)
|
5.30
|
(1.85)
|
||||||
Total from investment operations
|
.46
|
1.41
|
(2.77)
|
(1.36)
|
5.39
|
(1.62)
|
||||||
Distributions from net investment income
|
(.18)
|
(.21)
|
(.16)
|
(.08)
|
(.15)
|
(.26)
|
||||||
Distributions from net realized gain
|
(1.08)
|
-
|
(2.69)
|
(1.30)
|
(.48)
|
(1.41)
|
||||||
Total distributions
|
(1.26)
|
(.21)
|
(2.85)
|
(1.38)
|
(.62) C
|
(1.67)
|
||||||
Net asset value, end of period
|
$
|
15.78
|
$
|
16.58
|
$
|
15.38
|
$
|
21.00
|
$
|
23.74
|
$
|
18.97
|
Total Return D,E,F
|
2.84 % |
9.30%
|
(12.38)%
|
(6.35)%
|
29.36%
|
(7.95)%
|
||||||
Ratios to Average Net Assets B,G,H
|
||||||||||||
Expenses before reductions
|
1.79% I
|
1.81%
|
1.87%
|
1.86%
|
1.88%
|
1.89%
|
||||||
Expenses net of fee waivers, if any
|
1.79 % I |
1.81%
|
1.86%
|
1.86%
|
1.88%
|
1.89%
|
||||||
Expenses net of all reductions
|
1.79% I
|
1.81%
|
1.86%
|
1.86%
|
1.87%
|
1.88%
|
||||||
Net investment income (loss)
|
.58% I
|
1.37%
|
1.20%
|
.15%
|
.46%
|
1.14%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
4,851
|
$
|
5,355
|
$
|
6,937
|
$
|
12,375
|
$
|
16,069
|
$
|
20,774
|
Portfolio turnover rate J
|
49 % I |
24%
|
31%
|
48%
|
53%
|
56%
|
Fidelity Advisor® Real Estate Fund Class I |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
17.86
|
$
|
16.54
|
$
|
22.26
|
$
|
24.96
|
$
|
19.84
|
$
|
23.15
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.15
|
.38
|
.40
|
.27
|
.31
|
.46
|
||||||
Net realized and unrealized gain (loss)
|
.44
|
1.30
|
(3.14)
|
(1.48)
|
5.56
|
(1.92)
|
||||||
Total from investment operations
|
.59
|
1.68
|
(2.74)
|
(1.21)
|
5.87
|
(1.46)
|
||||||
Distributions from net investment income
|
(.26)
|
(.36)
|
(.29)
|
(.19)
|
(.27)
|
(.44)
|
||||||
Distributions from net realized gain
|
(1.08)
|
-
|
(2.69)
|
(1.30)
|
(.48)
|
(1.41)
|
||||||
Total distributions
|
(1.34)
|
(.36)
|
(2.98)
|
(1.49)
|
(.75)
|
(1.85)
|
||||||
Net asset value, end of period
|
$
|
17.11
|
$
|
17.86
|
$
|
16.54
|
$
|
22.26
|
$
|
24.96
|
$
|
19.84
|
Total Return C,D
|
3.39 % |
10.40%
|
(11.43)%
|
(5.43)%
|
30.65%
|
(6.99)%
|
||||||
Ratios to Average Net Assets B,E,F
|
||||||||||||
Expenses before reductions
|
.79% G
|
.80%
|
.84%
|
.86%
|
.88%
|
.86%
|
||||||
Expenses net of fee waivers, if any
|
.79 % G |
.79%
|
.83%
|
.86%
|
.87%
|
.86%
|
||||||
Expenses net of all reductions
|
.79% G
|
.79%
|
.83%
|
.86%
|
.87%
|
.85%
|
||||||
Net investment income (loss)
|
1.59% G
|
2.39%
|
2.23%
|
1.15%
|
1.46%
|
2.17%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
28,646
|
$
|
60,502
|
$
|
69,081
|
$
|
160,565
|
$
|
197,873
|
$
|
180,346
|
Portfolio turnover rate H
|
49 % G |
24%
|
31%
|
48%
|
53%
|
56%
|
Fidelity Advisor® Real Estate Fund Class Z |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
17.84
|
$
|
16.52
|
$
|
22.29
|
$
|
24.97
|
$
|
19.85
|
$
|
23.16
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.16
|
.41
|
.43
|
.33
|
.36
|
.50
|
||||||
Net realized and unrealized gain (loss)
|
.44
|
1.30
|
(3.15)
|
(1.48)
|
5.56
|
(1.92)
|
||||||
Total from investment operations
|
.60
|
1.71
|
(2.72)
|
(1.15)
|
5.92
|
(1.42)
|
||||||
Distributions from net investment income
|
(.30)
|
(.39)
|
(.36)
|
(.23)
|
(.32)
|
(.48)
|
||||||
Distributions from net realized gain
|
(1.08)
|
-
|
(2.69)
|
(1.30)
|
(.48)
|
(1.41)
|
||||||
Total distributions
|
(1.38)
|
(.39)
|
(3.05)
|
(1.53)
|
(.80)
|
(1.89)
|
||||||
Net asset value, end of period
|
$
|
17.06
|
$
|
17.84
|
$
|
16.52
|
$
|
22.29
|
$
|
24.97
|
$
|
19.85
|
Total Return C,D
|
3.44 % |
10.60%
|
(11.30)%
|
(5.21)%
|
30.95%
|
(6.80)%
|
||||||
Ratios to Average Net Assets B,E,F
|
||||||||||||
Expenses before reductions
|
.64% G
|
.64%
|
.65%
|
.64%
|
.64%
|
.65%
|
||||||
Expenses net of fee waivers, if any
|
.64 % G |
.64%
|
.65%
|
.63%
|
.64%
|
.65%
|
||||||
Expenses net of all reductions
|
.64% G
|
.64%
|
.65%
|
.63%
|
.64%
|
.64%
|
||||||
Net investment income (loss)
|
1.74% G
|
2.54%
|
2.41%
|
1.38%
|
1.69%
|
2.38%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
6,369
|
$
|
6,508
|
$
|
6,690
|
$
|
13,539
|
$
|
16,573
|
$
|
9,157
|
Portfolio turnover rate H
|
49 % G |
24%
|
31%
|
48%
|
53%
|
56%
|
Fidelity Central Fund
|
Investment Manager
|
Investment Objective
|
Investment Practices
|
Expense RatioA
|
Fidelity Money Market Central Funds
|
Fidelity Management & Research Company LLC (FMR)
|
Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity.
|
Short-term Investments
|
Less than .005%
|
Fidelity Advisor Real Estate Fund
|
$112,512
|
Gross unrealized appreciation
|
$60,768,350
|
Gross unrealized depreciation
|
(14,230,958)
|
Net unrealized appreciation (depreciation)
|
$46,537,392
|
Tax cost
|
$153,159,353
|
Short-term
|
$(2,504,747)
|
Total capital loss carryforward
|
$(2,504,747)
|
Purchases ($)
|
Sales ($)
|
|
Fidelity Advisor Real Estate Fund
|
52,865,488
|
94,021,825
|
Maximum Management Fee Rate %
|
|
Class A
|
.72
|
Class M
|
.72
|
Class C
|
.72
|
Class I
|
.71
|
Class Z
|
.56
|
Total Management Fee Rate %
|
|
Class A
|
.71
|
Class M
|
.71
|
Class C
|
.71
|
Class I
|
.71
|
Class Z
|
.56
|
Distribution Fee
|
Service Fee
|
Total Fees ($)
|
Retained by FDC ($)
|
|
Class A
|
- %
|
.25%
|
106,122
|
950
|
Class M
|
.25%
|
.25%
|
201,036
|
-
|
Class C
|
.75%
|
.25%
|
26,232
|
2,366
|
333,390
|
3,316
|
Retained by FDC ($)
|
|
Class A
|
4,676
|
Class M
|
648
|
Class CA
|
50
|
5,374
|
Amount ($)
|
|
Fidelity Advisor Real Estate Fund
|
656
|
Purchases ($)
|
Sales ($)
|
Realized Gain (Loss) ($)
|
|
Fidelity Advisor Real Estate Fund
|
4,893,599
|
6,609,741
|
1,276,295
|
Amount ($)
|
|
Fidelity Advisor Real Estate Fund
|
144
|
Total Security Lending Fees Paid to NFS ($)
|
Security Lending Income From Securities Loaned to NFS ($)
|
Value of Securities Loaned to NFS at Period End ($)
|
|
Fidelity Advisor Real Estate Fund
|
72
|
-
|
-
|
Six months ended
January 31, 2025
|
Year ended
July 31, 2024
|
|
Fidelity Advisor Real Estate Fund
|
||
Distributions to shareholders
|
||
Class A
|
$6,128,109
|
$1,689,144
|
Class M
|
5,665,635
|
1,436,091
|
Class C
|
370,255
|
84,828
|
Class I
|
2,433,399
|
1,372,528
|
Class Z
|
516,451
|
155,581
|
Total
|
$15,113,849
|
$4,738,172
|
Shares
|
Shares
|
Dollars
|
Dollars
|
|
Six months ended
January 31, 2025
|
Year ended
July 31, 2024
|
Six months ended
January 31, 2025
|
Year ended
July 31, 2024
|
|
Fidelity Advisor Real Estate Fund
|
||||
Class A
|
||||
Shares sold
|
284,444
|
451,227
|
$5,106,056
|
$7,090,438
|
Reinvestment of distributions
|
362,737
|
103,378
|
6,036,180
|
1,662,406
|
Shares redeemed
|
(547,906)
|
(1,436,554)
|
(9,832,733)
|
(22,498,145)
|
Net increase (decrease)
|
99,275
|
(881,949)
|
$1,309,503
|
$(13,745,301)
|
Class M
|
||||
Shares sold
|
98,106
|
347,408
|
$1,744,561
|
$5,408,153
|
Reinvestment of distributions
|
341,727
|
89,517
|
5,653,615
|
1,432,781
|
Shares redeemed
|
(519,626)
|
(996,785)
|
(9,273,841)
|
(15,582,053)
|
Net increase (decrease)
|
(79,793)
|
(559,860)
|
$(1,875,665)
|
$(8,741,119)
|
Class C
|
||||
Shares sold
|
23,012
|
36,190
|
$393,666
|
$540,520
|
Reinvestment of distributions
|
23,607
|
5,452
|
369,890
|
82,977
|
Shares redeemed
|
(62,265)
|
(169,564)
|
(1,063,383)
|
(2,502,399)
|
Net increase (decrease)
|
(15,646)
|
(127,922)
|
$(299,827)
|
$(1,878,902)
|
Class I
|
||||
Shares sold
|
160,233
|
743,512
|
$2,950,574
|
$11,842,316
|
Reinvestment of distributions
|
138,698
|
82,703
|
2,369,956
|
1,353,197
|
Shares redeemed
|
(2,012,437)
|
(1,615,757)
|
(38,119,200)
|
(26,190,165)
|
Net increase (decrease)
|
(1,713,506)
|
(789,542)
|
$(32,798,670)
|
$(12,994,652)
|
Class Z
|
||||
Shares sold
|
62,378
|
146,206
|
$1,138,814
|
$2,345,828
|
Reinvestment of distributions
|
28,558
|
8,833
|
484,109
|
144,068
|
Shares redeemed
|
(82,431)
|
(195,106)
|
(1,477,169)
|
(3,069,544)
|
Net increase (decrease)
|
8,505
|
(40,067)
|
$145,754
|
$(579,648)
|
![]() |


Contents
Common Stocks - 100.1%
|
|||
Shares
|
Value ($)
|
||
AUSTRALIA - 5.7%
|
|||
Real Estate - 5.7%
|
|||
Industrial REITs - 0.7%
|
|||
Goodman Group unit
|
1,940
|
43,262
|
|
Retail REITs - 2.9%
|
|||
Charter Hall Retail REIT
|
34,047
|
68,374
|
|
Scentre Group unit
|
43,577
|
98,618
|
|
166,992
|
|||
Specialized REITs - 2.1%
|
|||
Arena REIT unit
|
30,040
|
71,911
|
|
National Storage REIT unit
|
39,417
|
54,480
|
|
126,391
|
|||
TOTAL AUSTRALIA
|
336,645
|
||
BELGIUM - 0.9%
|
|||
Real Estate - 0.9%
|
|||
Residential REITs - 0.9%
|
|||
Xior Student Housing NV (a)
|
1,656
|
53,170
|
|
Xior Student Housing NV rights (b)
|
1,190
|
644
|
|
Xior Student Housing NV rights (b)(c)
|
1,675
|
2,166
|
|
TOTAL BELGIUM
|
55,980
|
||
CANADA - 2.8%
|
|||
Real Estate - 2.8%
|
|||
Industrial REITs - 1.1%
|
|||
Dream Industrial Real Estate Investment Trust
|
7,845
|
63,047
|
|
Residential REITs - 1.7%
|
|||
Boardwalk Real Estate Investment Trust
|
2,396
|
103,285
|
|
TOTAL CANADA
|
166,332
|
||
FRANCE - 2.1%
|
|||
Real Estate - 2.1%
|
|||
Diversified REITs - 1.5%
|
|||
Covivio SA/France
|
1,613
|
85,842
|
|
Retail REITs - 0.6%
|
|||
Unibail-Rodamco-Westfield unit
|
441
|
36,993
|
|
TOTAL FRANCE
|
122,835
|
||
GERMANY - 1.5%
|
|||
Real Estate - 1.5%
|
|||
Real Estate Management & Development - 1.5%
|
|||
LEG Immobilien SE
|
487
|
40,255
|
|
Vonovia SE
|
1,652
|
50,711
|
|
TOTAL GERMANY
|
90,966
|
||
HONG KONG - 1.3%
|
|||
Real Estate - 1.3%
|
|||
Real Estate Management & Development - 0.3%
|
|||
Hongkong Land Holdings Ltd (Singapore)
|
4,630
|
20,147
|
|
Retail REITs - 1.0%
|
|||
Link REIT
|
14,564
|
59,999
|
|
TOTAL HONG KONG
|
80,146
|
||
JAPAN - 8.6%
|
|||
Real Estate - 8.6%
|
|||
Industrial REITs - 3.0%
|
|||
GLP J-REIT
|
33
|
27,022
|
|
LaSalle Logiport REIT
|
93
|
85,943
|
|
Mitsui Fudosan Logistics Park Inc
|
101
|
66,430
|
|
179,395
|
|||
Real Estate Management & Development - 4.7%
|
|||
Katitas Co Ltd
|
2,611
|
36,504
|
|
Mitsubishi Estate Co Ltd
|
7,035
|
102,226
|
|
Mitsui Fudosan Co Ltd
|
12,665
|
114,312
|
|
Nomura Real Estate Holdings Inc
|
800
|
21,262
|
|
274,304
|
|||
Residential REITs - 0.9%
|
|||
Advance Residence Investment Corp
|
60
|
55,223
|
|
TOTAL JAPAN
|
508,922
|
||
NETHERLANDS - 0.2%
|
|||
Real Estate - 0.2%
|
|||
Real Estate Management & Development - 0.2%
|
|||
CTP NV (a)(d)
|
870
|
14,477
|
|
SINGAPORE - 2.8%
|
|||
Real Estate - 2.8%
|
|||
Diversified REITs - 0.4%
|
|||
Mapletree Pan Asia Commercial Trust
|
24,463
|
21,666
|
|
Real Estate Management & Development - 0.6%
|
|||
UOL Group Ltd
|
10,248
|
38,219
|
|
Retail REITs - 1.8%
|
|||
CapitaLand Integrated Commercial Trust
|
74,144
|
105,839
|
|
TOTAL SINGAPORE
|
165,724
|
||
SPAIN - 1.1%
|
|||
Consumer Discretionary - 0.4%
|
|||
Household Durables - 0.4%
|
|||
Neinor Homes SA (a)(d)
|
1,416
|
24,767
|
|
Real Estate - 0.7%
|
|||
Diversified REITs - 0.7%
|
|||
Merlin Properties Socimi SA
|
3,600
|
41,753
|
|
TOTAL SPAIN
|
66,520
|
||
SWEDEN - 1.9%
|
|||
Real Estate - 1.9%
|
|||
Real Estate Management & Development - 1.9%
|
|||
Catena AB
|
2,078
|
90,614
|
|
Swedish Logistic Property AB B Shares (b)
|
5,551
|
20,376
|
|
TOTAL SWEDEN
|
110,990
|
||
UNITED KINGDOM - 7.7%
|
|||
Real Estate - 7.7%
|
|||
Diversified REITs - 1.0%
|
|||
British Land Co PLC/The
|
5,476
|
25,611
|
|
LondonMetric Property PLC
|
14,629
|
33,810
|
|
59,421
|
|||
Health Care REITs - 1.2%
|
|||
Assura PLC
|
148,037
|
69,419
|
|
Industrial REITs - 0.3%
|
|||
Segro PLC
|
2,156
|
19,178
|
|
Office REITs - 0.5%
|
|||
Great Portland Estates PLC
|
3,600
|
12,878
|
|
Helical PLC
|
8,823
|
19,735
|
|
32,613
|
|||
Real Estate Management & Development - 2.6%
|
|||
Grainger PLC
|
56,343
|
148,801
|
|
Residential REITs - 1.1%
|
|||
UNITE Group PLC/The
|
6,296
|
66,901
|
|
Retail REITs - 1.0%
|
|||
Shaftesbury Capital PLC
|
39,284
|
60,544
|
|
TOTAL UNITED KINGDOM
|
456,877
|
||
UNITED STATES - 63.5%
|
|||
Real Estate - 63.5%
|
|||
Health Care REITs - 8.3%
|
|||
Ventas Inc
|
3,165
|
191,229
|
|
Welltower Inc
|
2,213
|
302,031
|
|
493,260
|
|||
Hotel & Resort REITs - 0.4%
|
|||
Ryman Hospitality Properties Inc
|
243
|
25,475
|
|
Industrial REITs - 12.4%
|
|||
Americold Realty Trust Inc
|
3,669
|
80,168
|
|
Prologis Inc
|
4,463
|
532,213
|
|
STAG Industrial Inc Class A
|
2,097
|
71,675
|
|
Terreno Realty Corp
|
767
|
50,177
|
|
734,233
|
|||
Residential REITs - 15.7%
|
|||
American Homes 4 Rent Class A
|
3,229
|
111,820
|
|
Camden Property Trust
|
533
|
60,607
|
|
Elme Communities
|
1,692
|
25,820
|
|
Equity LifeStyle Properties Inc
|
453
|
29,649
|
|
Equity Residential
|
2,177
|
153,762
|
|
Flagship Communities REIT Class A
|
6,130
|
89,743
|
|
Invitation Homes Inc
|
2,535
|
78,965
|
|
Mid-America Apartment Communities Inc
|
416
|
63,473
|
|
Sun Communities Inc
|
1,149
|
145,349
|
|
UDR Inc
|
4,006
|
167,211
|
|
926,399
|
|||
Retail REITs - 11.3%
|
|||
Acadia Realty Trust
|
610
|
14,054
|
|
Curbline Properties Corp
|
1,555
|
38,051
|
|
FrontView REIT Inc
|
750
|
12,930
|
|
InvenTrust Properties Corp
|
420
|
12,491
|
|
Kimco Realty Corp
|
8,229
|
184,742
|
|
Macerich Co/The
|
2,378
|
49,415
|
|
NNN REIT Inc
|
3,848
|
151,573
|
|
Phillips Edison & Co Inc
|
995
|
36,148
|
|
Regency Centers Corp
|
756
|
54,311
|
|
SITE Centers Corp
|
1,038
|
15,549
|
|
Tanger Inc
|
917
|
30,096
|
|
Urban Edge Properties
|
3,501
|
71,210
|
|
670,570
|
|||
Specialized REITs - 15.4%
|
|||
CubeSmart
|
1,709
|
71,265
|
|
Digital Realty Trust Inc
|
1,070
|
175,330
|
|
Equinix Inc
|
435
|
397,443
|
|
Extra Space Storage Inc
|
275
|
42,350
|
|
Four Corners Property Trust Inc
|
1,336
|
36,646
|
|
Iron Mountain Inc
|
60
|
6,094
|
|
Public Storage Operating Co
|
631
|
188,341
|
|
917,469
|
|||
TOTAL UNITED STATES
|
3,767,406
|
||
|
TOTAL COMMON STOCKS
(Cost $5,235,316)
|
5,943,820
|
||
|
TOTAL INVESTMENT IN SECURITIES - 100.1%
(Cost $5,235,316)
|
5,943,820
|
NET OTHER ASSETS (LIABILITIES) - (0.1)%
|
(3,406)
|
NET ASSETS - 100.0%
|
5,940,414
|
(a)
|
Security is exempt from registration under Regulation S of the Securities Act of 1933 and may be resold to qualified foreign investors outside of the United States. At the end of the period, the value of securities amounted to $92,414 or 1.6% of net assets.
|
(b)
|
Non-income producing
|
(c)
|
Security or a portion of the security purchased on a delayed delivery or when-issued basis.
|
(d)
|
Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $39,244 or 0.7% of net assets.
|
Affiliate
|
Value,
beginning
of period ($)
|
Purchases ($)
|
Sales
Proceeds ($)
|
Dividend
Income ($)
|
Realized
Gain (loss) ($)
|
Change in
Unrealized
appreciation
(depreciation) ($)
|
Value,
end
of period ($)
|
Shares,
end
of period
|
% ownership,
end
of period
|
Fidelity Cash Central Fund
|
34,600
|
495,676
|
530,276
|
972
|
-
|
-
|
-
|
-
|
0.0%
|
Total
|
34,600
|
495,676
|
530,276
|
972
|
-
|
-
|
-
|
-
|
|
Valuation Inputs at Reporting Date:
|
||||
Description
|
Total ($)
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Investments in Securities:
|
||||
Common Stocks
|
||||
Consumer Discretionary
|
24,767
|
24,767
|
-
|
-
|
Real Estate
|
5,919,053
|
4,887,615
|
1,031,438
|
-
|
Total Investments in Securities:
|
5,943,820
|
4,912,382
|
1,031,438
|
-
|
Statement of Assets and Liabilities
|
||||
|
As of January 31, 2025 (Unaudited)
|
||||
Assets
|
||||
Investment in securities, at value - See accompanying schedule
Unaffiliated issuers (cost $5,235,316):
|
$
|
5,943,820
|
||
Foreign currency held at value (cost $60)
|
60
|
|||
Receivable for investments sold
|
103,310
|
|||
Receivable for fund shares sold
|
3,794
|
|||
Dividends receivable
|
16,943
|
|||
Distributions receivable from Fidelity Central Funds
|
50
|
|||
Prepaid expenses
|
5
|
|||
Receivable from investment adviser for expense reductions
|
5,674
|
|||
Other receivables
|
1,363
|
|||
Total assets
|
6,075,019
|
|||
Liabilities
|
||||
Payable to custodian bank
|
$
|
77,337
|
||
Payable for investments purchased
|
||||
Regular delivery
|
7,898
|
|||
Delayed delivery
|
2,166
|
|||
Accrued management fee
|
4,196
|
|||
Distribution and service plan fees payable
|
1,318
|
|||
Audit fee payable
|
35,218
|
|||
Other payables and accrued expenses
|
6,472
|
|||
Total liabilities
|
134,605
|
|||
Net Assets
|
$
|
5,940,414
|
||
Net Assets consist of:
|
||||
Paid in capital
|
$
|
5,999,249
|
||
Total accumulated earnings (loss)
|
(58,835)
|
|||
Net Assets
|
$
|
5,940,414
|
||
Net Asset Value and Maximum Offering Price
|
||||
Class A :
|
||||
Net Asset Value and redemption price per share ($2,845,291 ÷ 270,933 shares)(a)
|
$
|
10.50
|
||
Maximum offering price per share (100/94.25 of $10.50)
|
$
|
11.14
|
||
Class M :
|
||||
Net Asset Value and redemption price per share ($1,263,177 ÷ 120,504 shares)(a)
|
$
|
10.48
|
||
Maximum offering price per share (100/96.50 of $10.48)
|
$
|
10.86
|
||
Class C :
|
||||
Net Asset Value and offering price per share ($230,055 ÷ 21,835 shares)(a)
|
$
|
10.54
|
||
Class I :
|
||||
Net Asset Value, offering price and redemption price per share ($1,254,392 ÷ 119,401 shares)
|
$
|
10.51
|
||
Class Z :
|
||||
Net Asset Value, offering price and redemption price per share ($347,499 ÷ 32,792 shares)
|
$
|
10.60
|
||
(a)Redemption price per share is equal to net asset value less any applicable contingent deferred sales charge.
|
||||
Statement of Operations
|
||||
Six months ended January 31, 2025 (Unaudited)
|
||||
Investment Income
|
||||
Dividends
|
$
|
97,597
|
||
Income from Fidelity Central Funds
|
972
|
|||
Income before foreign taxes withheld
|
$
|
98,569
|
||
Less foreign taxes withheld
|
(4,319)
|
|||
Total income
|
94,250
|
|||
Expenses
|
||||
Management fee
|
$
|
26,718
|
||
Distribution and service plan fees
|
8,407
|
|||
Custodian fees and expenses
|
10,647
|
|||
Independent trustees' fees and expenses
|
14
|
|||
Registration fees
|
21,026
|
|||
Audit fees
|
30,868
|
|||
Legal
|
3
|
|||
Miscellaneous
|
11
|
|||
Total expenses before reductions
|
97,694
|
|||
Expense reductions
|
(59,907)
|
|||
Total expenses after reductions
|
37,787
|
|||
Net Investment income (loss)
|
56,463
|
|||
Realized and Unrealized Gain (Loss)
|
||||
Net realized gain (loss) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
112,449
|
|||
Foreign currency transactions
|
(505)
|
|||
Total net realized gain (loss)
|
111,944
|
|||
Change in net unrealized appreciation (depreciation) on:
|
||||
Investment Securities:
|
||||
Unaffiliated issuers
|
(236,229)
|
|||
Assets and liabilities in foreign currencies
|
179
|
|||
Total change in net unrealized appreciation (depreciation)
|
(236,050)
|
|||
Net gain (loss)
|
(124,106)
|
|||
Net increase (decrease) in net assets resulting from operations
|
$
|
(67,643)
|
||
Statement of Changes in Net Assets
|
||||
Six months ended
January 31, 2025
(Unaudited)
|
Year ended
July 31, 2024
|
|||
Increase (Decrease) in Net Assets
|
||||
Operations
|
||||
Net investment income (loss)
|
$
|
56,463
|
$
|
121,966
|
Net realized gain (loss)
|
111,944
|
49,985
|
||
Change in net unrealized appreciation (depreciation)
|
(236,050)
|
300,274
|
||
Net increase (decrease) in net assets resulting from operations
|
(67,643)
|
472,225
|
||
Distributions to shareholders
|
(143,531)
|
(127,792)
|
||
Share transactions - net increase (decrease)
|
124,242
|
445,205
|
||
Total increase (decrease) in net assets
|
(86,932)
|
789,638
|
||
Net Assets
|
||||
Beginning of period
|
6,027,346
|
5,237,708
|
||
End of period
|
$
|
5,940,414
|
$
|
6,027,346
|
Fidelity Advisor® Global Real Estate Fund Class A |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
10.86
|
$
|
10.21
|
$
|
11.18
|
$
|
12.49
|
$
|
9.69
|
$
|
10.72
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.10
|
.23
|
.23
|
.17
|
.17
|
.15
|
||||||
Net realized and unrealized gain (loss)
|
(.21)
|
.67
|
(1.11)
|
(1.33)
|
2.76
|
(.58)
|
||||||
Total from investment operations
|
(.11)
|
.90
|
(.88)
|
(1.16)
|
2.93
|
(.43)
|
||||||
Distributions from net investment income
|
(.25)
|
(.25)
|
(.09)
|
(.15)
|
(.13)
|
(.23)
|
||||||
Distributions from net realized gain
|
-
|
-
|
-
|
-
|
-
|
(.37)
|
||||||
Total distributions
|
(.25)
|
(.25)
|
(.09)
|
(.15)
|
(.13)
|
(.60)
|
||||||
Net asset value, end of period
|
$
|
10.50
|
$
|
10.86
|
$
|
10.21
|
$
|
11.18
|
$
|
12.49
|
$
|
9.69
|
Total Return C,D,E
|
(1.02) % |
8.88%
|
(7.81)%
|
(9.40)%
|
30.59%
|
(4.61)%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
3.09% H
|
4.06%
|
3.85%
|
3.19%
|
4.19%
|
4.22%
|
||||||
Expenses net of fee waivers, if any
|
1.20 % H |
1.20%
|
1.20%
|
1.28%
|
1.38%
|
1.40%
|
||||||
Expenses net of all reductions
|
1.18% H
|
1.19%
|
1.19%
|
1.28%
|
1.37%
|
1.39%
|
||||||
Net investment income (loss)
|
1.78% H
|
2.31%
|
2.31%
|
1.45%
|
1.60%
|
1.47%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
2,845
|
$
|
2,937
|
$
|
2,771
|
$
|
3,021
|
$
|
2,747
|
$
|
1,732
|
Portfolio turnover rate I
|
35 % H |
32%
|
84%
|
33%
|
32%
|
52%
|
Fidelity Advisor® Global Real Estate Fund Class M |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
10.83
|
$
|
10.19
|
$
|
11.16
|
$
|
12.46
|
$
|
9.67
|
$
|
10.71
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.09
|
.21
|
.20
|
.14
|
.14
|
.12
|
||||||
Net realized and unrealized gain (loss)
|
(.21)
|
.65
|
(1.11)
|
(1.31)
|
2.76
|
(.58)
|
||||||
Total from investment operations
|
(.12)
|
.86
|
(.91)
|
(1.17)
|
2.90
|
(.46)
|
||||||
Distributions from net investment income
|
(.23)
|
(.22)
|
(.06)
|
(.13)
|
(.11)
|
(.21)
|
||||||
Distributions from net realized gain
|
-
|
-
|
-
|
-
|
-
|
(.37)
|
||||||
Total distributions
|
(.23)
|
(.22)
|
(.06)
|
(.13)
|
(.11)
|
(.58)
|
||||||
Net asset value, end of period
|
$
|
10.48
|
$
|
10.83
|
$
|
10.19
|
$
|
11.16
|
$
|
12.46
|
$
|
9.67
|
Total Return C,D,E
|
(1.14) % |
8.56%
|
(8.09)%
|
(9.51)%
|
30.20%
|
(4.87)%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
3.34% H
|
4.39%
|
4.03%
|
3.39%
|
4.41%
|
4.46%
|
||||||
Expenses net of fee waivers, if any
|
1.45 % H |
1.45%
|
1.45%
|
1.52%
|
1.63%
|
1.66%
|
||||||
Expenses net of all reductions
|
1.43% H
|
1.44%
|
1.45%
|
1.52%
|
1.62%
|
1.64%
|
||||||
Net investment income (loss)
|
1.53% H
|
2.06%
|
2.05%
|
1.21%
|
1.35%
|
1.22%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
1,263
|
$
|
1,271
|
$
|
918
|
$
|
1,070
|
$
|
876
|
$
|
658
|
Portfolio turnover rate I
|
35 % H |
32%
|
84%
|
33%
|
32%
|
52%
|
Fidelity Advisor® Global Real Estate Fund Class C |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
10.84
|
$
|
10.21
|
$
|
11.17
|
$
|
12.47
|
$
|
9.63
|
$
|
10.63
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.06
|
.16
|
.16
|
.09
|
.09
|
.07
|
||||||
Net realized and unrealized gain (loss)
|
(.21)
|
.66
|
(1.11)
|
(1.33)
|
2.75
|
(.58)
|
||||||
Total from investment operations
|
(.15)
|
.82
|
(.95)
|
(1.24)
|
2.84
|
(.51)
|
||||||
Distributions from net investment income
|
(.15)
|
(.19)
|
(.01)
|
(.06)
|
-
|
(.12)
|
||||||
Distributions from net realized gain
|
-
|
-
|
-
|
-
|
-
|
(.37)
|
||||||
Total distributions
|
(.15)
|
(.19)
|
(.01)
|
(.06)
|
-
|
(.49)
|
||||||
Net asset value, end of period
|
$
|
10.54
|
$
|
10.84
|
$
|
10.21
|
$
|
11.17
|
$
|
12.47
|
$
|
9.63
|
Total Return C,D,E
|
(1.36) % |
8.06%
|
(8.53)%
|
(9.97)%
|
29.49%
|
(5.31)%
|
||||||
Ratios to Average Net Assets B,F,G
|
||||||||||||
Expenses before reductions
|
3.81% H
|
4.78%
|
4.59%
|
3.93%
|
5.02%
|
4.46%
|
||||||
Expenses net of fee waivers, if any
|
1.95 % H |
1.95%
|
1.94%
|
2.02%
|
2.14%
|
2.16%
|
||||||
Expenses net of all reductions
|
1.94% H
|
1.94%
|
1.93%
|
2.02%
|
2.13%
|
2.15%
|
||||||
Net investment income (loss)
|
1.03% H
|
1.56%
|
1.57%
|
.72%
|
.85%
|
.71%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
230
|
$
|
271
|
$
|
193
|
$
|
203
|
$
|
223
|
$
|
185
|
Portfolio turnover rate I
|
35 % H |
32%
|
84%
|
33%
|
32%
|
52%
|
Fidelity Advisor® Global Real Estate Fund Class I |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
10.89
|
$
|
10.23
|
$
|
11.21
|
$
|
12.51
|
$
|
9.71
|
$
|
10.75
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.11
|
.26
|
.25
|
.20
|
.20
|
.17
|
||||||
Net realized and unrealized gain (loss)
|
(.21)
|
.67
|
(1.11)
|
(1.32)
|
2.76
|
(.58)
|
||||||
Total from investment operations
|
(.10)
|
.93
|
(.86)
|
(1.12)
|
2.96
|
(.41)
|
||||||
Distributions from net investment income
|
(.28)
|
(.27)
|
(.12)
|
(.18)
|
(.16)
|
(.26)
|
||||||
Distributions from net realized gain
|
-
|
-
|
-
|
-
|
-
|
(.37)
|
||||||
Total distributions
|
(.28)
|
(.27)
|
(.12)
|
(.18)
|
(.16)
|
(.63)
|
||||||
Net asset value, end of period
|
$
|
10.51
|
$
|
10.89
|
$
|
10.23
|
$
|
11.21
|
$
|
12.51
|
$
|
9.71
|
Total Return C,D
|
(.88) % |
9.22%
|
(7.61)%
|
(9.12)%
|
30.82%
|
(4.40)%
|
||||||
Ratios to Average Net Assets B,E,F
|
||||||||||||
Expenses before reductions
|
2.77% G
|
3.75%
|
3.31%
|
2.94%
|
3.81%
|
3.97%
|
||||||
Expenses net of fee waivers, if any
|
.95 % G |
.95%
|
.95%
|
1.02%
|
1.13%
|
1.16%
|
||||||
Expenses net of all reductions
|
.93% G
|
.94%
|
.95%
|
1.02%
|
1.12%
|
1.14%
|
||||||
Net investment income (loss)
|
2.03% G
|
2.56%
|
2.55%
|
1.71%
|
1.85%
|
1.71%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
1,254
|
$
|
1,191
|
$
|
1,162
|
$
|
1,766
|
$
|
1,483
|
$
|
1,066
|
Portfolio turnover rate H
|
35 % G |
32%
|
84%
|
33%
|
32%
|
52%
|
Fidelity Advisor® Global Real Estate Fund Class Z |
Six months ended
(Unaudited) January 31, 2025
|
Years ended July 31, 2024
|
2023
|
2022
|
2021
|
2020
|
|||||||
Selected Per-Share Data
|
||||||||||||
Net asset value, beginning of period
|
$
|
10.99
|
$
|
10.31
|
$
|
11.28
|
$
|
12.56
|
$
|
9.73
|
$
|
10.76
|
Income from Investment Operations
|
||||||||||||
Net investment income (loss) A,B
|
.12
|
.27
|
.28
|
.22
|
.22
|
.19
|
||||||
Net realized and unrealized gain (loss)
|
(.21)
|
.68
|
(1.13)
|
(1.32)
|
2.77
|
(.59)
|
||||||
Total from investment operations
|
(.09)
|
.95
|
(.85)
|
(1.10)
|
2.99
|
(.40)
|
||||||
Distributions from net investment income
|
(.30)
|
(.27)
|
(.12)
|
(.18)
|
(.16)
|
(.26)
|
||||||
Distributions from net realized gain
|
-
|
-
|
-
|
-
|
-
|
(.37)
|
||||||
Total distributions
|
(.30)
|
(.27)
|
(.12)
|
(.18)
|
(.16)
|
(.63)
|
||||||
Net asset value, end of period
|
$
|
10.60
|
$
|
10.99
|
$
|
10.31
|
$
|
11.28
|
$
|
12.56
|
$
|
9.73
|
Total Return C,D
|
(.84) % |
9.34%
|
(7.48)%
|
(8.93)%
|
31.07%
|
(4.29)%
|
||||||
Ratios to Average Net Assets B,E,F
|
||||||||||||
Expenses before reductions
|
2.64% G
|
3.61%
|
3.38%
|
2.71%
|
3.72%
|
3.54%
|
||||||
Expenses net of fee waivers, if any
|
.80 % G |
.80%
|
.80%
|
.89%
|
.97%
|
1.02%
|
||||||
Expenses net of all reductions
|
.78% G
|
.79%
|
.80%
|
.89%
|
.96%
|
1.00%
|
||||||
Net investment income (loss)
|
2.18% G
|
2.71%
|
2.70%
|
1.84%
|
2.01%
|
1.86%
|
||||||
Supplemental Data
|
||||||||||||
Net assets, end of period (000 omitted)
|
$
|
347
|
$
|
358
|
$
|
194
|
$
|
1,303
|
$
|
1,180
|
$
|
233
|
Portfolio turnover rate H
|
35 % G |
32%
|
84%
|
33%
|
32%
|
52%
|
Fidelity Central Fund
|
Investment Manager
|
Investment Objective
|
Investment Practices
|
Expense RatioA
|
Fidelity Money Market Central Funds
|
Fidelity Management & Research Company LLC (FMR)
|
Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity.
|
Short-term Investments
|
Less than .005%
|
Gross unrealized appreciation
|
$1,024,614
|
Gross unrealized depreciation
|
(366,657)
|
Net unrealized appreciation (depreciation)
|
$657,957
|
Tax cost
|
$5,285,863
|
Short-term
|
$(527,079)
|
Long-term
|
(289,534)
|
Total capital loss carryforward
|
$(816,613)
|
Purchases ($)
|
Sales ($)
|
|
Fidelity Advisor Global Real Estate Fund
|
1,256,571
|
1,104,254
|
Maximum Management Fee Rate %
|
|
Class A
|
.87
|
Class M
|
.87
|
Class C
|
.87
|
Class I
|
.80
|
Class Z
|
.71
|
Total Management Fee Rate %
|
|
Class A
|
.86
|
Class M
|
.86
|
Class C
|
.86
|
Class I
|
.80
|
Class Z
|
.71
|
Distribution Fee
|
Service Fee
|
Total Fees ($)
|
Retained by FDC ($)
|
|
Class A
|
- %
|
.25%
|
3,799
|
1,536
|
Class M
|
.25%
|
.25%
|
3,288
|
1,514
|
Class C
|
.75%
|
.25%
|
1,320
|
226
|
8,407
|
3,276
|
Retained by FDC ($)
|
|
Class A
|
274
|
Class M
|
31
|
Class CA
|
3
|
308
|
Amount ($)
|
|
Fidelity Advisor Global Real Estate Fund
|
38
|
Purchases ($)
|
Sales ($)
|
Realized Gain (Loss) ($)
|
|
Fidelity Advisor Global Real Estate Fund
|
37,280
|
55,147
|
6,067
|
Amount ($)
|
|
Fidelity Advisor Global Real Estate Fund
|
4
|
Expense Limitations
|
Reimbursement ($)
|
|
Class A
|
1.20%
|
28,707
|
Class M
|
1.45%
|
12,422
|
Class C
|
1.95%
|
2,456
|
Class I
|
.95%
|
12,142
|
Class Z
|
.80%
|
3,661
|
59,388
|
Six months ended
January 31, 2025
|
Year ended
July 31, 2024
|
|
Fidelity Advisor Global Real Estate Fund
|
||
Distributions to shareholders
|
||
Class A
|
$68,341
|
$65,583
|
Class M
|
26,507
|
20,354
|
Class C
|
3,544
|
4,497
|
Class I
|
33,619
|
28,380
|
Class Z
|
11,520
|
8,978
|
Total
|
$143,531
|
$127,792
|
Shares
|
Shares
|
Dollars
|
Dollars
|
|
Six months ended
January 31, 2025
|
Year ended
July 31, 2024
|
Six months ended
January 31, 2025
|
Year ended
July 31, 2024
|
|
Fidelity Advisor Global Real Estate Fund
|
||||
Class A
|
||||
Shares sold
|
20,591
|
25,269
|
$226,792
|
$253,147
|
Reinvestment of distributions
|
6,546
|
6,294
|
68,338
|
65,581
|
Shares redeemed
|
(26,574)
|
(32,550)
|
(287,398)
|
(322,865)
|
Net increase (decrease)
|
563
|
(987)
|
$7,732
|
$(4,137)
|
Class M
|
||||
Shares sold
|
2,521
|
36,978
|
$27,644
|
$377,014
|
Reinvestment of distributions
|
2,541
|
1,957
|
26,507
|
20,354
|
Shares redeemed
|
(1,838)
|
(11,751)
|
(19,990)
|
(115,045)
|
Net increase (decrease)
|
3,224
|
27,184
|
$34,161
|
$282,323
|
Class C
|
||||
Shares sold
|
1,203
|
11,367
|
$13,520
|
$113,511
|
Reinvestment of distributions
|
338
|
431
|
3,544
|
4,497
|
Shares redeemed
|
(4,680)
|
(5,682)
|
(52,434)
|
(56,703)
|
Net increase (decrease)
|
(3,139)
|
6,116
|
$(35,370)
|
$61,305
|
Class I
|
||||
Shares sold
|
14,553
|
10,965
|
$161,155
|
$111,722
|
Reinvestment of distributions
|
3,174
|
2,677
|
33,141
|
27,921
|
Shares redeemed
|
(7,704)
|
(17,818)
|
(83,876)
|
(169,830)
|
Net increase (decrease)
|
10,023
|
(4,176)
|
$110,420
|
$(30,187)
|
Class Z
|
||||
Shares sold
|
7,062
|
17,973
|
$79,608
|
$179,119
|
Reinvestment of distributions
|
795
|
577
|
8,367
|
6,068
|
Shares redeemed
|
(7,612)
|
(4,792)
|
(80,676)
|
(49,286)
|
Net increase (decrease)
|
245
|
13,758
|
$7,299
|
$135,901
|
Fund
|
Affiliated %
|
Fidelity Advisor Global Real Estate Fund
|
44%
|
![]() |
Item 8.
Changes in and Disagreements with Accountants for Open-End Management Investment Companies
See Item 7.
Item 9.
Proxy Disclosures for Open-End Management Investment Companies
See Item 7.
Item 10.
Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies
See Item 7.
Item 11.
Statement Regarding Basis for Approval of Investment Advisory Contract
See Item 7.
Item 12.
Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies
Not applicable.
Item 13.
Portfolio Managers of Closed-End Management Investment Companies
Not applicable.
Item 14.
Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers
Not applicable.
Item 15.
Submission of Matters to a Vote of Security Holders
There were no material changes to the procedures by which shareholders may recommend nominees to the Fidelity Advisor Series VIIs Board of Trustees.
Item 16.
Controls and Procedures
(a)(i) The President and Treasurer and the Chief Financial Officer have concluded that the Fidelity Advisor Series VIIs (the Trust) disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act) provide reasonable assurances that material information relating to the Trust is made known to them by the appropriate persons, based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report.
(a)(ii) There was no change in the Trusts internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Trusts internal control over financial reporting.
Item 17.
Disclosure of Securities Lending Activities for Closed-End Management Investment Companies
Not applicable.
Item 18.
Recovery of Erroneously Awarded Compensation
(a)
Not applicable.
(b)
Not applicable.
Item 19.
Exhibits
| (a) | (1) | Not applicable. |
| (a) | (2) | |
| (a) | (3) | Not applicable. |
| (b) | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Fidelity Advisor Series VII
| By: | /s/Stacie M. Smith |
| | Stacie M. Smith |
| | President and Treasurer (Principal Executive Officer) |
| | |
| Date: | March 25, 2025 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| By: | /s/Stacie M. Smith |
| | Stacie M. Smith |
| | President and Treasurer (Principal Executive Officer) |
| | |
| Date: | March 25, 2025 |
| By: | /s/Stephanie Caron |
| | Stephanie Caron |
| | Chief Financial Officer (Principal Financial Officer) |
| | |
| Date: | March 25, 2025 |